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Abstract 
As rising levels of antibiotic resistance limit treatment options against bacterial 
infections, phage therapy offers a promising alternative. However, as bacteria and 
phage have co-evolved for millennia within natural microbial communities, where 
lytic phages naturally regulate bacterial density, a diverse set of phage resistance 
mechanisms exist. Here, I explore how the structure of bacteria-phage 
communities influences the evolution of phage resistance, and how the 
evolutionary principles which shape these communities may be exploited to 
improve the rational design of phage therapeutics. Using network analysis to 
assess how environmental conditions influence the structure of bacteria-phage 
communities, I showed that imbalances in selection pressure can destabilise 
bacteria-phage communities and drive phage to extinction. The community 
structure of microbial communities is underpinned by extensive gene-gene 
interactions between multiple pairs of co-evolving species. By determining the 
breadth of cross-resistance individual resistance mutations can promote, I 
characterised how cross-resistance can structure a collection of phage strains, 
and how these interactions determine the evolution of multiple resistances. 
Further, I characterised how this could be exploited to limit the evolution of 
resistance against phage cocktails, revealing that the evolution of multi-phage 
resistances are influenced by the order of phage exposure, such that sequential 
exposure promotes accumulation of multiple strong phage-specific resistances 
whereas simultaneous exposure to phage pairs promotes weaker resistances. 
Finally, by comparing the efficacy of phage combinations of increasing diversity, 
I assessed the relative contributions of phage diversity, functional diversity and 
cross-resistance structure on the efficacy of phage cocktails. This revealed that 
functionally diverse phage combinations (i.e. those targeting multiple adsorption 
receptors) make more effective phage cocktails. These results provide insight into 
the fundamental evolutionary processes which determine the efficacy of phage 
cocktails, revealing simple concepts which may be implemented to simplify the 
rational design of therapeutic phage treatments, such as the maximisation of 
functional diversity.  
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Chapter One 
Introduction 
 
Bacterial communities are ubiquitous across a wide range of natural ecosystems, 
from deep sea hydrothermal vents to soils, and play a fundamental role in 
ecological and evolutionary processes in all of these locations (DeLong et al., 
2001; Fuhrman, 1999; Wilhelm and Suttle, 1999). Wherever bacteria exist it is 
likely that abundant and diverse communities of viral parasites of bacteria, 
bacteriophages, often abbreviated to phages, will co-occur. Phages are viruses 
that parasitise bacterial cells, hijacking their cellular machinery and reproduce 
(Weinbauer, 2004). This process results in lysis of the bacterial host. Therefore, 
phage are believed to play an important role in the regulation of bacterial 
populations, and consequently the composition of bacterial communities, whilst 
cell lysis also results in the release of nutrients (Weinbauer, 2004; Weinbauer and 
Rassoulzadegan, 2004). Hence, phage are considered key global regulators of 
carbon and nutrient cycling across both aquatic and terrestrial environments 
(Weinbauer and Rassoulzadegan, 2004; Wilhelm and Suttle, 1999).  
Since phage were first discovered in the early 20th century (Duckworth, 1976; 
d’Herelle, 1917), it has been proposed that their bactericidal actions could be 
harnessed to treat bacterial infections, a treatment termed phage therapy 
(Carlton, 1999). Indeed, in many parts of Eastern Europe phage therapy has been 
used successfully for many years, however, the discovery of Penicillin less than 
15 years after the discovery of phages meant that researchers in the western 
hemisphere largely ignored this research and phage therapy was not adopted 
(Levin and Bull, 2004). With rising rates of antibiotic resistance worldwide and 
greater understand of the propensity for bacteria to develop resistance by de novo 
mutation or horizontal gene transfer, new antimicrobial treatments are urgently 
required that can be used to combat drug resistant infections (World Health 
Organisation, 2014). Like antibiotics, bacteria can easily evolve resistance to 
phage attack, and, therefore, to maximise the potential benefits and durability of 
phage therapy a better understanding of the fundamental ecological and 
evolutionary processes that determine the efficacy of phage therapies is required.  
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Here, I examine the evolutionary principles governing phage resistance evolution 
in bacteria that structure natural communities and determine co-existence 
between bacteria and phage, towards developing an evolutionary framework to 
aid the rational design of phage therapy cocktails.  
1.1 Perpetual evolution can be driven by biotic interactions 
1.1.1 Antagonistic coevolution within bacteria-phage interactions 
Infection of bacterial cells is an essential stage in the life cycle of phage, and 
hence links the evolutionary fate of phage to their bacterial host species through 
a process of antagonistic coevolution: Phage infection selects for bacterial 
adaptations which promote phage resistance, so phage must counter-adapt to 
maintain infectivity and continue to replicate, leading to continual cycles of 
adaptation and counter-adaptation. This follows the Red Queen hypothesis of 
coevolution (Van Valen, 1973) where biotic conflicts drive perpetual evolution of 
interacting species. 
There are two main theories which describe the dynamics of antagonistic 
coevolution, these are not mutually exclusive and the prominent mode may be 
determined by the associated fitness costs within the local ecological context 
(Brockhurst et al., 2014). Arms race dynamics (ARD; Gandon et al., 2008), also 
known as Escalatory Red Queen (ERQ; Brockhurst et al., 2014), is driven by 
directional selection for increasingly resistant hosts and increasingly infectious 
parasites over time, in which novel mechanisms of phage infectivity or host 
resistance emerge and accumulate, being driven to fixation by recurrent selective 
sweeps (Lenski and Levin, 1985). In contrast, fluctuating selection dynamics 
(FSD; Gandon et al., 2008), also known as Fluctuating Red Queen (FRQ; 
Brockhurst et al., 2014), is driven by negative frequency-dependent selection 
whereby common host genotypes are targeted by phage infection and selected 
against, leading to an increased frequency of rarer host genotypes which 
eventually become the most common, and so the cycle repeats (Levin et al., 
1988).  
1.1.2 What are the costs of perpetual antagonistic coevolution? 
Both dynamic models have been identified in experimental pairwise bacteria-
phage systems using Pseudomonas fluorescens SBW25 with the associated 
phage Ф2. Perpetual ARD results in directional selection and is therefore limited 
by the potential number of novel mutations which can arise and the impact of 
accumulating fitness costs (Buckling and Rainey, 2002; Hall et al., 2011a). As a 
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result, after several hundreds of generations of coevolution a switch to FSD is 
observed (Hall et al., 2011b). FSD removes the directional pressure for additional 
novel mutations and associated costs, making FSD more sustainable over time 
and in stressful environments where the fitness costs of ARD are magnified. 
Therefore, whilst novel interactions often result in strong directional selection on 
both species promoting an ARD period, persistent antagonistic coevolution 
appears to be maintained by switching to FSD. Thereafter bouts of ARD could 
occur in response to changes in environmental conditions or due to additional 
biotic interactions (Brockhurst et al., 2014).  
Long term FSD promotes diversity within populations because genetic diversity 
is not purged by selective sweeps (Harrison et al., 2013; Lopez Pascua et al., 
2014). Increased host diversity supports broader genetic polymorphism of 
resistance phenotypes which could in turn protect the population upon 
encountering new phage genotypes (Lively, 2010). Diversity can also be 
sustained in ARD coevolution, provided the cost of resistance is high enough that 
susceptible bacteria retain a fitness advantage (Sasaki, 2000). This diversity can 
result in compartmentalised specificity (Bascompte, 2010), allowing long-term 
bacteria-phage coexistence even if highly resistant bacterial genotypes emerge. 
1.1.3 The local environmental context determines co-evolutionary dynamics 
The Red Queen principle states that biotic factors are sufficient to drive perpetual 
evolution, however, this does not preclude evolutionary responses to abiotic 
factors. Nutrient availability can constrain evolutionary dynamics by limiting 
population sizes, and hence, limiting the genetic variation available to selection 
(Kassen et al., 2000). Therefore, whilst ARD seem prevalent in high quality 
environments, such as in nutrient rich media (Lopez Pascua et al., 2014) a switch 
to FSD has been observed in lower quality environments, such as experimental 
soil microcosms (Gómez and Buckling, 2011). Variation in nutrient availability 
may also limit ARD, by impeding the selective sweeps characteristic of 
coevolution driven by directional selection (Harrison et al., 2013). Environments 
which impose higher stress on one partner in the co-evolutionary relationship are 
likely to imbalance co-evolutionary dynamics and can result in extinction of one 
partner. For example, increasing temperatures impose stronger environmental 
stress on the phage than on the bacterial host, and therefore although the phage 
can survive if the bacteria is held in evolutionary stasis, when they are forced to 
co-evolve, the phage is driven to extinction (Zhang and Buckling, 2011). At the 
individual level, phage resistance is often associated with fitness costs, such as 
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reduced ability to utilise nutrients (Middelboe et al., 2009), and hence there are 
trade-offs between phage resistance (biotic factors) and adaptation to the local 
environment (abiotic factors) (Bohannan et al., 2002). Pleiotropic effects 
associated with resistance mutations can reduce the potential for the host to 
adapt to environmental changes (Scanlan et al., 2015a), especially in 
environments where the expression of many diverse traits is necessary.  
Spatial heterogeneity of abiotic factors, such as resource levels, or of biotic 
factors, such as community composition can influence the mode and rate of 
coevolution across a landscape. Antagonistic coevolution accelerates molecular 
evolution (Paterson et al., 2010) and hence, minor changes which result in 
variation in the rate of coevolution can result in localised differences within 
communities (Lopez-Pascua and Buckling, 2008; Vogwill et al., 2009). Bacteria-
phage coevolution may be reduced in static conditions due to decreased 
dispersal and lower encounter rates (Brockhurst et al., 2006), promoting FSD 
(Brockhurst et al., 2004). Further, population structure can develop in static 
conditions to create spatial refuges, such as wall dwelling sub-populations 
(Schrag and Mittler, 1996), which may promote co-existence as phage-free 
refuges maintain host diversity and allow maintenance of a susceptible host sub-
populations. On the other hand, population mixing increases the rate of dispersal 
within an environment can enhance the encounter rate between hosts and 
parasites (Haraguchi and Sasaki, 2000), imposing stronger selection for 
resistance and thus accelerating the rate of coevolution and promoting ARD 
(Brockhurst et al., 2003, 2004). Interestingly, a shift from FSD to ARD was 
observed with increased population mixing in soil microcosms (Gómez et al., 
2015a), indicating that even in low resource environments, the effect of mixing 
can substantially alter coevolutionary dynamics by altering the balance of the 
cost:benefit ratio of resistance. 
1.2 Phage classification and biodiversity 
1.2.1 Morphological diversity of phages 
Phages can be classified by morphology, describing their component nucleic acid 
and the structural proteins surrounding this which form a protective capsid. 
Phages may contain DNA or RNA (either single or double stranded), with 
genomes ranging from only a few kb to examples of giant phages with large 
genomes of up to 300kb (Hertveldt et al., 2005). The phage genome is protected 
from the environment by protein structures built of repeating subunits; these often 
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form an icosahedral capsid, but can also form rod-like structures known as 
filamentous phages (Figure 1.1B).  
Tailed phages, known collectively as Caudovirales, represent approximately 96% 
of known phages (Figure 1.1B; Ackermann, 2007). The phage tail is a complex 
multi-unit structure which is involved in attachment and entry into the host cell, 
and in the case of Myoviridae, the tail is covered in a contractile sheath which 
acts in a syringe-like mechanism to inject phage DNA into the host cell (Fokine 
and Rossmann, 2014).  
Figure 1.1 The life cycle and morphological classification of phages 
Lytic versus lysogenic life cycles (A) and morphological diversity of phages (B) 
Source: Ofir and Sorek, 2018 
1.2.2 Phage life cycles  
The life cycle of a phage determines how it interacts with a bacterial host, and 
can determine the influence of evolutionary interactions. Whilst some phages are 
strictly lytic (i.e. replicate and lyse the bacterial cell to release progeny; Figure 
1.1A), other phages are able to adopt an alternative life cycle, termed lysogeny, 
where the phage DNA is incorporated within the host genome (Clokie et al., 
2011). This lifestyle decision enables phage to minimise the risk of extinction if 
the chance of replication of reduced, for example, if there are multiple phage co-
infecting one cell (Ofir and Sorek, 2018). Further, lysogeny can act as a bacterial 
regulatory switch, by disrupting bacterial gene expression at the insertion site, 
and relieving repression upon induction of phage replication (Ofir and Sorek, 
2018). In contrast,  filamentous phages (Inovirus, Figure 1B) are able to replicate 
without cell lysis as viral progeny is extruded from the bacterial cell (Ceyssens 
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and Lavigne, 2010). Phage therapies therefore advocate the use of strictly lytic 
phages.     
1.2.3 Host ranges and other characteristics 
The nature of host attachment by recognition of cell surface receptors means that 
phages are often highly specialised to infect specific bacterial species, or even 
subsets of strains within a single bacterial species. However, there are examples 
of broad host range phages which can infect multiple bacterial species (Jensen 
et al., 1998), and of plasticity promoting expansion of host range (Ross et al., 
2016). The global distribution of highly specialised phages may therefore by 
limited by the host distribution, and hence by host permissible environmental 
conditions. A global survey of phages infecting Pseudomonas aeruginosa, a 
ubiquitous bacterial species found in a diverse environments ranging from soil 
and aquatic ecosystems to human bacterial infections, found 15 novel and 
genetically distinct phages, with diverse morphological characteristics and 
genome sizes, yet highly overlapping host ranges (Ceyssens et al., 2009). 
However, high levels of phage diversity can also occur within local geographical 
scales; a set of 83 phages isolated from the same urban sewage sample 
displayed variation in their tolerance to various stressors including pH, extremely 
high or low temperatures, organic solvents and detergents (Jurczak-Kurek et al., 
2016).  
1.3 Phage resistance mechanisms and counter-defence strategies 
1.3.1 The genetic basis of constitutive phage resistance 
The most basic form of resistance to phage infection is to prevent attachment to 
the bacterial cell by modifying cell-surface receptors to which phage adsorb 
(Bertozzi Silva et al., 2016; Rakhuba et al., 2010). Single nucleotide 
polymorphisms can sufficiently modify cell-surface receptors to prevent phage 
infection, and even provide cross-resistance to other phages targeting the same 
receptor (Betts et al., 2016a, 2018; Chan et al., 2016; Gurney et al., 2017). 
However, environmental context may modulate the degree of evolved surface 
modification, as complete receptor loss may impose much higher fitness costs 
with more complex environments, due to pleiotropic effects limiting nutrient 
acquisition, motility, and many other expressed traits (Bohannan et al., 2002; 
Cornforth et al., 2018; Scanlan et al., 2015a; Skurnik et al., 2013). Common 
phage adsorb targets include the Type IV pili, lipopolysaccharide (LPS) and TonB 
(Bertozzi Silva et al., 2016; Betts et al., 2016a, 2018), modification of which can 
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prevent twitching motility (Type IV pilus; Burrows, 2012), affect bacterial virulence 
(Type IV pilus and LPS; Cryz et al., 1984; Hahn, 1997; Lam et al., 2011), and 
prevent uptake of iron-siderophore complexes (TonB; Poole et al., 1996). 
Therefore alternative methods of modifying receptors, such as glycosylation, may 
be favoured to limit cost to the host (Harvey et al., 2018). Phage may counter-
adapt to overcome surface modification by acquiring mutations in genes 
associated with host attachment, which also provides an evolutionary mechanism 
for host range expansion (Duffy et al., 2006). A more generalist mechanism of 
phage defence is the production of exopolysaccharides to mask cell-surface 
receptors (Labrie et al., 2010; Scanlan and Buckling, 2012). Whilst this 
mechanism can prove costly to the host (i.e. through investment in 
exopolysaccharide production), this type of defence mechanism can provide 
cross-resistance to other phages and antibiotics, and even protect bacteria from 
the host immune system (Hentzer et al., 2001; Leid et al., 2005). However, 
inevitably, phage counter-defence mechanisms do exist in the form of lytic 
enzymes which can degrade extracellular matrix (Davidson et al., 1977; Hanlon 
et al., 2001).  
Restriction modification (RM) systems provide active phage defence and act by 
recognising and degrading foreign DNA, therefore they can provide a generalist 
mechanism of defence against phages and other mobile DNA. Host DNA is 
modified to prevent recognition by degradation complexes (Stern and Sorek, 
2011), and as such is energetically costly. Even so, RM defence mechanisms are 
not infallible; if phage DNA is not degraded before the host enters a reproductive 
cycle, the phage DNA will be modified along with the host DNA, resulting in 
production of phage viruses which are able to avoid this resistance mechanism 
(Sneppen et al., 2015). Active phage counter-adaptation has also been identified 
ranging from DNA modification to avoid detection to more complex mechanisms 
such as co-injection of binding proteins along with phage DNA which sequester 
the restriction enzymes (Samson et al., 2013).  
1.3.2   Inducible resistance mechanisms and adaptive immunity 
Phage DNA can also be recognised and degraded by CRISPR-Cas systems 
(clustered regularly interspaced short palindromic repeats), which provide the 
bacterial host with adaptive immunity against phages and other mobile DNA 
(Horvath and Barrangou, 2010). CRISPR-based defence works by building up a 
library of fragments of foreign DNA within the CRISPR array, a process known as 
‘spacer acquisition’, which are transcribed to produce short guide RNAs which 
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direct the CRISPR-cas complex to cleave matching DNA within the cell, thereby 
degrading invasive phage DNA (Barrangou et al., 2007; Marraffini, 2015). Thus, 
a bacterial host may acquire a diverse spacer library, providing adaptive immunity 
against a broad range of phages. Expression of this mechanism of phage defence 
is costly, but these costs are limited if expression is only induced upon phage 
infection (Westra et al., 2015). High nutrient levels can sustain constitutive 
expression of phage resistance mechanisms, whereas in low resource 
environments inducible mechanisms may limit unnecessary expenditure of 
energy if phage are not present (Westra et al., 2015). Phage can overcome 
CRISPR recognition by simple single point mutations to escape recognition by 
the spacer (Deveau et al., 2008). Active phage counter-defence mechanisms 
have also been identified, including the production of anti-CRISPR proteins which 
can inhibit DNA-binding and even modulate CRISPR activity to promote 
transcriptional repression (Bondy-Denomy et al., 2015).  
Abortive infection (Abi) systems offer a last-ditch line of defence against phage 
infection for the bacterial population: programmed cell death can be triggered by 
phage components recognised within the bacterial cell resulting in cellular suicide 
of infected cells via a toxin-antitoxin mechanism (Dy et al., 2014). This limits 
phage reproduction and therefore protects the remaining susceptible bacterial 
population from phage infection. Phage mechanisms exist to defeat Abi 
mechanisms, and include production of phage anti-toxin molecules which bind 
the bacterial toxin component to prevent cell death (Samson et al., 2013).  
1.3.3 Novel anti-phage defence mechanisms 
Whilst the mechanistic basis of some phage resistance mechanisms are 
becoming well characterised (e.g., the RM and CRISPR-Cas systems), it is 
predicted that many mechanisms of phage resistance remain to be discovered 
(Koonin et al., 2017). For example, a potentially novel mechanism of resistance, 
termed BREX (‘Bacteriophage Exclusion’), was recently discovered. Unlike the 
RM and CRISPR-Cas systems, BREX does not appear to work via cleavage or 
degradation of phage DNA, but rather blocks the replication of phage DNA 
(Goldfarb et al., 2015). Searching for new phage defence systems clustered 
nearby to known systems in bacterial genomes recently led to the identification 
of nine new mechanisms of anti-phage defence, and an additional anti-plasmid 
system (Doron et al., 2018). Clustering of phage defence systems on genomic 
islands may promote horizontal gene transfer, for example, the presence of RM 
systems correlates with high rates of genetic exchange (Koonin et al., 2017; 
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Oliveira et al., 2016), and many Abi systems are encoded on plasmids (Hoskisson 
and Smith, 2007; O’Driscoll et al., 2006). The wide taxonomic prevalence of 
CRISPR, with up to ~40% of bacterial genomes and ~ 90% of archea containing 
CRISPR-like DNA repeats (Horvath and Barrangou, 2010), and on-going 
discovery of new phage defence mechanisms [e.g. BREX is present in ~10% of 
bacterial genomes (Goldfarb et al., 2015)], indicates an ancient origin of these 
mechanisms of phage resistance.  
1.4 Network analysis as a tool to study evolutionary interactions 
1.4.1 Bacteria-phage infection networks 
The evolutionary trajectory of each member of a complex community is likely to 
be influenced by ecological interactions with other species (Barraclough, 2015). 
These interactions can be characterised using bipartite bacteria phage infection 
networks (BPINs), which are often visualised as a 2-dimensional matrix, where 
bacteria are represented on one axis, and phage on the other (Figure 1.2). These 
networks may contain quantitative information, such as the frequency or strength 
of observed interactions. Key network properties include connectance (i.e. the 
proportion of interactions which are realised), nestedness and modularity, which 
describe the population level structure of interactions, and robustness, which 
calculates the stability of the network in response to sequential loss of members 
(Dormann et al., 2008, 2009). The network structure provides information about 
the range of interactions and co-evolutionary dynamics which have shaped the 
bacteria-phage community, for example modularity describes the specialisation 
of the network. At one extreme end, each bacteria and phage have a specialised 
interaction (Figure 1.2: one-to-one), but more commonly this would resolve as 
modules of specialised interactions (Figure 1.2: modular) (Beckett, 2015; Weitz 
et al., 2013). Nested networks display a hierarchy of phage host range (i.e. 
specialist to generalist) on one axis and a hierarchy of bacterial resistance range 
on the other (Figure 1.2: nested) (Beckett, 2015; Weitz et al., 2013). Although 
nested-modular networks have been predicted in nature (Beckett and Williams, 
2013), a comprehensive meta-analysis of 38 bacteria-phage studies, revealed 
that nested structures predominate (Flores et al., 2011).  
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Figure 1.2 Characterising the network structure of bacteria-phage infection 
networks 
Each matrix indicates a different potential structure of a bacteria-phage 
community. Each column designates one phage strain, and the coloured boxes 
indicate host range as the number of different bacteria (rows), which the phage 
can infect.  
1.4.2 Using interaction structure within a community to distinguish background 
dynamics  
Identifying all of the interacting species within a bacteria-phage community can 
reveal the signature of the coevolutionary dynamics which have shaped the 
population structure to date (Weitz et al., 2013). The directionality of ARD means 
that each novel mutation providing further resistance or infectivity is added to the 
previous background, and so resistance or infectivity ranges increase as ARD 
proceeds. This means that within a population there will exist a hierarchical 
structure where each genotype present is a subset of a more generalist genotype, 
which is one step further down the coevolutionary race. Using bipartite networks 
to visualise bacteria-phage interactions in a population undergoing ARD 
demonstrates this hierarchy as a nested pattern (e.g. Figure 1.2) where 
interaction range for each bacteria or phage is nested within a more generalist 
pattern.  
The network signature of FSD is more complicated to characterise; as only the 
most abundant bacteria are targeted, numerous genotypes may co-exist and if 
each independently co-evolves against specialised phages, each interaction 
would have its own evolutionary trajectory potentially forming their own hierarchy 
of genotypes as they diversify. Therefore, separate modules may develop where 
bacteria and phage specialise to resist/infect one another, and genotypes within 
each module may form a nested structure of resistance/infectivity range. 
Therefore, a modular nested bacteria-phage infection network would be observed 
(Beckett and Williams, 2013). However, this same pattern could theoretically be 
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achieved by ARD on a multi-species level if bacteria-phage interactions are 
species specific. 
1.4.3 Community structure can determine robustness of microbial communities 
The degree of connectivity within a community can also help us assess the 
robustness of a community to changes in the environment, or invasion by novel 
competitors or parasites. For example, highly modular networks may be more 
stable, as collapse of a single module will not necessarily influence the 
surrounding community, whereas changes to a hierarchical nested structure 
could have a domino effect, such that loss of one member could destabilise the 
whole community (Thébault and Fontaine, 2010). As such, key community 
members may create network ‘hubs’ which, if lost, could have wide-reaching 
collateral effects on connected species (Agler et al., 2016). By understanding the 
genetic interactions which shape a community, it may therefore be possible to 
predict how communities would respond to change, and how diverse bacterial 
infections may respond to treatment.  
1.5 A model system to study the effect of phage therapy  
1.5.1 Pseudomonas aeruginosa – a multi-drug resistant pathogen 
Numerous mechanisms of antimicrobial resistance exist which can limit the 
success of antibiotic treatments, including efflux pumps, target modification and 
enzymes which bind and degrade the drug (Blair et al., 2015). These resistances 
are commonly encoded on mobile elements, such as plasmids, and multiple 
different resistances can be clustered together to form resistance ‘cassettes’, 
promoting the spread of multi-drug resistance by horizontal gene transfer 
(Alekshun and Levy, 2007; Bennett, 2008; Reece and Phillips, 1995). Encoding 
antibiotic resistance determinants  can increase the fitness of bacterial pathogens 
even at low, environmental, concentrations of antibiotics (Bottery et al., 2016) 
which further promotes the spread of resistance.  
Pseudomonas aeruginosa is an opportunistic pathogen, which commonly 
colonises burn wounds and the lungs of cystic fibrosis (CF) and bronchiectasis 
patients (Driscoll et al., 2007). It is associated with very high occurrence and 
range of antibiotic resistance, with some strains displaying pandrug resistance to 
all antibiotics in current use, due to a combination of both chromosomal and 
plasmid-encoded resistance mechanisms (Breidenstein et al., 2011; Lister et al., 
2009; Livermore, 2002).  
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1.5.2 The complexity of interactions within a clinical infection may influence 
therapy success  
The interaction between biotic and abiotic factors could be an important 
consideration for phage therapy, as many pathogens, such as P. aeruginosa, are 
commonly contracted from environmental reservoirs rather than from patient-
patient contact (Rogues et al., 2007; Trautmann et al., 2005). As such, evolution 
in the environmental niche, which is influenced by both abiotic conditions and 
biotic interactions in the presence of both lytic and lysogenic phage strains as well 
as protist predation and inter-specific competition, has major consequences for 
the evolutionary strategies adopted during human infection (Friman et al., 2009). 
Treatment may therefore be hindered by bacterial evolutionary adaptation. In 
chronic infections, such as that of the CF airways, P. aeruginosa undergoes 
evolutionary diversification leading to a genetically diverse population adapted to 
the local environment which is difficult to eradicate, often persisting over 
numerous years (Burns et al., 2001; Conrad et al., 2013; Winstanley et al., 2016). 
Once within the CF lung, whilst the environment provides a rich nutrient source 
there are numerous new challenges, including defending against host immune 
response and antibiotic treatments (Smith et al., 2006). Most CF patients undergo 
intensive antibiotic therapy from a very young age, and whilst this appears to clear 
intermittent infections, this commonly only delays the development of chronic 
infections (Burns et al., 2001; Frederiksen et al., 1997). The respiratory system 
provides a range of compartmentalised environments, each with distinct abiotic 
characteristics; the paranasal sinuses have been suggested to provide a niche in 
which bacteria are protected from both antibiotics and immune responses 
enabling the pathogen to re-colonise the remainder of the respiratory system 
following antibiotic treatment, eventually forming a chronic infection (Folkesson 
et al., 2012). Therefore, the potential for use of phage therapy could be greatly 
influenced by the heterogeneity within an infection, in terms of the localised 
differences in pathogen virulence and susceptibility in response to varying 
selection pressures, which develop as bacteria adapt and diversify (Harrison, 
2007; Winstanley et al., 2016).  
1.5.3 Using phage to combat P. aeruginosa infections 
Due to high rates of antibiotic resistance in P. aeruginosa the possibility of using 
phage therapy to combat these infections has recently been revisited. Phage 
cocktails have proven to be highly effective in suppressing the growth of P. 
aeruginosa in vitro, performing better than individual phage strains (Betts et al., 
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2016a, 2018), and although rates of evolved resistance were similar, the strength 
of resistance increased with parasite diversity as the rate of host adaptation 
accelerated (Betts et al., 2018). However, pre-adapting phages to evolved host 
resistance has been shown to improve their efficacy against this pathogen, and 
constrain the evolution of resistance (Betts et al., 2013; Friman et al., 2016). 
Further, phage cocktails have been shown to cure otherwise lethal P. aeruginosa 
infections in waxmoth models (Hall et al., 2012), and eliminate this bacterium in 
tissue cultures of biofilm-forming CF airway cells (Alemayehu et al., 2012). The 
potential use of phages to prevent biofilm formation in medical devices has been 
explored using an in vitro model using hydrogel-coated catheters, and showed 
promising results, which were maximised by using phage cocktails over single 
phage strains (Fu et al., 2010). In addition to these promising in vitro results, a 
number of studies have shown that phages can effectively treat P. aeruginosa 
infections within various models of disease within mice, including lung infections 
(Morello et al., 2011; Waters et al., 2017), burn wounds (McVay et al., 2007), and 
gut-derived septicaemia (Watanabe et al., 2007). These studies also demonstrate 
simple and successful methods of phage therapy administration, for example, 
nasal inhalation of phage products was sufficient in the murine lung model 
(Waters et al., 2017) and oral administration was used in the murine gut-disease 
model (Watanabe et al., 2007).  
1.5.4 Phage adsorption targets of P. aeruginosa  
Determining the cell-surface receptors which are recognised by phage to allow 
adsorption is important in understanding the potential for bacteria to evolve 
resistance by surface modification. Two common targets on the membrane of P. 
aeruginosa, which are commonly mutated in the presence of phages, include the 
Type IV pilus and  Lipopolysaccharide (LPS) (Betts et al., 2016a; Gurney et al., 
2017).   
Type IV pili are protein structures which adhere to surfaces, extend and retract to 
allow twitching motility, and are important in biofilm formation, hence Type IV pili 
have a fundamental role in colonisation of new hosts, and therefore  modification 
of these structures may attenuate bacterial virulence (Figure 1.3; Burrows, 2012). 
Due to the complex protein structure of the Type IV pilus, consisting numerous 
protein subunits which act together mechanically, and the further genes involved 
in biosynthesis and regulation of pilus expression (Mattick et al., 1996), there are 
a vast number of genetic targets which can influence the structure of the Type IV 
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pilus resulting in a wide variety of phenotypes ranging from complete loss to 
hyperpiliation (Chiang and Burrows, 2003). Further, phage attachment to Type IV 
pilus can also be deterred by glycosylation of the pilus structure (Harvey et al., 
2018).  
 
Figure 1.3 Structure of the Type IV pilus 
Multiple subunits of the protein PilA form the major pilin which is inserted into the 
bacterial membrane through a pore formed by PilQ. Extension and retraction of 
the major pilin is co-ordinated by the motor proteins PilB and PilT. Figure adapted 
from Maier and Wong, 2015.  
Lipopolysaccharide (LPS) is also an important virulence factor of P. aeruginosa 
as a target for the human immune system, and therefore has evolved a variable 
structure such that one bacterial cell may present multiple different variations of 
LPS (Figure 1.4; Lam et al., 2011). LPS is composed of three main sections: lipid 
A anchors the structure to the bacterial membrane and is attached to the core 
oligosaccharide to form the uncapped LPS (Figure 1.4, far left), which can then 
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be capped by a variable O-antigen structure composed of A- and B-bands (King 
et al., 2009). The mutation of specific LPS biosynthesis genes may prevent 
biosynthesis of individual variations whilst maintaining other forms within the cell, 
with the most drastic mutations leading to loss of all but the uncapped LPS (Figure 
1.4, DwbpL; Lam et al., 2011).  
 
Figure 1.4 Diversity of lipopolysaccharide structures which may be 
displayed on one bacterial cell  
Structural diversity of LPS within one bacterial cell is achieved by variation in the 
O-antigen structure which caps the core LPS. Mutation of biosynthesis genes can 
limit the diversity of LPS structures displayed; (✓) indicates presence and (✗) 
indicates the absence of each structure across a range of genotypes. Figure 
adapted from Lam et al., 2011. 
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1.6 Is phage therapy a realistic alternative to antibiotics? 
1.6.1 Historical and current use of phage therapy 
The therapeutic use of phages to treat antibiotic infections dates back to the 
1920s, where Felix d’Herelle experimented with phage treatments against 
bacterial dysentery in Paris, and later developed the first commercially available 
phage cocktails (Pirnay et al., 2012). Whilst the western world turned its back on 
phage therapy as a lack of scientific understanding of phage biology led to 
expansive and unfulfilled claims about the  effectiveness of phage treatments and 
antibiotics were discovered, phage therapy has been continually used in eastern 
Europe for over  60 years (Monk et al., 2010).  The Eliava Institute in Georgia 
have developed an expansive collection of phages, frequently replenishing these 
stocks from environmental samples, which is screened against specific 
pathogenic strains to develop cocktails of multiple phages, some of which are 
available over-the-counter (Kutter et al., 2010; Pirnay et al., 2012). These 
combinations may be highly diverse, targeting as many as 23 different bacterial 
strains (Kutter et al., 2010). This methodology allows rapid adaptation of 
therapeutics in response to the evolution of resistance, which is further enhanced 
by ‘training’ phages against problematic bacterial strains (Pirnay et al., 2012). In 
fact, two of the phage products first designed by d’Herelle (pyophage and 
intestiphage) are still in use in Georgia today; this is achieved by regular testing 
(every 6 months) against bacterial strains in current circulation which allows the 
phage formula to be continually updated to maintain efficacy (Kutter et al., 2010). 
In contrast to the use of commercially available diverse phage cocktails in 
Georgia, the Hirszfeld Instute in Poland promote the use of personalised phage 
therapeutics, selected from a phage bank against patient-specific bacterial strains 
and implemented either as individual phages, or combinations (Kutter et al., 
2010). These practices allow rapid isolation and implementation of new 
therapeutic products in response to the evolution of resistance, however, these 
methodologies are generally incompatible with pharmaceutical regulations in 
western Europe and the USA, where Good Manufacturing Practice (GMP) 
requires extensive testing, clinical trials for each component and interaction within 
a medicinal product (Pirnay et al., 2012).  
1.6.2 Evolutionary hurdles for phage therapy 
Before it can be employed routinely, there are a number of considerations in the 
use of phage therapy that must first be addressed. Firstly, phage have co-evolved 
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with bacteria for millions of years and as such, many bacterial resistance 
mechanisms are present to resist phage infection (see section 1.2), therefore 
even weak resistance may prevent phage from completely clearing a bacterial 
infection. A better strategy may be to use phage to re-structure microbial 
communities or reduce pathogen virulence (León and Bastías, 2015), so that 
either multiple phage in combination or the combined use of phage with antibiotics 
could together eradicate a bacterial infection (Chan et al., 2016; Schmerer et al., 
2014). Secondly, much more research is needed to fully understand the 
pharmacology of phage infection, i.e. how phage are influenced by the patient’s 
immune system (pharmacokinetics) and how the body reacts to phage 
(pharmacodynamics) (Abedon, 2014; Abedon and Thomas-Abedon, 2010). For 
example, can auto-dosing (i.e. relying on phage to self-propagate; Abedon and 
Thomas-Abedon, 2010; Loc-Carrillo and Abedon, 2011) provide sufficiently high 
phage titres to clear an infection? On the other hand, the patient’s immune system 
may be required to clear even phage-sensitive cells from the infection site (Roach 
et al., 2017).  Finally, it is important to realise that bacterial infections are not 
clonal populations in which every individual will respond identically to the 
treatment, but diverse, often multi-species, communities, and treat them as such 
(Levin and Bull, 1996). The evolution of resistance to phage therapies is 
unavoidable, however, if we can understand how and why different resistance 
mechanisms are selected, perhaps we can rationally design phage-based 
therapies to limit the evolution of broad resistances.   
1.6.3 Rational design of phage therapeutics 
Maximising host range is important to enable treatment of diverse bacterial 
genotypes and even multiple species, therefore the isolation of broad-spectrum 
phages using multiple hosts (Ross et al., 2016), and continued characterisation 
of novel phages (Amgarten et al., 2017; Ceyssens et al., 2009; Sepúlveda-Robles 
et al., 2012), is an important factor in optimising phage treatments. However, 
current strategies in the development of phage cocktails are often based solely 
on maximising the host range targeted (e.g. Ross et al., 2016), commonly taking 
only the most virulent and generalist phage available against each target species, 
and do not take into account many of the fundamental aspects of bacteria-phage 
coevolution within a community context. This is in part due to the lack of simple 
experimental mechanisms of characterising interactions between multiple phage 
species, a gap in knowledge which is being filled by the use of bacteria-phage 
infection network (BPIN) analysis (e.g. Gurney et al., 2017). This tool will 
 26 
hopefully enable rational design of phage cocktails to test the importance of 
multiple factors such as between-phage interactions and complementation of 
specialist and generalist phage infection strategies.  
Limiting the evolution of resistance is, fundamentally, one of the most promising 
ways to prolong durability of phage treatments. One way of tackling this issue is 
to pre-adapt phages to the possible mechanisms of host-resistance which may 
arise during treatment (Betts et al., 2013; Friman et al., 2016; Kelly et al., 2011). 
Alternatively, maximising differences in selection pressures imposed by 
combined treatments, either as multiple phages targeting different receptors 
(McCallin et al., 2013; Tanji et al., 2004; Yen et al., 2017), or by combining phages 
with antibiotics (Torres-Barceló and Hochberg, 2016), could limit the resistance 
options available to the host. This works in two ways; firstly, by limiting mutation 
frequency as the chance two resistance mutations targeting distinct receptors 
occurring in the same cell is lower than if only one mutation is required, and 
secondly, by maximising fitness costs to the host. Cumulative fitness costs and 
in particular negative epistasis between individual resistance mutations can limit 
the potential for accumulation of multiple resistances, or result in a trade-off in 
resistance strength to multiple phages if phage-specific mutations interact 
negatively (Bohannan et al., 2002; Koskella et al., 2011; Scanlan et al., 2015a).  
With the emergence of pandrug resistance [PDR; i.e. non-susceptibility to all 
classes of antibiotics (Sweeney et al., 2018)], there is growing interest in 
combination therapies, whereby multiple antibiotics, or phage-antibiotic 
combinations, are employed with the idea that resistance is harder to evolve 
against multiple targets at once (Baym et al., 2016; Torres-Barceló and Hochberg, 
2016). The evolution of resistance to antibiotics commonly results in cross 
resistance, but can also cause collateral sensitivity, as strengthening one 
resistance trades-off against a second (Pál et al., 2015). By mapping these 
collateral effects using network analysis, it is possible to design treatment 
combinations, or sequential cycles, which can limit the evolution of cross-
resistance, and optimise collateral sensitivity (Baym et al., 2016; Imamovic and 
Sommer, 2013). Sequential application of antibiotics has shown promising 
results, with the development of treatment cycles which limit the evolution of 
collateral resistance and promote sensitivity to further treatment (Imamovic and 
Sommer, 2013). However, comparison of simultaneous and sequential phage 
treatments showed that whilst sequential phage treatments may be as effective 
as simultaneous ones, exposure to phage cocktails promoted the highest 
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decreases in bacterial density (Hall et al., 2012). Further work is required to 
determine how these principles should be best employed to optimise the rational 
design of phage treatments.   
1.6.4 Clinical trials of phage therapy 
The use of phage therapy in the treatment of P. aeruginosa infections has been 
widely studied and has even progressed to clinical trials in human patients. 
Topical use of phage suspensions has been shown to clear P. aeruginosa 
infections within skin grafts of burns victims (Sivera Marza et al., 2006). A six-
phage cocktail (Biophage-PA), reduced clinical indicators of disease in chronic 
infections of the ear (otitis) involving antibiotic-resistant P. aeurgionsa (Wright et 
al., 2009). Phage cocktails can also be developed to treat multi-species 
infections, such as combinations of P. aeruginosa and Staphylococcus aureus 
within burn wounds; the safety of one such cocktail, BFC-1 (Merabishvili et al., 
2009), has been demonstrated in a small clinical trial in Belgium, but the efficacy 
of the cocktail was undetermined (Rose et al., 2014). Clinical trials can be limited 
by a range of factors, and often by a failure to recruit patients due to regulatory 
constraints on recruitment and variable incidences of disease (Sybesma et al., 
2018). One such trial which has encountered these issues involves the phage 
cocktail Phagoburn, which is designed to target P. aeruginosa and Escherichia 
coli ; the trial was completed in 2017, and full results are expected to be published 
soon (Servick, 2016; http://www.phagoburn.eu/). Phage therapy has also been 
implemented in numerous individual cases, many with successful outcomes, 
under the Declaration of Helsinki (Verbeken et al., 2007), which allows the use of 
phage therapy when no other therapeutic options exist. For details of additional 
clinical trials currently in progress, and reports of individual case studies 
implementing phage therapy, see Sybesma et al, (2018).  
1.6.5 Regulatory challenges facing phage therapy approval 
There are a number of regulatory hurdles which must also be considered to allow 
implementation of phage therapy across the EU. Firstly, despite widespread use 
of phage therapy for nearly 100 years across Eastern Europe, there are only a 
limited number of clinical trials which have run to completion, leading to concerns 
about the safety of phage therapy (Pirnay et al., 2015; Sybesma et al., 2018), 
although as mentioned above, no adverse responses have been recorded to date 
from clinical trials in progress (section 1.5.4). Secondly, the current European 
framework for production of medicinal products imposes heavy restrictions on the 
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production of phage therapeutics, requiring the same good manufacturing 
practices as other medicinal drug production (Sybesma et al., 2018). However, 
this limits the potential for personalised cocktails to be prepared and imposes time 
delays on processing of novel phages and pre-adapting stock phages to resistant 
genotypes in current circulation. An alternative regulatory framework is under 
development in Belgium, through which phage therapies can be considered as a 
‘Magistral preparation’, which would allow phage preparations to be tailor-made 
to meet the requirements of individual patients within a hospital pharmacy (Pirnay 
et al., 2018).  This suggests that any principles of rational design which can 
simplify the production requirements for phage therapy would greatly simplify the 
regulatory process of phage production.  
1.7 Thesis outline 
This thesis explores how the structure of bacteria-phage interactions, and the 
underlying gene-gene interactions, influence the evolution of phage resistance. 
Firstly, I used bacteria-phage infection networks to characterise the changes in 
community structure through time to determine the abiotic factors which influence 
the evolution of phage resistance and constrain bacteria-phage co-existence 
(Chapter Two). Next, I defined how genetic interactions may underpin bacteria-
phage community structure by determining how resistance evolution creates 
modular cross-resistance networks based upon adsorption receptor modification 
(Chapter Three). By contrasting the evolution of resistance against phage pairs 
applied either simultaneously or sequentially, I found that these different modes 
of selection influence the strength and cost of evolved resistances (Chapter Four). 
Finally, I assessed the effect of phage diversity, and the potential influence of 
cross-resistance structure, on the efficacy of phage combinations, (Chapter Five). 
These data provide valuable insight into the mechanisms of resistance evolution 
which influence the efficacy of phage therapies, which I expand upon in Chapter 
Six to discuss the potential implications for the rational design of phage therapies.  
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Chapter Two 
Ecological conditions determine extinction risk in 
co-evolving bacteria-phage populations1 
2.1 Introduction 
Microbial communities are subject to a broad range of biotic and abiotic selection 
pressures and are capable of rapid evolutionary change in response 
(Barraclough, 2015). Antagonistic interactions, such as between bacteria and 
bacteriophages (phages), in particular drive continuous evolutionary change 
through recurrent cycles of adaptation and counter-adaptation, known as Red 
Queen coevolution (Brockhurst et al., 2014; Koskella and Brockhurst, 2014; Van 
Valen, 1973). This process may be driven by directional selection favouring ever 
broader ranges of resistance and infectivity achieved by recurrent selective 
sweeps [Arms Race dynamics (ARD) (Lenski and Levin, 1985)], or proceed by 
sustained allele frequency oscillations driven by negative frequency-dependent 
selection [Fluctuating Selection dynamics (FSD) (Levin et al., 1988)]. The stability 
of coevolutionary interactions relies upon interaction symmetry, both in terms of 
the selection acting upon each partner and correspondingly their potential for 
adaptation (Brockhurst et al., 2014).  Failure of either partner to adapt quickly 
enough could result in their extinction (Smith, 1976). Host-parasite communities 
are vulnerable to host extinction through failure to evolve resistance against 
increased parasite virulence (Rafaluk et al., 2015), whereas parasite extinction 
could result from either an inability to overcome evolved host resistance (Zhang 
and Buckling, 2016), or via extinction of the host . The risk of extinction may be 
dependent on the pattern of coevolutionary dynamics, which have been shown to 
vary depending on ecological conditions (Gómez and Buckling, 2011; Lopez 
Pascua et al., 2014). Strong directional selection under ARD coevolution may 
exacerbate asymmetries in evolutionary potential between the coevolving 
partners [e.g. phage infectivity evolution requires more mutational steps than 
reciprocal bacterial resistance evolution (Buckling and Brockhurst, 2012)] driving 
the more constrained partner to extinction. We are interested here in how 
                                               
1 Wright, R.C.T., Brockhurst, M.A., and Harrison, E. (2016). Ecological conditions determine 
extinction risk in co-evolving bacteria-phage populations. BMC Evolutionary Biology. 16, 227. 
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ecological context, and associated abiotic selection pressures, influences the risk 
of coevolution-induced extinction. 
Although not extensively investigated, recent studies suggest that abiotic 
environmental conditions can affect coevolution-induced extinction risk (Gómez 
et al., 2015b; Zhang and Buckling, 2011, 2016). Phage adapting to deteriorating 
thermal conditions, for example, were able to adapt to thermal stress when their 
bacterial host was held in evolutionary stasis, but were driven to extinction in the 
presence of co-evolving hosts (Zhang and Buckling, 2011). Additional selection 
from gradually increasing temperatures, to which phage are far more sensitive, 
constrained the phage’s ability to adapt to increased bacterial resistance, leading 
to extinction of the phage population (Zhang and Buckling, 2011). Imbalanced 
antagonistic coevolution can therefore increase the extinction risk for phage 
populations, however it is unclear how this varies with the intensity of coevolution. 
Numerous ecological factors are known to alter the strength of reciprocal 
selection driving bacteria-phage coevolution. Increasing resource supply, by 
supporting larger population sizes, increases bacteria-phage encounter rates 
(Lopez-Pascua and Buckling, 2008), and has been shown to drive phage 
extinction in both liquid media (Zhang and Buckling, 2016) and in soil (Gómez et 
al., 2015b). However, the effects of nutrient enrichment go beyond demography; 
increased resource availability reduces the fitness costs associated with host 
resistance (Zhang and Buckling, 2016). There is a documented trade-off between 
bacterial resistance and growth rate (Scanlan et al., 2015a), which is fundamental 
to the maintenance of diversity in microbial communities, by preventing highly 
competitive and resistant host strains from dominating the population (Jessup and 
Forde, 2008). The allocation of this trade-off varies across environmental 
conditions; when resource availability is high more energy can be allocated to 
resistance mechanisms (Boots, 2011), effectively reducing the fitness costs 
associated with bacterial resistance. Therefore, it is challenging to distinguish the 
impact of intensity of coevolution from the effect of reduced fitness costs in driving 
phage extinction in nutrient enriched conditions. 
Population mixing (Brockhurst et al., 2003) accelerates coevolution in a similar 
way to increased resource availability (Lopez-Pascua and Buckling, 2008); 
increased bacteria-phage encounter rates strengthen reciprocal selection for the 
evolution of increased resistance and infectivity in bacteria and phage populations 
respectively. However, whereas increased resource availability mitigates the 
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fitness costs associated with bacterial resistance (Lopez-Pascua and Buckling, 
2008; Zhang and Buckling, 2016), population mixing does not. In contrast, 
unmixed populations experience reduced encounter rates due to the 
development of spatial and temporal host refuges against phage infection 
(Schrag and Mittler, 1996).  
In this study, we explore how two ecological variables altering the intensity of 
bacteria phage coevolution,  population mixing and resource level, affect the 
extinction risk of coevolving bacteria-phage populations in the Pseudomonas 
fluorescens SBW25 – lytic phage SBW25ɸ2 model system (Brockhurst et al., 
2007). We predicted that environments supporting more intense coevolution, i.e. 
well-mixed, high resource supply environments, would be those most likely to 
drive coevolution-induced extinction. To test this hypothesis, we experimentally 
coevolved replicate bacteria-phage populations by serial transfer under high or 
low resource supply, with or without population mixing in a full factorial 
experimental design and monitored population densities of each species over 
time. 
2.2 Materials and Methods  
2.2.1 Culture techniques  
All cultures were grown in microcosms (30 ml glass universal bottles with loose 
fitting plastic lids) containing 6ml of either high or low nutrient level media. Low 
nutrient level was obtained by 100-fold dilution of standard (high resource level) 
King's Media B (KB) into M9 salt solution. Cultures were grown at 28°C in either 
a static incubator or orbital shaker set to 200rpm for 1min in every 30min (mixed 
treatment). Cultures were propagated by serial transfer, sub-culturing 1 percent 
into fresh media every 48h, for twenty transfers.  
2.2.2 Experimental design  
Four treatments were established consisting of high and low resource levels with 
mixed and static environments of each. Independent clones of P. fluorescens 
SBW25 and bacteriophage SBW25φ2 were isolated and used to found 24 
replicate populations (4 treatments x 6 replicates). Each replicate microcosm was 
inoculated with 108 P. fluorescens SBW25 cells and 106 SBW25φ2 particles. 
Bacteria and phage densities were calculated every second transfer; bacterial 
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density as colony forming units (CFU/ml) by plating diluted cultures on KB agar 
plates, and phage density as plaque forming units (PFU/ml) by plating a serial 
dilution of filtered culture on a soft agar lawn of ancestral bacteria.  
2.2.3 Sampling techniques 
At every second transfer whole population samples, phage populations and 20 
individual bacterial clones were isolated and stored at -80°C in glycerol solution 
(20%). Phage populations were obtained by filtration (0.22μm filters) to remove 
bacteria.  
2.2.4 Resistance and infectivity profiles approaching phage extinction 
To investigate the mechanism of phage extinction in low resource level 
treatments, we characterised bacterial resistance and phage infectivity levels 
within each population approaching the phage extinction time point. The transfer 
at which early phage extinction events were most common was designated as 
the ‘extinction time point’ (T=4 for low static; T=6 for low mixed), and the previous 
sampling point as the ‘pre-extinction time point’ (T=2 for low static; T=4 for low 
mixed). Twenty phage clones per replicate were isolated from phage population 
glycerol stocks of the pre-extinction time point by plating phage filtrate on 0.8% 
agar containing exponentially growing ancestral bacteria. The twenty bacterial 
clones from each low resource level replicate at the pre-extinction time point 
(henceforth 'contemporary bacteria’) and at the extinction time point (henceforth 
'future bacteria’) were each assayed for resistance against their respective pre-
extinction phage set.    
Assays were performed in 96 well microtitre plates containing standard 
concentration of KB media in M9 salts for all treatments. Phage were added at a 
density approximately 10 times higher than bacterial density (multiplicity of 
infection, MOI = 10). The absorbance at 600nm was measured at t=0 and t=20h 
to give a relative bacterial growth rate (RBG) (Poullain et al., 2008) compared to 
a control in the absence of phage, given by equation 1. 
For phage i, bacteria j:    
                                                     
(1) 
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The threshold for binary infection outcome was calculated by modelling a normal 
distribution over the resistance peak of the RBG distribution and taking the 95% 
confidence interval (RBG=0.781). The proportion of possible pairwise interactions 
within each replicate population (20 bacteria clones x 20 phage clones = 400 
possible interactions) that resulted in infection (RBG<0.781), describes qualitative 
population-level susceptibility. This is referred to (e.g. Figure 2.3) as the 
‘Proportion of realised interactions’. Link strength (1-RBG) of realised interactions 
measures quantitative susceptibility at the individual level, such that 0 describes 
completely resistant bacteria and 1 completely susceptible bacteria. 
2.2.5 Statistical analysis  
Phage extinction was analysed using a survival model (fitted to a parametric 
Weibull distribution) on the time of extinction taken as the time point phage 
became undetectable in each replicate, with censoring to account for phage 
populations which survived the entire experiment. Analysis of the bacterial 
densities over time was performed using a generalised least squares (GLS) linear 
model with auto-correlation over time within replicates on log10 transformed CFU 
values. In this model, time, presence or absence of phage, nutrient level and 
mixing status were given as fixed effects. Individual linear mixed effect models 
were made for both population-level (proportion of realised interactions) and 
individual-level (link strength) susceptibility as the response variable, fitting 
mixing, phage extinction status and bacterial time point (contemporary or future) 
as interacting fixed effects, and replicate population as a random effect. Tukey 
post hoc testing was used to isolate the drivers of significant main effects. 
2.3 Results 
Out of six replicate populations per treatment, phage extinction was observed in 
all low resource replicates under population mixing and half of those in static 
conditions. Phage extinction was less common in high resource conditions, with 
only one extinction event in static conditions, and three out of six replicates in 
mixed populations (Figure 2.1). The likelihood of phage extinction was increased 
by low resource levels and population mixing (survival model: resource level Z=-
2.59, p=0.00954; population mixing Z=-2.28, p=0.0226). There was no significant 
interaction between these two treatments (survival model: interaction between 
resource and mixing Z=0.106, p=0.915); the individual effects were additive to 
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give the highest likelihood of phage extinction in the low resource, mixed 
environment. In contrast, no bacterial population extinctions were observed. 
Bacterial population densities were approximately 4-fold higher in high compared 
to low resource environments whilst population mixing had a small effect, 
increasing bacterial density by approximately 45% (GLS:  high resource t=9.83, 
p<0.0001; mixing t=2.36, p=0.0185; Figure 2.2). 
 
Figure 2.1 Survivorship of phage replicate populations through time is 
determined by treatment conditions 
Survivorship is given as the proportion of replicate populations within each 
treatment in which phage are present at each transfer. Phage populations were 
judged to be extinct if phage were undetectable by plating undiluted filtrate of the 
respective replicate population.   
Extinction events occurring in low resource populations were further investigated 
by estimating the susceptibility of bacterial populations to infection by phage 
clones from their sympatric populations approaching the extinction time points. 
Bacterial susceptibility was characterised by two distinct measurements. Firstly, 
population-level susceptibility is described by the proportion of realised 
interactions on a scale from 0, where all bacteria sampled are resistant to infection 
from all phage sampled, to 1, indicating all bacteria were susceptible to all phage 
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(i.e. ancestral level susceptibility). The second metric, link strength, gives an 
estimate of the mean quantitative susceptibility of bacteria, measured as the 
reduction in bacterial growth caused by phage infection, for each replicate 
population. We observed high levels of resistance to phage from the pre-
extinction time point in contemporary (pre-extinction) bacteria irrespective of 
whether phage subsequently survived or became extinct (Figure 2.3A-B). There 
was no difference in the proportion of realised interactions between bacterial 
sampling points for extinction populations (Figure 2.3A; PRI Tukey p=0.9036).  
 
Figure 2.2 Contrasting density profiles over time for bacteria and phage 
populations  
Phage densities (blue) denote plaque forming units (PFU/ml) and bacterial 
densities (red) are colony forming units (CFU/ml). Different lines represent the 6 
replicate populations within each treatment. 
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Figure 2.3 Changes in bacterial susceptibility across low resource 
treatments approaching phage extinction time points.  
A, B mean (± SE) proportion of realised interactions (using binary threshold of 
susceptibility) and C, D mean (± SE) link strength of realised interactions within 
replicate populations of mixed and static low resource treatments. Bacteria 
sampled at pre-extinction time points (Contemporary) or extinction time points 
(Future) assayed against phage sampled from the same replicate population at 
the pre-extinction time point. Designated ‘Extinct’ (A, C) or ‘Survived’ (B, D) based 
on phage presence at transfer 10. ‘N’ describes the number of replicate 
populations represented under each heading. The dashed line in C and D shows 
the link strength of ancestral phage against ancestral bacterial. 
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However, in replicates where phage survived beyond the time-point where 
extinctions were observed in other replicates, bacteria sampled from the 
extinction time point (future) were significantly more susceptible to infection by 
pre-extinction time point phage (Figure 2.3B; PRI Tukey p<0.0001). In addition, 
increased link strength in future compared to contemporary bacteria in survival 
populations indicated greater quantitative susceptibility at the individual level 
(Figure 2.3D; LS Tukey p=0.0337) suggesting that phage survival relied upon the 
reinvasion of highly phage-susceptible bacterial genotypes. This pattern was 
consistent for both mixed and unmixed environments. Population mixing had no 
significant effect on proportion of realised interactions in extinction populations 
(Figure 2.3A, PRI Tukey p=0.9551). However, link strength was greater in mixed 
than static conditions (Figure 2.3C, LS Tukey p=0.0410), indicating population 
mixing promoted higher individual-level susceptibility in extinction populations.  
2.4 Discussion 
We have found that low resource conditions and population mixing both act to 
increase the likelihood of phage extinction. These findings, in part, contradict our 
predictions that more intense coevolution, known to be accelerated by both high 
resource availability and high rates of population mixing, should promote 
coevolution-induced phage extinction.  
Our predictions were based on previous studies that found elevated phage 
extinction in nutrient-enriched environments using the same bacteria-phage 
model system (Gómez et al., 2015b), which Buckling and Zhang formalised as a 
‘coevolutionary paradox of enrichment’ (Zhang and Buckling, 2016). They 
hypothesised that increasing nutrient levels can destabilise the coevolutionary 
interaction between bacteria and phage by increasing the intensity of antagonistic 
coevolution, selecting for increased bacterial resistance to phage infection, whilst 
ameliorating the costs associated with resistance mutations. As a result, the 
stronger selection for increased phage infectivity destabilises the coevolutionary 
interaction between bacteria and phage, and may therefore result in phage 
extinction in enriched environments (Zhang and Buckling, 2016). However, we 
found the opposite; the likelihood of phage extinction was increased at low 
resource levels.  
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Whilst these studies are not directly comparable (our experiment was conducted 
using different culture media and at different population sizes) these broadly 
contrasting outcomes are likely to be due to differences in the magnitude of the 
resource manipulations in each study. In our study we implemented a much more 
minimal low-resource condition [100-fold dilution of KB growth media compared 
with a maximum 10-fold dilution of LB media used by Zhang and Buckling (2016)]. 
Under comparable (i.e. static growth) conditions we observed far higher rates of 
extinction in low resource conditions (3 out of 6 replicates) than the more 
intermediate resource levels used in the previous study (0.1 and 0.3LB), where 
no extinctions were observed. Extinction rates under high resources were more 
similar between experiments (1 out of 6 replicates in our static 1KB treatment 
compared to 2 out of 8 replicates in their 2.7LB treatment). High rates of phage 
extinction may therefore be a result of the ecological effects of very low resource 
environments, suggesting that the stability of coevolutionary interactions may be 
maximised under intermediate resource levels.  
Interestingly, however, the mechanisms driving extinction at high and low 
resources are likely to derive from the same fundamental process; limiting the 
potential of phage to evolve infectivity in response to bacterial resistance. Under 
high resource environments accelerated rates of antagonistic coevolution 
increases demand for novel resistance and infectivity mutations. In contrast, low 
resource levels sustained smaller population sizes which can limit the supply of 
resistance and infectivity mutations (Gandon and Michalakis, 2002). Because 
phage infectivity is known to require several mutational steps to overcome a 
single bacterial resistance mutation (Buckling and Brockhurst, 2012; Samson et 
al., 2013) both increasing demand or limiting supply of mutations is likely to 
disproportionately constrain the ability of phage to adapt compared with bacteria 
and thus lead to an imbalance in bacteria-phage coevolution and ultimately phage 
extinction.  
Under very low resources these effects are likely to be further exacerbated by the 
impact of reduced host diversity due to more stringent bottlenecks, which can 
result in coevolution-induced phage extinction through stochastic loss of 
susceptible bacteria (Hesse and Buckling, 2015). An important caveat of our 
experimental design is that the magnitude of bottlenecking imposed by 
experimental transfers varies dependent on the population density supported by 
each treatment, such that the reduced population sizes in low resource conditions 
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also translate to a more stringent bottleneck. Furthermore, low resource 
conditions have been shown to inhibit the establishment of bacteria-phage 
interactions, reducing connectivity of the population (i.e. lower density of realised 
interactions) and thus further increasing vulnerability to extinction (Poisot et al., 
2011). This mechanism is supported by our resistance assays which show that 
phage extinction in low resource treatments was associated with high levels of 
bacterial population-level resistance (Figure 2.3A). Moreover, populations in 
which phage were maintained experienced reinvasion of highly susceptible 
bacteria, displacing resistant host genotypes (Figure 2.3B,D).  
Differences in resistance and infectivity profiles between treatments may also be 
influenced by variation in the type of resistance evolved by hosts, and in phage 
infection dynamics (e.g. adsorption, burst size, latent period), in response to 
different ecological pressures. However, as the literature strongly supports the 
intensification of co-evolution with increasing resources levels, our interpretation 
is based on the assumption that the changes in resistance and infectivity we have 
observed are primarily influenced by the differences in co-evolutionary rate and 
dynamics across resource levels and with population mixing (Brockhurst et al., 
2003; Lopez-Pascua and Buckling, 2008; Zhao et al., 2017). Lopez-Pascua et al 
(2008) observed corelated changes in bacterial resistance and infectivity 
indicating reciprocal selection, the hallmark of co-evolution, which increased at 
higher resources levels (up to 1KB) indicating more intense co-evolution, and 
stalled at low resources equivalent to those we employed (0.01KB). Further, a 
recent study which characterised the rate of bacteria-phage co-evolution and the 
frequency of phage extinction across a similar range of nutrient levels (0.01-1KB) 
observed similar results, with the greatest stability in bacteria-phage coexistence 
at intermediate resource levels (0.1KB). Therefore, whilst resistance and 
infectivity are complex traits which may be influenced by complex and interacting 
selection effects across different ecological conditions (i.e. fitness effects of 
resistance evolution, changes in infection dynamics etc.), differences in the rate 
of co-evolution across ecological gradients are a primary factor in determining 
changes in these traits, and thus in the stability of bacteria-phage co-existence.  
As predicted, population mixing was shown to increase the risk of phage 
extinction. Higher encounter rates in mixed environments, which stimulate more 
intense coevolution (Brockhurst et al., 2003), increased the risk of phage 
extinction consistently across high and low resource supply levels. Population 
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mixing may act to intensify the coevolutionary imbalances promoted in each 
resource condition, which limit phage adaptation, thereby increasing the 
likelihood of phage extinction. Conversely, static conditions provide spatial 
refuges for susceptible bacteria by reducing dispersal and lowering encounter 
rates (Brockhurst et al., 2006), thereby limiting selection for bacterial resistance. 
In turn, this alleviates selection for increased phage infectivity and as a result may 
stabilise the coevolutionary interaction, promoting co-existence. Bacterial spatial 
refuges may be ‘self-organised’ in nature: Modelling of bacteria-phage 
populations demonstrates that density-dependent mechanisms, such as biofilm 
formation, may promote formation of phage-exclusion zones (Heilmann et al., 
2012). High phage densities could develop on the boundaries, but do not 
penetrate such zones, enabling susceptible bacterial genotypes to persist thereby 
promoting stable bacteria-phage coexistence.   
Our results suggest that coevolution-induced phage extinction is promoted by 
abiotic conditions which destabilise the symmetry of antagonistic coevolution. 
This highlights the importance of feedbacks between ecological processes and 
the co-evolutionary interactions embedded within communities. We currently 
understand little about the effects of environmental changes across space and 
time on the stability of microbial populations, or the impact of short term 
responses to such changes on the long-term evolutionary trajectory of these 
communities. Whilst a predator-prey style paradox of enrichment may apply to 
bacteria-phage interactions in some situations, it is clear that the multivariate 
ecological and evolutionary effects of resource enrichment or depletion depend 
on the broader ecological and evolutionary context. 
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Chapter Three 
Cross-resistance is modular in bacteria-phage 
interactions2 
3.1 Introduction 
Natural microbial communities are comprised of complex networks of species 
interactions, wherein each species may be engaged in ecological interactions 
with many other species (Friman and Buckling, 2013; Hambly and Suttle, 2005; 
Waterbury and Valois, 1993). In this community context, the evolutionary 
response of a focal species to a given pairwise species interaction can promote 
an “evolutionary cascade” through the adjacent interacting species (Betts et al., 
2016b; Toju et al., 2017). In the context of bacteria-phage interaction networks, 
we expect that the impact of a given phage resistance mutation will depend on 
the connectivity of that bacterial host within the community network (Dallas and 
Cornelius, 2015), and the degree of cross-resistance provided by the mutation 
against other phage species in the network (Koskella et al., 2011). While the 
statistical structure of interactions in bacteria-phage networks has been well-
studied (Weitz et al., 2013), the structure and underlying genetic basis of cross-
resistance networks remain poorly understood. This considerably limits our ability 
to predict how cross-resistance evolution affects bacteria-phage communities 
across different environmental, agricultural and clinical contexts.   
The extent of cross-resistance provided by a given resistance mutation is likely 
to depend on the genetic correlations between bacterial resistance traits selected 
by the different phage species. Cross-resistance is likely for cases of positive 
genetic correlation; for example, binding to shared receptors can cause 
synergistic pleiotropy between specific resistances, e.g. a mutation in the 
lipopolysaccharide (LPS) biosynthesis pathway is likely to promote cross-
resistance to other phages that also adsorb to LPS  (Lenski, 1984, 1988). In 
contrast, cross-resistance is less likely if there is antagonistic pleiotropy, where 
resistance to one phage increases susceptibility to an alternative phage [e.g. 
through replacement of a CRISPR spacer (Horvath and Barrangou, 2010)], or no 
                                               
2 Wright, R.C.T., Friman, V-P., Smith, M.C.M., and Brockhurst, M.A. (2018). Cross-resistance 
is modular in bacteria-phage interactions. PLOS Biology 16 (10), e2006057 
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genetic correlation, for instance if the phages bind to different receptors and 
accumulation of multiple resistance mutations is therefore required (Bohannan et 
al., 1999). Because individual resistance mechanisms frequently incur fitness 
costs by impairing the normal functioning of the molecule acting as the phage 
receptor, accumulation of multiple resistance mechanisms may be limited by their 
combined fitness costs, particularly if there is negative epistasis among the fitness 
costs of resistance mutations (Bohannan et al., 2002; Koskella et al., 2011). Even 
though pleiotropic costs should limit the evolution of generalist resistance, cross-
resistance is commonly observed (Betts et al., 2016a; Hall et al., 2012). Most of 
this evidence is however based on relatively simple phage communities and it is 
less clear how the range of cross-resistance provided by different resistance 
mutations is related to the magnitude of fitness costs in more complex bacteria-
phage networks.  
Understanding the structure of bacterial cross-resistance to phage infection also 
has important applied implications with relation to phage therapy, i.e., the use of 
phages as antimicrobials to treat bacterial infections (Kutter et al., 2010). Phage 
cocktails (i.e. combinations of different phages) have been shown to delay the 
evolution of resistance in bacteria, both in vitro (Barbosa et al., 2013) and in vivo 
(Fischer et al., 2013), compared to challenge with a single phage. Effective phage 
cocktails often contain phages that target different bacterial receptors, e.g. 
(McCallin et al., 2013; Yen et al., 2017), and as a result multiple resistance 
mutations in different receptor genes are required to provide resistance to all the 
phages present in the cocktail (Tanji et al., 2004). The requirement for bacteria to 
accumulate multiple resistance mutations is thought to enhance the evolutionary 
robustness of phage cocktails because there is a lower probability of resistance 
emerging. Furthermore, resistance to multiple phages is likely to be associated 
with greater fitness costs assuming additivity of fitness costs associated with each 
resistance mutation (Koskella et al., 2011). These assumptions may not apply, 
however, if very generalist cross-resistance is available via a single mutation 
affecting the expression of multiple phage receptors. This suggests therefore that 
minimising the potential for cross-resistance could be a key feature of effective 
phage cocktail design. However, this has not been tested experimentally. 
Here we determined the network structure and genetic basis of cross-resistance 
against a collection of 27 phages infecting the opportunistic human pathogen, 
Pseudomonas aeruginosa. The cross-resistance network contained both 
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symmetric (reciprocal) and asymmetric (non-reciprocal) interactions forming two 
cross-resistance modules defined by high within- but low between-module cross-
resistance. Within cross-resistance modules, resistance mutations targeted 
distinct phage receptors, whereas between module cross-resistance was caused 
by mutations targeting a global regulator likely to control the expression of 
multiple phage receptors. The range of cross-resistance provided by a mutation 
was not correlated to its fitness cost, except that global regulator mutations 
causing between module cross-resistance were costlier than mutations causing 
within module cross-resistance. Furthermore, the degree and symmetry of cross-
resistance predicted the ability of phage combinations to suppress bacterial 
growth and the frequency of resistance mutations. Together, our data suggest 
that an understanding of cross-resistance interactions could help to predict the 
impact of resistance evolution on host-parasite community structure and aid the 
rational design of therapeutic phage cocktails. 
3.2 Materials and Methods 
3.2.1 Study organisms   
A total of 27 different phage strains (Table S3.1) that were able to infect P. 
aeruginosa PA01 strain were used.  Four of the phage strains have been 
previously characterised and are known to be phylogenetically, structurally and 
serologically different (Friman et al., 2016; Merabishvili et al., 2007) and promote 
bacterial resistance evolution to differing degrees (Hall et al., 2012). The 
remaining 23 phage strains were isolated at the same time and location [Sewage 
water treatment facility, Jyväskylä, Finland; for isolation protocols and infectivity 
ranges see (Mattila et al., 2015)]. Sequence data is available for only two of these 
strains. 
3.2.2 Characterisation of phage genetic relatedness 
The genetic similarity of all phage strains was characterised using RAPD PCR 
(random amplification of polymorphic DNA) that uses a set of primers (Table 
S3.2) to amplify random sections of DNA, giving a unique PCR banding pattern 
for each distinct phage genotype. Phage DNA was extracted using the QIAamp 
DNA Mini Kit (Qiagen, Hilden, Germany), then a PCR was performed on each 
phage DNA sample (27 phages), with each primer (0.8µm final primer 
concentration; Table S3.3) under the following conditions:  4 initial cycles of 94°C 
for 45s, 30°C for 120s, 72°C for 60s, followed by 25 cycles of 94°C for 5s, 30°C 
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for 30s, 72°C for 30s, ending with 72°C for 10 mins. PCR products were run on 
1% Agarose gels, for 30 mins at 200V.  A difference matrix based on these 
banding patterns (i.e. the proportion of bands which two phage do not have in 
common), was used to make a neighbour joining tree [R package ‘ape’, (Paradis 
et al., 2004)].  
3.2.3 Culture conditions 
All bacterial cultures were grown in 6ml King’s media B (KB) in 30ml glass 
microcosms with loose fitting plastic lids and incubated at 37°C with orbital 
shaking (200rpm). Phage cultures were prepared by inoculating frozen stocks 
into 30ml microcosms containing 6ml KB with 60µl of PA01 overnight culture 
(approximately 109 cells ml-1). Following overnight incubation at 37°C, shaken, 
phage stocks were isolated by filtration (0.22µm) and stored at 4°C.  
3.2.4 Selecting spontaneous phage-resistant mutants 
To select spontaneous phage-resistant mutants, a modified fluctuation test was 
used (Harrison et al., 2015). To establish 135 independent sub-populations of 
PAO1, we selected a single colony and incubated for 8h before diluting by 1 in 10 
into individual wells of 96-well microplates containing 200µl of KB medium. 
Following overnight incubation, each of the bacterial populations was exposed to 
one of the 27 phages. Specifically, the overnight bacterial cultures were diluted 
by 10-2 directly into 200µl of a phage stock solution, giving a multiplicity of infection 
of approximately 100 phage particles per bacterial cell, and 5 independent 
bacterial populations per phage strain. From each bacteria-phage mixture 100µl 
was plated on KB solid agar and incubated overnight. Two colonies per plate were 
then re-streaked onto KB agar plates and grown overnight to remove phage 
particles. We then picked a single colony from each streak plate to give 10 
resistant mutants per phage strain (270 in total), which were then grown overnight 
in KB before preparing glycerol stocks (40% glycerol) and storing at -80°C. These 
overnight cultures were also filter sterilised (0.22µm) and plated on KB soft agar 
(0.8%) containing ancestral PA01 to check for any remaining phage particles. If 
phages were detected, phage-free stocks were created by re-streaking the 
resistant mutant from glycerol stocks and repeating the last step. For seven 
replicates, we were unable to isolate phage-free stocks, therefore these replicates 
were excluded from the analysis, leaving 263 resistant mutants in total.  
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3.2.5 Cross-resistance assays  
To assess the extent of cross-resistance conferred by resistance against 
individual phage strains, all 263 resistance mutants were assayed against each 
of the 27 phage strains individually. Cross-resistance assays were performed in 
96 well microplates (final volume of 150µl) in KB media, at an approximate 
multiplicity of infection of 10 phage particles per bacterial cell. The relative 
bacterial growth (RBG; Poullain et al., 2008), was calculated by comparing 
absorbance readings (600nm at t = 0 and t = 8h) in the presence and absence of 
phage (Eq. 1). RBG is a quantitative measure of bacterial resistance where 1 
indicates equal growth in the presence and absence of phage (i.e. complete 
resistance), and 0 indicates zero growth (i.e. complete susceptibility).  
For phage i, bacteria j: 
𝑅𝐵𝐺$% = 	 [)*+,--(/012)4)*+,--(/052)]78[)*+,--(/012)4)*+,--(/052)]9:;<=:>8																																																(1) 
Cross-resistance range describes the proportion of phages to which each 
resistant bacterial replicate mutant is resistant to, using a resistance threshold 
(RBG = 0.798) calculated as the 95% confidence interval of a normal distribution 
modelled over the peak of resistance within the complete RBG distribution (Figure 
S3.1). 
3.2.6 Measuring the fitness costs associated with cross-resistance 
To determine the fitness costs associated with different cross-resistance profiles, 
the growth of all resistant mutants was measured in the absence of phage and 
compared to growth of the ancestral PA01 strain. Bacterial cultures were 
inoculated directly from glycerol stocks into 150µl of KB media in 96 well 
microplates. Absorbance at 600nm measured every 30min for 24h (37°C, 
shaken) to create a growth curve for each resistant mutant. Due to variation in 
the type of fitness costs observed (i.e. increased lag, reduced maximum OD and 
reduced growth rate; Figure S3.2), we used the integral of each growth curve as 
a combined measure of the effect of resistance mutations on bacterial growth. 
The integral of the growth curve correlates well with each of the other growth 
parameters (Figure S3.3, Figure S3.4). The integral of each growth curve gives 
the total growth for each bacterial strain; dividing this value by the average 
integral for the ancestral PA01 strain gives an estimate of relative fitness.  
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3.2.7 Determining the cross-resistance network  
Cross-resistance interactions between two phage strains can be quantified as the 
proportion of resistance mutants screened against one phage that display cross-
resistance (RBG above 0.798) against the second phage, giving a directional 
metric of cross-resistance strength (CRF). To enable comparison of pairwise 
phage interactions a non-directional cross-resistance index (CRI) was used as 
the mean of the two directional CRF values.  
CRF can be used to construct an interaction network showing all directional 
cross-resistance interactions within a phage community. Firstly, an adjacency 
matrix is produced, containing directional CRF values for all possible phage pairs. 
The R package ‘igraph’ (Csardi and Nepusz, 2006) was used to convert the 
adjacency matrix into a network graph (a list of all the realised links in the network, 
and their associated weights; graph.adjacency function), which can then be 
plotted (plot.igraph function) as a directional weighted network. In the network, 
each node represents a single phage strain and the directional connections are 
weighted by CRF, showing the frequency of cross-resistance against each phage. 
A community-detection algorithm [cluster_edge_betweenness function in the 
‘igraph’ R package (Csardi and Nepusz, 2006)] was used to identify the phage 
strains within the cross-resistance network that formed modules. This edge-
betweenness algorithm (Girvan and Newman, 2002; Newman and Girvan, 2004) 
finds the optimum community structure of a given network by assigning a 
‘betweenness’ value to every link in the network based on the frequency with 
which the link is used to create pathways between all possible pairs in the 
network. High ‘betweenness’ values indicate links between poorly connected 
modules. By removing these links in a stepwise manner (recalculating 
‘betweenness’ values each time), the algorithm can define modules within the 
community. The subnetwork of the ten phages used in further analysis was 
extracted from this full network. 
3.2.8 Quantifying the frequency of phage resistance mutations  
Modified fluctuation tests (Harrison et al., 2015) were used to estimate bacterial 
mutation frequencies against either individual phage strains or combinations of 
two phage strains. Three microcosms were inoculated from single colonies of the 
ancestral PA01 strain. After overnight incubation, each microcosm was sub-
cultured into 55 wells of a 96 well microplate, diluting by 10-1 to a final volume of 
200µl then allowed to grow overnight at 37°C in a static incubator. Concurrently, 
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stock solutions of 10 phage strains (a subset representing each node within the 
CRF network; Figure S3.5) were prepared (as above). Phage combinations were 
assembled, consisting of each phage alone (100µl) and 1:1 mixtures of each 
possible phage pair (final volume 100µl), to give 55 different phage combinations. 
One independent 200µl PA01 culture from each of the three replicate microplates 
was then diluted 100-fold into each of the phage solutions, giving a multiplicity of 
infection of approximately 100 phage particles per bacterial cell, and incubated 
for 30 mins at 37°C in a static incubator.  
Initial bacterial cell density was estimated by plating serial dilutions of six random 
200µl PA01 cultures per replicate microplate. The number of phage-resistant 
spontaneous mutants was then calculated by plating 60µl of each bacteria-phage 
mixture onto solid KB agar to give colony forming units per ml (CFU/ml). The ratio 
of phage-resistant mutants to initial bacterial cell density provides an estimate of 
the mutational frequency (MF, Eq. 2) against each phage combination, then 
comparison to the individual phage strains gives relative mutational frequency 
(RMF, Eq. 3). 
 For phage suspension i, bacteria j: 
																																																											𝑀𝐹$ = 	 [ABC/EF]78[ABC/EF]9:;<=:>8																																																												                                                                 
(2) 
For phage pair i1 and i2,  
𝑅𝑀𝐹 =	 𝑀𝐹$G$HI𝑀𝐹$G.𝑀𝐹$H	 
(3) 
3.2.9 Suppression of bacterial growth by phage combinations 
To determine the ability of phage combinations to suppress growth of the 
ancestral PA01 strain, bacterial growth was measured over 24h in the presence 
of individual phage strains and all possible pairwise phage combinations of 10 
phage strains. This phage subset contains all four phages from module 1, and six 
module 2 phage (Figure S3.5), and is comprised of asymmetric (N=11) and 
symmetric (N=13) cross-resistance interactions, as well as pairwise interactions 
which promote no cross-resistance (N=21). Individual colonies of ancestral PA01 
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were inoculated into KB media, and following overnight incubation, were 
transferred to fresh KB media in 96 well microplates, diluting ten-fold. Phage 
suspensions were added at an approximate multiplicity of infection of 100, for 
both individual phage and pairwise phage combination treatments (prepared from 
phage stock solutions with a 1:1 ratio). Absorbance at 600nm was measured 
every 30min for 24h during incubation at 37°C with regular orbital shaking to 
produce growth curves for PA01 in the presence of each individual phage strain 
and all possible pairwise phage combinations within the phage subset (Figure 
S3.5), each replicated three times. 
3.2.10 Sequence analysis 
To assess the genetic basis of cross-resistance, we randomly chose one resistant 
mutant screened against each phage within the cross-resistance subnetwork 
(Figure S3.5), along with additional mutants representing symmetrical and 
asymmetrical cross-resistance profiles within resistance module 1, to be 
sequenced (22 independent spontaneous mutants in total). Bacteria were 
sequenced using the Illumina MiSeq platform, followed by bioinformatic analysis 
as follows: reads were aligned using Burrows-Wheeler Aligner (Li and Durbin, 
2009), SNPs and small indel variants were called by GATK HaplotypeCaller 
(McKenna et al., 2010), then gene information was added using SNPeff 
(Cingolani et al., 2012). Variants were filtered for quality by the following 
parameters: coverage of >20 reads per base pair, and frequency of alternative 
allele in >80% of reads. The quality of each variant was further assessed visually 
using an alignment viewer [igv; (Robinson et al., 2011)]. Additionally, called 
variants occurring in all 22 sequenced mutants were discarded as these represent 
mutations present in the ancestral PAO1 compared to the available reference 
strain used (accession ID AE004091). All sequence data has been uploaded to 
the European Nucleotide Archive (accession ID PRJEB27828). 
3.2.11 Confirmation of phage surface receptor targets 
To confirm that distinct cell surface receptors are required for infection by module 
1 phages compared to module 2, we tested the ability of all 27 phage strains to 
infect a pilB transposon mutant (PW8623 pilB-G07::ISlacZ/hah; Pseudomonas 
aeruginosa Two Allele Library) versus wildtype PAO1. Bacteria lawns were 
prepared as follows: three colonies were selected for each bacterial strain, 
inoculated into KB media (6ml) and grown overnight at 37°C, shaken; 200ul of 
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each culture was added to 12ml of soft KB agar (0.6% agar) and poured over set 
standard KB agar (1.2% agar) in a 120mm square petri dish to form a bacterial 
lawn. Filtered phage stocks were serially diluted, and each dilution was spot 
plated (5µl) onto a lawn of each bacteria. Plates were incubated at 37°C for 24h, 
then phage plaques were counted and density calculated as plaque forming units 
per ml.  
3.2.12 Statistical analysis 
All analysis was conducted in R (R Core Team, 2016). Resistant mutants 
originating from the same subpopulation were treated as paired replicates to 
prevent pseudo-replication. This means for 263 resistant mutants, we have 133 
independent replicates. Variation in cross-resistance range between different 
focal phages was analysed using the non-parametric Kruskal-wallis test, after 
averaging within subpopulations.  To test for associations between cross 
resistance range and focal resistance or relative fitness, linear mixed effects 
models [R package ‘lmerTest’ (Kuznetsova et al., 2017)] were used with 
subpopulation included as a random effect. Variation in relative fitness between 
mutants with different network-level cross-resistance (i.e. within/between 
modules) was analysed using a one-way anova followed by post-hoc testing 
(Tukey test). Comparison of phage densities between transposon mutant (pilB) 
and wild type hosts was performed using a linear mixed effects model, with 
bacteria and phage treated as interacting fixed effects. Statistical analysis of the 
effect of cross-resistance interaction type (i.e. symmetric/asymmetric) on RMF 
data was performed using the Kruskal-Wallis test, followed by post-hoc testing 
(pairwise Mann-Whitney U) to compare interaction types.  
3.3 Results 
3.3.1 Variation in cross-resistance provided by individual resistance mutations 
To determine the extent of cross-resistance we tested 263 spontaneous resistant 
mutants of P. aeruginosa PAO1 selected against each of 27 phages (i.e. 10 
resistant mutants were selected against each focal phage; 7 mutants were 
discarded due to persistent phage contamination) for their ability to resist infection 
by all other phages (cross-resistance). Resistance was determined by measuring 
relative bacterial growth (RBG) of each spontaneous mutant in the presence 
versus absence of each phage where mutants were classified as resistant if their 
RBG exceeded a binary resistance threshold [RBG = 0.798; calculated as the 
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95% confidence interval of a normal distribution modelled over the peak of 
resistance within the complete RBG distribution (Figure S3.1)]. We observed 
variation in the pattern and range of cross-resistance among spontaneous 
resistance mutations (Figure 3.1; Figure S3.6). First, the degree of cross-
resistance selected by the different focal phages varied extensively, ranging from 
conferring resistance against less than 10% to up to 80% of all phages (Figure 
S3.6; Kruskal-Wallis c226=66.6, p<0.0001). Second, both focal resistance and 
cross-resistance phenotypes varied considerably between independently evolved 
resistant mutants selected against the same focal phage (Figure S3.6). Together 
these results suggest that the magnitude of cross-resistance depends on the focal 
resistance selected, and that multiple resistance mechanisms may exist against 
the same focal phage, resulting in different levels of cross-resistance between 
independent replicate mutants.  
 
Figure 3.1 Cross-resistance network describing quantitative cross-
resistance between all possible phage combinations 
Each node represents a phage strain and arrows between nodes show directional 
cross-resistance frequency (CRF) between two phages. The line widths are 
scaled by the proportion of replicate mutants selected against the focal phage 
(origin node) which have resistance above the binary threshold (Figure S3.1) to 
the second phage (target node). Node colours define resistance modules 
identified using an ‘edge-betweenness’ algorithm. A subset of 20 phage strains 
that all showed strong symmetric cross-resistance were grouped together as the 
node labelled ‘Other’.   
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3.3.2 Cross-resistance range was not limited by fitness costs or strength of focal 
resistance 
The evolution of broad, generalist cross-resistance could be constrained if it was 
associated with relatively higher costs compared to more specialised resistance, 
or if mutations providing cross-resistance concomitantly provided only weak 
resistance against the focal phage. In contrast, while all resistance mutations 
selected against focal phage were costly (Figure 3.2A; one-sided t-tests: all 
p<0.005), we observed no overall relationship between the range of cross-
resistance provided by resistance mutations and their associated costs (Figure 
3.2A; linear mixed effects model: t236=-0.655, p=0.513). Moreover, we observed 
a positive relationship between the strength of focal resistance and the range of 
cross-resistance provided by resistance mutations (Figure 3.2B; linear mixed 
effects model: t245=15.09, p<0.0001). These results suggest that the evolution of 
cross-resistance is unlikely to be constrained by trade-offs due to associated 
fitness costs or the strength of the focal resistance. 
3.3.3 The structure of the cross-resistance network 
Network analysis of the directional cross-resistance frequency (CRF) of all 
pairwise phage combinations produced a cross-resistance network with two 
distinct modules (Figure 3.1). Within each module, all possible pairwise phage 
combinations were connected by some degree of cross-resistance, whereas 
cross-resistance between the two modules was more limited (narrower arrows 
between nodes denote low frequency of cross-resistance interactions) and 
observed only between a small proportion of all the potential phage pairs (8/92, 
i.e. around 8.7%, Figure 3.1). Within modules, asymmetric (i.e. non-reciprocal) 
cross-resistance was more common within module 1, while module 2 was 
dominated by symmetric (i.e. reciprocal) cross-resistance (note that the ‘other’ 
node in module 2 of Figure 3.1 contains a subset of 194 mutants providing 
consistently strong symmetric cross-resistance against 20 phages). The high 
degree of symmetric cross-resistance observed in module 2 could not be 
explained simply by the genetic similarity of the focal phages as estimated from 
their RAPD PCR banding patterns (Figure S3.7). Between module cross-
resistance was always asymmetric and typically from module 1 to module 2 
(Figure 3.1). This network structure was robust to the binary threshold value used 
to classify resistance, although using lower thresholds led to increased numbers 
of asymmetric connections between modules (Figure S3.8). Symmetric cross-
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resistance is likely to occur where both phages select for similar modifications to 
a shared receptor, whereas asymmetric cross-resistance could result if phages 
selected for different modifications to a shared receptor that varied in the extent 
of disruption or for entirely different resistance mechanisms that varied in the 
extent of generalism. To study this at the genetic level, we next obtained whole 
genome sequences for resistant mutants selected against a subset of 10 focal 
phages that represented all nodes of the cross-resistance network (Figure S3.5). 
Figure 3.2 Effect of relative fitness and focal resistance on cross-resistance 
range 
Relationship between cross-resistance range (the proportion of non-focal phages 
to which the bacterial mutant has resistance above the binary threshold) and 
relative fitness of spontaneous resistance mutants (A) measured as growth 
relative to the ancestral strain in phage-free standard media conditions, and (B), 
the strength of focal resistance, given as growth in the presence of the phage 
selected against, relative to growth in the absence of phage (RBG).  
3.3.4 Molecular basis of within and between module cross-resistance 
We obtained whole genome sequences for 22 independent spontaneous 
resistant mutants of PAO1 selected against 10 focal phages to identify mutational 
changes associated with specific phage resistance profiles (Figure 3.3; Figure 
S3.5). Cross-resistance within module 2 was associated with mutations in LPS 
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biosynthesis genes, wzy and wbpL, whereas cross-resistance within module 1 
was associated with mutations in various genes encoding type IV pilus 
biosynthesis (Figure 3.3; Table S3.3). These included genes encoding 
mechanical components of the type IV pilus, such as the motor proteins PilB and 
PilT, and enzymes involved in type IV pilus biosynthesis and assembly such as 
PilD, a prepilin peptidase. These data confirm that cross-resistance modules were 
determined by distinct phage adsorption cell-surface receptors, specifically, the 
LPS for module 2 phages and the type-IV pilus for module 1 phages. We 
confirmed distinct receptor usage by testing the ability of all 27 phages to infect 
an unpiliated pilB transposon mutant: whereas module 1 phages were unable to 
form plaques on the unpiliated host, module 2 phages infected the unpiliated 
mutant at the same efficiency as they infected the piliated wild type PAO1 host 
(all p>0.1; Figure S3.9). Between module cross-resistance was associated with 
mutations in genes encoding the transcriptional regulators, RpoN and PilS (Figure 
3.3; Table S3.3). This suggests that more generalist phage resistance required 
changes in bacterial gene regulation, which are likely to have broader-scale 
effects on the bacterial phenotype than mutations affecting structural genes 
performing steps in biosynthetic pathways. In addition, weaker between module 
cross-resistance was associated with a mutation of the prepilin peptidase 
encoding gene pilD (Figure S3.10); here the likely mechanism of between module 
cross-resistance less clear. 
3.3.5 Fitness cost of between-module cross-resistance is gene-specific 
To test if the different classes of resistance mutations identified by sequencing 
were associated with different magnitudes of fitness cost we estimated the fitness 
of each of the genome sequenced strains relative to PAO1 in the absence of 
phage.  Between module cross-resistance was associated with higher fitness 
costs than within module cross-resistance (Figure 3.4A; ANOVA with post-hoc 
Tukey test: module 1, p=0.009; module 2, p=0.015), but this was entirely due to 
far higher fitness costs caused by resistance mutations in the rpoN gene 
compared to resistance mutations in either type-IV pilus or LPS biosynthesis 
associated genes (Figure 3.4B). Thus, between module cross-resistance 
mutations in global regulators that are likely to disrupt many cellular functions are 
highly costly in the absence of phage, which may limit their long-term survival in 
bacterial populations.  
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Figure 3.3 Genetic basis of phage resistance  
Circles represent different phage resistant mutants selected against different 
focal phages (indicated by the colour shade; see key) and dots on each circle 
show the position of mutated genes.  Colour represents the cross-resistance 
profile of each sequenced resistant mutant: resistance within module 1 (purple), 
within module 2 (green), and between-modules (generalist resistance, blue). 
3.3.6 Cross-resistance determines the evolution of resistance to phage 
combinations 
We hypothesised that the degree and symmetry of cross-resistance between a 
pair of phages would predict the frequency of resistance evolution against phage 
combinations. Specifically, we predicted the highest frequency of resistance 
mutation would occur against pairs selecting for symmetric cross-resistance, 
followed by asymmetric cross-resistance, and lowest for no cross-resistance. To 
test this, we first estimated the frequency of resistance mutations against phage 
pairs relative to individual phages for all possible combinations of the subset of 
10 phages representing all nodes of the cross-resistance network (Figure S3.5). 
One phage (PA5P2) was excluded from further analysis because the absolute 
resistance mutation frequencies observed against this phage were unfeasibly 
high (~1.7 x 10-3 for PA5P2 alone; Figure S3.11). This could possibly indicate that 
a physiological mechanism of resistance against PA5P2 infection exists, in 
addition to the Type IV pilus-associated mutational mechanism observed in the 
sequenced resistant clone (Figure 3.3; Table S3.3).  
 
ϕPA13P1 PA10P2 14/1 PA2P1 PA5P1 PA7P2 KZ PA5P2 PT7 PNM
Between-module resistance
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Figure 3.4 Effect of cross-resistance type and mutational target on relative 
fitness of spontaneous resistant mutants  
Fitness relative to the phage-susceptible PAO1 ancestor of 263 spontaneous 
resistant mutants sorted by A) cross-resistance type or B) mutated locus. Colours 
denote cross-resistance type: within module 1 only (purple), within module 2 only 
(green), and between modules (blue). The dashed line (relative fitness = 1) 
represents equal fitness to the ancestor.   
We found a positive relationship between the cross-resistance index (CRI; a non-
directional measure of cross-resistance) and the relative mutation frequency 
(linear regression R2=0.280, F1,106=42.7, p<0.0001). Moreover, consistent with 
our hypothesis, the relative mutation frequency was highest for phage pairs that 
selected for symmetric cross-resistance (Figure 3.5; Symmetrical vs. 
Asymmetrical p=0.001; Symmetrical vs. None p<0.0001) and lowest for phage 
pairs that selected no cross-resistance (Figure 3.5; Asymmetrical vs. None 
p<0.0001). Thus, cross-resistance per se increased the frequency of resistance 
mutations, with the effect being strongest when cross-resistance was symmetric.  
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Figure 3.5 Relative mutational frequency for resistance against phage pairs 
exerting symmetrical, asymmetrical and no cross-resistance 
Relative mutational frequency compares the frequency of resistance mutations 
against phage pairs to the geometric mean of mutational frequency against each 
individual phage. Dashed line represents equal frequency of resistance mutations 
against a phage pair versus the constituent phages individually.  
Consistent with the observed resistance mutation frequencies, phage pairs that 
selected no cross-resistance suppressed the growth of PAO1 most effectively 
during 24h, whereas the effect of phage pairs that selected symmetric cross-
resistance rarely differed from the best-performing individual phage (Figure 
S3.12). Interestingly, two phages did not conform to this pattern: Firstly, phage 
PA10P2 alone was sufficient to completely suppress bacterial growth, and all 
pairs including this phage were highly effective regardless of the symmetry of the 
cross-resistance. Secondly, phage pairs containing PA2P1 consistently 
performed poorly irrespective of the symmetry of cross-resistance. These results 
suggest that structure of cross-resistance predicts the performance of phage 
combinations, but that strong phage identity effects can override this by either 
increasing or decreasing the efficacy of a phage combination more than expected 
by cross-resistance alone. 
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3.4 Discussion 
We analysed the network structure and underlying genetic basis of cross-
resistance evolution in the bacterium P. aeruginosa PAO1 selected against 27 
phages. Our data show that spontaneous resistance mutations against a focal 
phage commonly provide cross-resistance against other phages. The cross-
resistance network was highly modular, containing two cross-resistance modules 
with high within- but weak between-module cross-resistance interactions. At the 
genetic level, cross-resistance modules were defined by shared mutational 
targets encoding biosynthesis of phage adsorption receptors (LPS or type IV 
pilus, respectively), while between module cross-resistance was associated with 
mutations targeting regulatory genes. The strength, direction and symmetry of 
cross-resistance between phage pairs predicted both the frequency of resistance 
mutation and the efficacy with which the phage pair suppressed bacterial growth: 
The highest performing phage combinations were those that selected no cross-
resistance, whereas the lowest performing combinations selected symmetric 
cross-resistance. Taken together, these data suggest that cross-resistance will 
commonly shape the dynamic structure of bacteria-phage communities, and that 
it is likely to be an important predictor of the robustness of phage therapy to 
resistance evolution. Further experiments will be required, however, to test 
whether cross-resistance predicts the efficacy of phage cocktails in more complex 
in vivo environments.  
Our finding that cross-resistance was common for our phage collection suggests 
that resistance evolution events may frequently disrupt the structure of bacteria-
phage interaction networks. Cross-resistance evolution has the effect of reducing 
connectance at the whole community level more than would be expected if all 
interactions were strictly pairwise. The effect of connectance on community 
stability is dependent on underlying species interaction network architecture; 
reduced connectance can increase stability in trophic networks by enhancing 
modularity, but may reduce stability in networks with nested structures (Thébault 
and Fontaine, 2010). Bacteria-phage networks typically have a nested-modular 
network structure (Beckett and Williams, 2013; Flores et al., 2013), thus the 
impact of cross-resistance-mediated reduced connectance is likely to depend on 
precisely where in the network cross-resistance interactions occur. It seems 
reasonable to assume that modularity in bacteria-phage interaction networks may 
be caused by the same mechanism that causes cross-resistance modularity, 
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namely shared phage receptors. If this assumption is correct, then cross-
resistance evolution may frequently lead to the collapse of isolated nested 
modules without destabilising the broader interaction network. Resistance in our 
experiments arose largely through mutations affecting the expression or 
biosynthesis of surface receptors. Notably, PAO1 lacks a CRISPR-Cas system 
and it is likely that CRISPR-mediated phage resistance would cause cross-
resistance to only very closely related phages that are sequence identical for the 
genomic region targeted by the newly integrated spacer. In systems where both 
resistance mechanisms occur, by which mechanism resistance evolves is thought 
to depend on ecological conditions, with surface receptor modification favoured 
in high resource environments with high phage densities (Westra et al., 2015), 
suggesting that in such systems the structure of cross-resistance evolution may 
be highly ecologically contingent.  
While resistance mutations were costly, we found no overall relationship between 
the range of cross-resistance provided by resistance mutations and their 
associated fitness costs, suggesting that the evolution of cross-resistance is 
unlikely to be constrained by fitness trade-offs except for rare cases of very 
generalist between-module cross-resistance (Figure 3.4B). This finding is 
somewhat surprising since previous studies of pairwise bacteria-phage 
interactions and interactions between bacteria and multiple phage species have 
reported that broader resistance ranges are associated with higher costs (Gómez 
and Buckling, 2011; Koskella et al., 2011). In contrast to these studies, however, 
we did not allow broad resistance ranges to evolve via accumulation of multiple 
sequential mutations but instead measured the effects of single spontaneous 
resistance mutations on cross-resistance. It seems likely therefore that higher 
costs of generalist phage resistance described previously arise from negative 
epistasis between multiple resistance mutations rather than from inherent costs 
of cross-resistance itself. At a community level, cross-resistance could limit the 
ability of phages to maintain bacterial diversity via density dependent killing 
(Thingstad, 2000). This could be mitigated by migration between local 
communities, promoting invasion of novel phages to which resistance is absent 
in the local community, or through phage counter-adaptation. For example, phage 
have been shown to switch hosts in multi-host environments (Betts et al., 2016b), 
and expand host range through spontaneous mutation (Duffy et al., 2006; Meyer 
et al., 2012). An important caveat is that fitness costs measured in simple lab 
environments are likely to underestimate the full extent of the pleiotropic effects 
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of resistance mutations in more complex in vivo environments relevant to phage 
therapy. For example, loss of the type-IV pilus is likely to be highly detrimental in 
vivo where type-IV pilus-mediated motility, attachment and biofilm formation play 
important roles in pathogenesis (Persat et al., 2015).   
The modular structure of the cross-resistance network was determined by the 
shared phage receptors modified by resistance mutations. Within cross-
resistance modules, mutations targeted biosynthesis of specific surface receptor 
targets for phage binding (Table S3.3), specifically the type IV pilus in module 1 
or the LPS biosynthesis in module 2. Resistance to the same phage could be 
provided by mutations to different genes in the same pathway. For example, 
mutations selected against phage PA5P2 affected PilD [a peptidase which 
processes prepilins; (Nunn and Lory, 1991)], PilQ [which is involved in assembly 
and transport; (Martin et al., 1993)], and PilT [a motor protein which power pilus 
retraction; (Chiang et al., 2008)]. By contrast, mutations that provided very 
generalist between-module resistance targeted the regulatory genes, rpoN and 
pilS. RpoN is an alternative sigma factor which regulates transcription of 
approximately 700 genes, influencing a diverse range of functions including 
motility (via both type IV pilus and flagella associated genes), quorum sensing, 
mucoidy and biofilm formation (Lloyd et al., 2017). PilS is part of a two-component 
regulatory system which promotes pilus expression by activating RpoN (Hobbs 
et al., 1993). The diverse regulatory function of RpoN makes it difficult to identify 
the specific mechanism of generalist phage resistance. However, RpoN 
regulation of LPS-associated genes has been identified in P. aeruginosa [rfaD; 
(Lloyd et al., 2017)] and shown to directly influence LPS expression in Salmonella 
enterica [via rfaH; (Bittner et al., 2002, 2004)]. It is possible, therefore, that global 
regulatory mutations affecting the expression of multiple phage receptors could 
be typical for very generalist phage resistance. Crucially, only less than 10% of 
resistance mutants possessed generalist cross-resistance against both LPS and 
pilus binding phages, which suggest that these mutations are rarer. This is 
intuitive since there are many more mutational targets in each biosynthesis 
pathway compared to the single copy of the rpoN gene. Moreover, the 
evolutionary success of global regulator-mediated resistance may be limited by 
the extensive pleiotropic effects of such mutations on the bacterial phenotype. 
Consistent with this, rpoN mutants suffered the greatest impairment in growth rate 
of all the observed resistance mutations (Figure 3.4B). Interestingly, between 
module cross-resistance could be achieved at lower cost through mutations 
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affecting pilS, which were no more costly than other resistance mutations in type-
IV pilus-associated genes, suggesting that loss of PilS-mediated activation of 
RpoN may have been less disruptive to the cell than loss of RpoN itself. Because 
RpoN controls expression of important virulence-related functions, such as 
quorum sensing and biofilm formation, phage combinations that select for these 
mutations may concomitantly drive reduced virulence.  
Surprisingly, we observed that asymmetric cross-resistance was common within 
our cross-resistance network. Reducing the threshold used to define resistance 
further increased asymmetric connections between modules, suggesting that 
asymmetric cross-resistance may often be rather weak. While the mechanistic 
basis of symmetric cross-resistance appears conceptually straightforward - the 
two phages select for similar modifications to and/or loss of a shared receptor 
[e.g. via LPS modification (Betts et al., 2016a)] - the situation is likely to be more 
complex for asymmetric cross-resistance. We propose two potential routes to 
asymmetric cross-resistance: First, phages may select qualitatively different 
mechanisms of resistance offering different degrees of generality, for example 
one phage may select for mucoidy (Labrie et al., 2010; Scanlan and Buckling, 
2012), masking a number of different phage receptors thus providing cross-
resistance, whereas the other phage may select for modification of a specific 
receptor only and limited cross-resistance. Second, resistance mutations for each 
phage may target different points in a biosynthesis pathway, such that mutations 
affecting the start of the pathway will provide greater cross-resistance than those 
affecting targets downstream (Scanlan et al., 2015a). Consistent with the latter 
mechanism, within module 1, the observed mutations in rpoN which are likely to 
result in an unpiliated phenotype, provided complete cross-resistance within 
module 1, whereas mutations to genes lower down the pilus biosynthesis 
pathway [e.g. pilB and pilT encoding motor proteins which control extension and 
retraction of the pilus respectively; (Chiang et al., 2008)], provided cross 
resistance to only half of module 1 phage. Understanding the mechanistic basis 
of cross-resistance in general, and the symmetry of cross-resistance in particular, 
should be a target of future research.   
Our findings show that cross-resistance and its symmetry predicts the efficacy of 
phage combinations both in terms of the frequency of resistance mutation and 
the efficiency of suppression of bacterial growth. Frequencies of resistance 
mutation were the highest for phage pairs with symmetric cross-resistance and 
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the lowest for phage pairs that showed no cross-resistance, suggesting either 
multi-step mutational changes or rarer generalist resistance mutations were 
required in the latter scenario. Consequently, phage pairs that exerted no cross-
resistance often completely supressed bacterial growth, whereas failure to 
supress bacterial growth was more common for phage pairs that promoted some 
degree of cross-resistance evolution. Our analysis also identified individual phage 
strains that increased (or decreased) the performance of phage combinations 
more than predicted by cross-resistance alone. Although we observed an overall 
positive association between the strength of focal resistance and the strength of 
cross-resistance, in some cases focal resistance caused by a mutation was 
quantitatively weaker than the cross-resistance(s) or undetectable. Since 
spontaneous resistant mutants have not had the opportunity to specialise their 
resistance against the focal phage, it is perhaps unsurprising that stronger cross-
resistance can arise by chance. More puzzling are the cases of undetectable focal 
resistance despite there being observable cross-resistance and a resistance 
mutation identified in the genome sequence. This phenomenon was limited to 
particular phages: fKZ (pilR mutation), PA5P1 (wzy mutation) and PT7 (pilS, pilT 
and pilJ mutations). While we do not understand the mechanism underlying 
missing focal resistance, it is possible that this could be caused by extremely high 
rates of phage evolution to overcome the resistance mutation during the RBG 
assay, or particular phages being able to use an alternative surface receptor 
(Bertozzi Silva et al., 2016). This suggests that other properties of phage life-
history are likely to affect their usefulness in phage combinations and that 
predictions based on cross-resistance networks could be sensitive to strong 
phage identity effects.  
Pseudomonas aeruginosa is a common cause of opportunistic infections, 
frequently of burn wounds, and is also the major pathogen associated with 
chronic infections of the cystic fibrosis (CF) airway (Bjarnsholt et al., 2009; Driscoll 
et al., 2007; Pirnay et al., 2003; Willner et al., 2012). High-level antibiotic 
resistance frequently makes P. aeruginosa CF infections non-responsive to 
antibiotic treatments and consequently very difficult to eradicate (Deredjian et al., 
2011). As a result, phage therapy has been suggested as a potential alternative 
or complementary treatment (Morello et al., 2011; Pires et al., 2015; Torres-
Barceló et al., 2014). Phage therapy has shown promising results against P. 
aeruginosa in both artificial CF lung sputum-like environments and murine models 
(Waters et al., 2017). However, clinical trials of phage therapy on P. aeruginosa 
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colonised burn wounds have proved inconclusive thus far (Merabishvili et al., 
2009; Rose et al., 2014). Our results suggest that unknown patterns of cross-
resistance selected by the phages used in therapeutic cocktails could account for 
some degree of variation in the efficacy of phage therapies in these studies. Using 
combinations of phages that do not select for cross-resistance could potentially 
improve the efficacy and robustness of phage cocktails, increasing their ability to 
suppress bacterial growth by limiting resistance evolution. While caution is 
required when making inferences from simple lab experiments to far more 
complex in vivo environments, our data suggest that analysis of cross-resistance 
networks could aid the design process for improved therapeutic phage cocktails 
and warrants future in vivo experimental tests.  
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Chapter Four 
Effect of sequential versus simultaneous 
exposure to phages on host resistance evolution 
4.1 Introduction 
As antimicrobial resistance continues to rise, with a potentially devastating impact 
on human health and the world economy (O’Neill, 2014), there has been renewed 
interest in the therapeutic use of phages to treat bacterial infections, which offers 
a viable alternative to antibiotics for some infections (Roach and Debarbieux, 
2017). Yet as with antibiotics, the evolution of bacterial resistance to phages could 
limit treatment success (Rohde et al., 2018). Phage cocktails are considered 
better than single phage treatments as they can target a broader host range and 
are potentially more evolutionarily robust (Chan et al., 2013; Torres-Barceló, 
2018). Conceptually, combining multiple phages into one treatment has the 
potential to suppress the evolution of resistance as multiple specific resistance 
mutations are less likely to arise in the same cell (Latino et al., 2016), and may 
impose additive fitness costs (Bohannan et al., 2002; Koskella et al., 2011). By 
delaying and/or moderating the evolution of resistance (Barbosa et al., 2013; 
Fischer et al., 2013), phage cocktails could therefore increase the likelihood of 
treatment success. However, co-evolution with multiple phage strains is also 
known to increase the rate of host evolution (Betts et al., 2016a, 2018), increasing 
the speed at which resistant genotypes could sweep through population making 
subsequent treatments more difficult. There is considerable interest therefore in 
understanding the evolutionary principles of phage cocktail design, for example, 
pre-adapting phage strains can improve their durability to the host evolving 
resistance (Betts et al., 2013; Friman et al., 2016; Kelly et al., 2011), and imposing 
concurrent selection for multiple resistances may limit the potential of host 
resistance evolution (Filippov et al., 2011; Tanji et al., 2004). 
Host resistance is commonly acquired through mutations altering cell-surface 
receptors to prevent phage adsorption (Betts et al., 2016a, 2018; Gurney et al., 
2017). As a collateral effect, this can provide cross-resistance to other phages 
targeting the same adsorption receptor (Chapter 3, Betts et al., 2016), and even 
to antibiotics (Chan et al., 2016). If single phage-specific resistance mechanisms 
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can protect the host from multiple phages targeting the same receptor, resistance 
may evolve as easily against multiple phages as against individual phage 
(Chapter 3). However, resistance to phage combinations targeting multiple 
adsorption receptors may be more difficult to acquire, requiring either generalist 
resistance (Betts et al., 2016a; Scanlan and Buckling, 2012), or multiple specific 
resistances (Tanji et al., 2004). We have previously found that phage 
combinations can be no more effective than a single phage if they promote cross-
resistance, whereas phage combinations which do not promote cross-resistance 
to one another better suppress bacterial growth due to reduced frequencies of 
resistance mutations (Chapter 3). Similar to the concept of combining antibiotic 
and phage treatments (Torres-Barceló and Hochberg, 2016), by imposing 
selection on multiple different targets concurrently, we may impose additive, or 
even synergistic (i.e. higher than additive) stress on the bacterium. 
Depending on the architecture of genetic correlations among multiple resistance 
mechanisms, concurrent selection may force a trade-off in resistance strength at 
a mechanistic level (e.g. mutation in receptor increasing antibiotic susceptibility; 
Chan et al., 2016; Kirby, 2012), or lead to untenably high fitness costs if the costs 
of each mutation accumulate additively or synergistically via negative epistasis 
(Bohannan et al., 2002; Koskella et al., 2011). Single mutations may be acquired 
which provide generalist resistance, however, this often either imposes 
substantial fitness costs (e.g. where mutations in transcriptional regulators such 
as RpoN disrupt many cell functions; Chapter 3), or only provides weak resistance 
(e.g. mucoidy; Betts et al., 2016; Scanlan and Buckling, 2012). Some sequential 
phage treatments have been proven equally as effective as simultaneous 
application (Hall et al., 2012), however it is unclear whether they promote different 
resistance profiles. Additionally, phage treatments prior to antibiotic treatment 
have been shown to improve bacterial killing more than either sequential 
treatments or the reverse order (i.e. antibiotic first; Chaudhry et al., 2017; 
Kumaran et al., 2018), suggesting there are important order effects when multiple 
selection pressures which are imposed. These differences may be compounded 
over longer evolutionary timescales; for example, over short timescales single 
mutations which can promote broad phage resistance may be selected for, 
whereas over longer timescales bacteria which accumulate multiple resistance 
mutations, along with potentially compensatory mutations, may be more 
dominant. We are interested in unravelling the mechanistic basis of resistance to 
multiple phage strains to determine if the degree of resistance evolution, and its 
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associated fitness costs, are dependent on the order of sequential exposure to 
phages, or if simultaneous exposure can produce equivalent resistance.  
We compared the evolution of multi-phage resistance with Pseudomonas 
aeruginosa PAO1 strain against pairs of phage strains targeting either the same 
or different cell-surface receptors (LPS and Type IV pilus), selected in one-step 
(i.e. simultaneous exposure) or sequentially against one phage at a time for both 
sequential orders. For both treatments, resistant mutants were selected over 
limited time frames (less than 48h total growth per selection phase) to select only 
spontaneous mutants which would occur in a naturally diverse population. We 
found that sequential exposure allowed accumulation of multiple phage-specific 
resistances provided by mutations in cell surface receptor targets of phage 
adsorption without imposing any trade-offs in resistance strength. Further, the 
order of phage exposure determined the fitness costs of sequential resistance, 
such that certain sequential orders imposed much higher fitness costs than the 
same phage pair in the reverse order. In contrast, simultaneous selection for 
phage resistances resulted in weaker resistance to both phages compared to the 
strength of sequential resistance yet imposed similar fitness costs. This suggests 
that phage combination treatments can be rationally designed to limit the strength 
of evolved resistances and to maximise fitness costs associated with resistance.  
4.2 Materials and Methods 
4.2.1 Strains and culture conditions 
Bacterial cultures of P. aeruginosa PAO1 were grown in King’s media B (KB), as 
6ml volumes in a 30ml glass microcosm with loose plastic fitting lids, and 
incubated at 37°C, shaken (180rpm). Four genetically distinct phage strains with 
characterised adsorption targets (see Chapter 3), were used to select phage 
resistance: PA5P2 and PT7 (Type IV pilus-binding phage), PA10P2 and 14/1 
(LPS-binding phage). Phage cultures were prepared directly from frozen glycerol 
stocks, added to approximately 107 cells ml-1 of ancestral PAO1 from overnight 
culture and incubated overnight at 37°C, shaken (180rpm). Phage stocks were 
purified by filtration to remove bacteria (0.22µm), and stored at 4°C. 
4.2.2 Selection of spontaneous phage-resistant mutants 
We used a modified fluctuation test (Harrison et al., 2015) to select spontaneous 
phage-resistant mutants against all pairwise phage combinations, under both 
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simultaneous and sequential selection. Three independent bacterial colonies 
were selected by streaking out the ancestral bacteria directly from glycerol stock 
onto KB agar (incubated overnight at 37°C); colonies were inoculated into 6ml KB 
and incubated at 37°C (shaken) for 8h, then used to found 10 subpopulations by 
diluting each culture 10-fold into 10 wells of a 96 well microplate containing KB 
media to a final volume of 200µl. Samples of these initial bacterial cultures were 
also frozen (20% glycerol, -80°C) to be used for replicates, and assigned the 
names PAO1_FT1, PAO1_FT2, PAO1_FT3.  
For each ancestral replicate, we selected phage resistance against each of the 4 
individual phage strains independently (1st step of sequential selection) and 
simultaneously against each possible phage pair (i.e. 6 different pairwise 
combinations) by exposing each of the 10 bacterial subpopulations to a different 
phage treatment. Bacterial subpopulations were diluted 100-fold into 600ul of 
phage stock solution (300ul of each phage for simultaneous selection) in deep-
well 96 well plates, giving a multiplicity of infection of ~100 phage per bacteria at 
a density of ~107 bacterial cells per ml, then plated out in 60ul volumes onto KB 
agar. For combinations with low expected mutation frequency, the complete 
mixture was plated (i.e. all 600ul in 60ul volumes). Following incubation at 37°C 
for 24h, single colonies were picked from each plate and re-streaked onto KB 
agar to remove phage particles and incubated overnight. If no colonies were 
present, the same plates were incubated for a further 24h at 37°C to allow slow-
growing mutants time to produce colonies, which were then selected and re-
streaked as before. Single colonies were selected from streak plates and grown 
overnight in 6ml KB, before glycerol stocks were prepared (20% glycerol, stored 
at -80°C) and characterised for phage-resistance by cross-streaking against pure 
stocks of each phage strain on KB agar. Any phage treatments for which no 
bacterial colonies could be selected, or where selected colonies lacked any 
phage resistance, the whole selection process was repeated using the same 
initial ancestral clone, inoculated directly from the glycerol stock to produce 
bacterial subpopulations. One clone per ancestral replicate was then chosen for 
further characterisation (i.e. resistance strength, fitness costs and sequence 
analysis), based on initial cross-streaking results. This produced a total of 12 
resistant mutants selected against single phage strains (1st step sequential 
selection – 3 ancestral replicates x 4 phage strains), and 18 resistant mutants 
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selected against two phages simultaneously (i.e. 3 ancestral replicates x 6 
pairwise phage combinations).  
To complete sequential selection, we next exposed resistant bacteria selected 
against individual phages (i.e. 1st step sequential selection) to each additional 
phage strain (2nd step sequential selection). Clones selected in the first step of 
sequential selection were inoculated directly from glycerol stocks in to 6ml KB 
and grown for 8h at 37°C, then diluted 10-fold into 3 wells of a 96 well plate to 
found 3 subpopulations per clone, which were used to select 2nd step sequential 
resistance against each of the other phage strains using the same protocol as 
above. This produced a further 36 resistant mutants (3 ancestral replicates x 4 
1st-step phages x 3 2nd step phages). As before, any clones lacking phage-
resistance, or phage treatments producing no viable colonies, were repeated. 
This was mainly an issue for combinations including phages PA5P2 and PT7 
(both Type IV pilus binding): up to 75% of populations yielded no resistant 
mutants, further compounded by a lack of ‘true’ resistance in the selected 
colonies (up to 90% of selected colonies lacking quantitative resistance when 
selected against combinations including PT7 or PA5P2). Therefore, treatments 
containing phage PT7 (under both sequential and simultaneous selection) were 
later discarded due to extremely low mutation frequencies, lack of phage-
resistance in selected colonies and high levels of bacterial contamination, 
indicating that true PT7 resistance is very difficult to acquire in combination with 
other phage strains. 
4.2.3 Quantitative resistance assays 
To determine the strength of resistance provided by mutations selected at each 
stage of sequential selection, and by simultaneous exposure to multiple phages, 
all spontaneous resistant mutants were assayed against all ancestral phage 
strains. Resistance assays were performed in 96 well microplates in KB media 
added to a final volume of 150µl. A ratio of approximately 10 phage per bacteria 
was used, giving densities of ~107 bacterial cells and ~108 phage particles per ml 
(i.e. multiplicity of infection of ~10). The strength of resistance was measured as 
Relative Bacterial Growth (RBG) in the presence of phage relative to in the 
absence of phage (Eq.1, where t denotes time and Abs for absorbance at 600 
nm; Poullain et al., 2008), such that a value of 1 indicates complete resistance 
(i.e. equal growth in the presence and absence of phage). Differences in 
resistance strength between selection treatments, and stages of sequential 
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selection, were analysed using ANOVAs followed by post-hoc Tukey tests, on 
data blocked by ancestral replicate and phage pair identity.  
For phage i, bacteria j: 
																							𝑅𝐵𝐺$% = 	 [)*+,--(/012)4)*+,--(/052)]78[)*+,--(/012)4)*+,--(/052)]9:;<=:>8																																																					(1) 
4.2.4 Relative fitness of phage-resistant mutants 
To assess the fitness costs imposed by different resistance mutations, we 
compared the growth of all resistant mutants to the ancestral PAO1 strain in the 
absence of phage. Bacterial cultures were inoculated into 150µl KB media in 96 
well microtitre plates directly from glycerol stocks, and incubated at 37°C with a 
shaking cycle every 30mins when optical density was measured as absorbance 
at 600nm, for a total of 48h to produce a growth curve. The maximum growth rate 
was calculated for each resistant mutant and divided by the mean ancestral 
maximum growth rate (replicates matched within plates) to give relative fitness. 
A relative fitness of 1 indicates equal fitness with the ancestral strain, indicating 
that any resistance mutations present impose no fitness costs. The effect of 
selection treatment on bacterial fitness was determined using ANOVAs followed 
by post-hoc Tukey tests, on data blocked by ancestral replicate and phage pair 
identity.  
4.2.5 Sequence analysis 
All spontaneous phage-resistant mutants were sequenced using the Illumina 
MiSeq platform (performed by MicrobesNG, University of Birmingham), and 
resistance mutations were detected using the following bioinformatics analysis: 
short-reads were aligned to an annotated PAO1 reference using Burrows-
Wheeler Aligner (Li and Durbin, 2009), GATK Haplotype Caller (McKenna et al., 
2010) was used to identify SNPs and small indel variants, followed by annotation 
of gene information using SNPeff (Cingolani et al., 2012). Called variants were 
quality filtered by coverage (>20 reads per bp), and frequency of alternative allele 
(>80% of reads match alternative). Variants which occurred in all replicates were 
discarded as they represent differences between the annotated PAO1 reference 
genome (accession ID AE004091) and the ancestral genotype used in our 
experiments. All replicates evolved from ancestral clone PAO1_FT3 contained 
the same SNP in gene PA3676; therefore, because this mutation must have 
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arisen prior to the fluctuation test (i.e. when individual ancestral colonies were 
selected) and imposed no detectable fitness effect, it was ignored in subsequent 
analyses. Larger genetic variations, including deletions over 100bp and 
duplication events, were identified by analysing changes in coverage depth in R 
(R Core Team, 2016), and all variants were verified visually using an alignment 
viewer (Robinson et al., 2011). Variation in the number of mutations acquired 
under different selection regimes was assessed using an ANOVA with post-hoc 
Tukey tests, including a main effect of ancestral replicate. The relative fitness of 
mutants carrying either single or double resistance mutations were compared 
using post-hoc Tukey tests following an ANOVA.  
4.3 Results 
4.3.1 Sequential resistance is rarely limited by a trade-off in resistance strength 
By exposing the bacterial host to different phages in a sequential manner, we 
were able to assess how the strength of resistance to each phage is influenced 
by the order of phage exposure. For a pair of phages targeting lipopolysaccharide 
(LPS) receptors (PA10P2 and 14/1), we typically found that the first-step 
resistance mutation provided resistance to both phages of approximately 
equivalent strength (Figure 4.1A, Tukey test on ANOVA interaction: p>0.99 in 5 
out of 6 replicates). Hence, sequential selection for second-step resistance to the 
alternate LPS-associated phage did not tend to increase resistance against this 
second phage (Figure 4.1A, Tukey test on ANOVA interaction: all p>0.1). 
Moreover, following the second-step of sequential selection we observed only 
minimal trade-offs in resistance to the first phage (maximum decrease ~15%). 
Nonetheless the order of exposure to phages appeared to have an effect on the 
occurrence of trade-offs: whereas no trade-off was observed in 14/1 resistance 
following second-step sequential selection of PA10P2 resistance (Figure 4.1A, 
Tukey test on ANOVA interaction: all p>0.1), PA10P2 resistance was slightly 
reduced following second-step sequential selection of 14/1 resistance in 2 out of 
3 replicates (Figure 4.1A, Tukey test on ANOVA interaction: mean differences of 
-0.140 and -0.259, both p<0.001). 
By contrast, for pairs of phages that targeted different receptors, that is either the 
LPS or the Type-IV Pilus, the first-step resistance mutation rarely provided 
effective cross-resistance to the second-step phage. Whereas first-step 
resistance mutations against phage targeting LPS (PA10P2 or 14/1) provided 
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weak cross-resistance to the Type IV pilus-associated phage (PA5P2) in 2 out of 
6 replicates (Figure 4.1B-C, Tukey test on ANOVA interactions: p = 0.010 and 
0.001), first-step resistance mutations against PA5P2 provided no cross-
resistance against the LPS-binding phages. This suggests that, unlike for the 
phage pair that shared the LPS receptor, multiple resistance mutations were 
required to protect against sequential phage pairs that targeted different receptors 
(Figure 4.1B-C, Tukey test on ANOVA interaction: resistance to second phage 
after 1st step c.f. 2nd step all p<0.001). However, the strength of the first-step 
resistance was rarely reduced following sequential selection for the second-step 
resistance (1 out of 12 replicates). Indeed, we observed increases in the strength 
of the first-step resistance in half of the replicates following acquisition of the 
second-step resistance mutation (Figure 4.1B/C, Tukey test on ANOVA 
interaction: all p<0.001). This implies that where phages target different receptors 
their resistances are additive when selected sequentially, and rarely impose 
trade-offs in the strength of resistance to phages which adsorb to different cell-
surface receptors. 
4.3.2 Simultaneous phage selection results in weak resistance to both phages 
To determine if equivalent resistances against pairs of phages could be achieved 
in one-step rather than two sequential steps, we also selected resistant mutants 
against each phage pair simultaneously. Simultaneous selection by the phage 
pair targeting the LPS generally produced weak resistance against both phages, 
indeed these mutations provided weaker resistance than both the first step and 
second step resistance mutations observed during sequential selection with the 
same phages (Figure 4.1A; Tukey test on ANOVA interaction, simultaneous 
weaker than 1st-step sequential in 5/6 replicates p<0.05; simultaneous weaker 
than 2nd-step sequential in 5/6 replicates, p<0.05). Similarly, simultaneous 
selection for resistance against the phage pairs targeting different receptors 
consistently resulted in weaker resistance to both phages compared to sequential 
resistance (Figure 4.1B-C; Tukey test on ANOVA interactions: PA5P2 resistance 
- all replicates weaker with p<0.005; PA10P2 resistance - 3/6 replicates weaker 
with p<0.05; 14/1 resistance - all replicates weaker with p<0.05). Together these 
results indicate that simultaneous exposure to multiple phages can reduce the 
strength of evolved resistance, even when the phage strains target the same 
receptor  and  promote  reciprocal  cross-resistance.  Overall,  this  suggests that  
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Figure 4.1 Trade-offs in the strength of resistance to each selection phage   
Strength of resistance, measured as reduction in bacterial growth (RBG), such 
that 1 indicates equal growth in the presence and absence of phage. Selection 
treatment for focal resistance is indicated by colour (see individual keys). 
Background shading indicates the mean resistance strength for the first step in 
sequential resistance treatments to highlight changes in resistance to the first-
step phage in the second step of sequential selection treatments.  
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simultaneous exposure to multiple phages limits resistance evolution, but that this 
constraint can be overcome if the phages are encountered sequentially.   
4.3.3 Cost of resistance against multiple phages can be determined by selection 
order 
Sequential acquisition of resistance against multiple phages provided stronger 
resistance against both phages compared to mutants selected by simultaneous 
exposure, where in general only weak resistance against both phages was 
observed. The emergence of highly resistant bacteria could be limited if strong 
resistance against multiple phages arising from sequential acquisition of 
resistance mutations was associated with higher costs (i.e. lower relative fitness). 
Thus, we next compared the growth kinetics of the resistant mutants relative to 
the phage-susceptible ancestral bacterial genotype. Sequential resistance was 
more costly than simultaneous resistance in only less than half of replicates 
(Figure 4.2; Tukey test on ANOVA interactions: sequential resistance more costly 
in 6/13 replicates p<0.05; sequential less costly in 2/13 replicates p<0.05; no 
significant difference in 5/13 replicates). This suggest that strong resistance 
against multiple phages can often be acquired sequentially at no additional cost 
compared to weaker resistance acquired simultaneously. Nonetheless, order 
effects were important in determining the cost of resistance for some sequential 
resistances. When the first-step resistance was against a Type IV pilus binding 
phage followed by second-step resistance against a LPS-binding phage, we 
observed significant reductions in relative fitness following the second-step in half 
of the replicates (Figure 4.2B-C; Tukey test on ANOVA interaction: 3/6 replicates 
p<0.05), whereas no significant change in fitness cost was observed in the 
opposite direction (i.e. exposure to first LPS-binding then type-IV pilus-binding 
phage). This suggests that the cost of resistance is mutation-specific, and fitness 
can be determined by order effects, suggesting that there may be epistatic 
interactions between specific resistance mutations.     
4.3.4 The genetic basis of phage resistance after sequential versus simultaneous 
phage exposure 
To assess how the genetic basis of resistance varied between treatments, we 
sequenced the whole genomes of three resistant mutants from each pairwise 
combination of the phages PA5P2, PA10P2 and 14/1 under both sequential and 
simultaneous selection regimes. Whereas single-phage resistance (i.e. first-step 
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of sequential selection) promoted acquisition of single mutations, selection of 
multiple phage-resistances was generally provided by multiple resistance 
mutations in both simultaneous and sequential selection regimes (Tukey test on 
ANOVA interaction: 2nd-step sequential v.s. 1st-step sequential, diff=1.20, 
p<0.0001; simultaneous v.s. 1st-step sequential, diff=1.18, p<0.001; simultaneous 
v.s. 2nd-step sequential, diff=-0.018, p=0.997). 
For sequential resistance, we found that the first step resistance against all 
phages relied upon single variants in receptor-specific genes (Figure 4.3A; Table 
S4.1), with only one case of a secondary mutation which was likely due to hitch-
hiking. Most mutations conferring first-step resistance to LPS-binding phages 
(PA10P2 and 14/1) targeted the wzy gene, which encodes a polymerase involved 
in synthesis of the LPS B-band O-antigen (Table S4.1, see also Section 1.5.4 and 
Figure 1.4 for an overview of LPS structure). The LPS O-antigen forms a 
polysaccharide cap on the external bacterial membrane; this is variably 
expressed and one bacterial cell may display numerous LPS types with varying 
cap structure (Lam et al., 2011).  All first-step resistance mutants selected using 
the type-IV pilus binding phage PA5P2 carried a single mutation affecting Type-
IV pilus-associated genes (Figure 4,3A; Table S4.1; see also Section 1.5.4 and 
Figure 1.3 for an overview of Type IV pilus structure), including pilB (encoding a 
motor protein controlling pilus extension), pilN (encoding a product involved in 
pilus assembly), and pilR (encoding part of a two-component system regulating 
pilin production).  
Sequential resistance against combinations of phages targeting different 
receptors required a combination of two mutations, each affecting a distinct 
receptor-specific target (Figure 4.3B; Table S4.1). Second-step resistance 
against the type-IV pilus binding phage PA5P2 required mutations targeting 
genes involved in pilus motility (pilT and pilU), extension and retraction (pilB and 
pilY1 respectively), and structural pilins (pilE) (note however that for two 
replicates we were unable to identify the first-step mutations and therefore these 
sequences were discarded). Second-step resistance against an LPS-binding 
phage (PA10P2 or 14/1) commonly required secondary mutations in wzy, the 
same gene that provided first-step resistance against these phages. Interestingly, 
however, in two out of three replicates of sequential selection with PA5P2 
followed by 14/1, we observed second-step mutations in a distinct target, galU, a  
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Figure 4.2 Relative fitness of resistant mutants is determined by selection 
regime 
Fitness is measured as the maximum growth rate achieved during a 48h growth 
period and given relative to that of the ancestral genotype; a value above 1 (light 
grey background) indicates lack of fitness costs associated with resistance 
mutation(s). Selection treatment for focal resistances is indicated by colour (see 
individual keys). The mean relative fitness of simultaneous selection treatments 
is shown as a dashed purple line, with light purple shading to indicate standard 
error. Plot headings indicate which ancestral replicate was used in the fluctuation 
test.  
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uridylyltransferase involved in LPS biosynthesis. Additional mutations in non-
receptor-specific genes were found in 3 out of 6 replicates where resistance to 
the Type IV pilus-associated phage was followed by sequential LPS-associated 
resistance, whilst no additional mutations were found in the reverse treatment 
order (i.e. LPS followed by Type IV pilus) (Figure 4.3B; Table S4.1). Taken 
together these genetic data confirm that trade-offs in resistance strength between 
combinations of phages which bind different receptors were uncommon when 
resistance was acquired sequentially because multiple receptor-specific 
mutations were acquired providing additive resistance.   
For sequential resistance against pairs of phages targeting the same receptor we 
observed order effects for the number and targets of mutations observed. Only 
one mutation was detected per replicate following sequential selection with 14/1 
followed by PA10P2, whereas for the reverse order we observed secondary 
mutations in the second-step mutants (Figure 4.3B; Table S4.1). For two 
replicates, we observed mutations in a gene of unknown function, PA0429, whilst 
the third replicate gained a second LPS-associated mutation (wapH, predicted 
glycosyl transferase; Table S4.1). It is unclear why parallel mutations in PA0429 
would be selected because they provided no increase in resistance to 14/1 (in 
fact the first step resistance mutations in these replicates already provided strong 
cross-resistance to 14/1; Figure 4.1), nor any reduction of the associated fitness 
costs (Figure 4.4; Tukey test on ANOVA: wzy-wzy+PA0429 p=0.978). By 
contrast, the wapH mutation did improve 14/1 resistance; here the first-step 
resistance mutation in the LPS biosynthesis gene rml, encoding a 
thymidylyltransferase, provided weak cross-resistance to 14/1 (Tukey test on 
ANOVA: strength of focal resistance vs. cross-resistance, diff = -0.463, 
p<0.0001), and furthermore, gaining the second-step resistance mutation was not 
associated with any increase in fitness costs (Figure 4.4; Tukey test on ANOVA: 
rmlA-rmlA+wapH p=1). 
In striking contrast, whereas multiple receptor-specific mutations were 
accumulated during two-step sequential selection of resistance against phages 
targeting different receptors, this pattern was never observed under simultaneous 
selection (Figure 4.3C). Half of the resistant mutants resulting from simultaneous 
exposure to phage pairs with different receptor targets carried mutations in LPS-
associated genes without any additional Type IV pilus-specific mutations (Figure 
4.3C). Indeed, surprisingly, we were unable to identify any mutations in 2 out of  
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Figure 4.3 Treatment regimes determine the frequency and type of 
resistance mutations selected  
Total number of identified mutations per resistant mutant across phage selection 
treatments (plot headings) under A) single B) sequential or C) simultaneous 
selection. Colours indicate category of mutational target (see key). 
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6 replicates, suggesting that these clones had either displayed phenotypic 
resistance or had subsequently undergone a reversion mutation to restore 
sensitivity. These potential alternative resistance strategies may also explain a 
high error rate in selection of resistant mutants against Type IV pilus-binding 
phages: up to 90% of clones selected against combinations containing Type IV 
pilus-binding phages were found to lack true resistance to the selection phages, 
indicating an alternative mechanism of resistance, or rapid reversion. Additionally 
the high level of failure to select any resistant colonies against these phages (up 
to 90% failure rate against certain combinations containing Type IV pilus-binding) 
indicates that true resistance mutations are potentially either very rare, or impose 
such high fitness costs that the bacteria cannot proliferate. In two simultaneous 
resistance mutants we observed duplication of the same two genes (approx. 1Mb 
apart) both with links to DNA recombination: one encoding a single-strand DNA 
binding protein (ssb) and the other a putative exonuclease (PA3263). However, 
what links this duplication to phage resistance is currently unclear. 
Despite LPS binding phages promoting strong reciprocal cross-resistance, 2 out 
of 3 simultaneous resistance mutants selected against PA10P2 and 14/1 which 
target the LPS had secondary mutations in non-LPS genes. One had a large 
deletion of approx. 250 kbp (around 4% of the whole genome), affecting over 200 
genes including galU, the LPS biosynthesis gene that was also mutated under 
sequential selection against PA5P2 and 14/1 (Figure 4.3C). This indicates that 
whilst PA10P2 and 14/1 both adsorb to the LPS, they probably target different 
sites, such that the strength of cross-resistance depends on specific effects of 
mutations on the LPS structure. Overall, this suggests that survival in the 
presence of two phages may be a stochastic process, where resistance against 
only one of the phages or a phenotypic resistance response may be sufficient to 
enable persistence of the bacterium. 
4.3.5 Fitness costs associated with specific resistance mutations 
Overall, mutants which acquired multiple resistance mutations were less fit than 
those with single resistance mutations (t-test, t93.2=4.63, p<0.0005). Fitness costs 
were often additive for combinations of LPS and Type-IV pilus mutations, with 
pairs of resistance mutations imposing greater costs than single resistance 
mutations on their own (Figure 4.4). Second-step mutations in the LPS-
associated gene galU increased fitness costs in combination with first-step 
mutations in Type IV pilus genes (Figure 4.4; Tukey test on ANOVA: pilN-
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pilN+galU p<0.0001; pilR-pilR+galU p<0.0001), but this was not the case for wzy 
which imposed no additional cost (Figure 4.4; Tukey test on ANOVA: pilR-
pilR+wzy p=0.826). Similarly, for sequential resistance selected against the pair 
of LPS-binding phages, secondary mutations in both LPS and non-LPS targets 
were effectively cost-free (Figure 4.4; Tukey test on ANOVA: wzy-wzy+PA0429 
p=0.978; rmlA-rmlA+wapH p=1.00). Whilst we were unable to calculate epistatic 
effects for most double mutants, as different loci were targeted in respective 
stages of sequential selection or multiple mutations were acquired concurrently, 
these results indicate that fitness costs of sequential resistance against multiple 
phages are likely to depend on epistatic interactions between multiple resistance 
mutations.  
 
Figure 4.4 Contrasting fitness costs resulting from specific combinations 
of single and double mutations 
Fitness relative to the ancestor, where a value of 1 indicates equal fitness and 
below 1 indicates a fitness cost associated with labelled single (left panel) or 
double (right panel) mutations. The dashed line indicates predicted additive cost 
of two mutations affecting different receptors, given as the sum of the mean cost 
of individual receptor-specific mutations (grey band; single LPS mutations = 
0.886, single Type IV pilus specific mutations RF = 0.880). 
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4.4 Discussion 
We compared the evolution of multi-phage resistance selected sequentially 
versus simultaneously against pairs of phage targeting either the same, or 
different cell-surface receptors for adsorption. Sequential resistance to phage 
combinations targeting different receptors was acquired by accumulation of 
multiple receptor-specific mutations which promoted strong additive resistance to 
both phage strains without trade-offs in the strength of resistance to each phage. 
In comparison, simultaneous exposure to multiple phages resulted in weaker 
resistance to both phage, through either single receptor-specific mutations, or 
other major genetic variations (i.e. deletion and duplication events) affecting a 
larger number of genes. Further, although sequentially-acquired resistance was 
generally much stronger, it often imposed no greater cost to host fitness than the 
corresponding (weaker) simultaneous resistance. This suggests that 
simultaneous phage exposure imposes far greater constraint on resistance 
evolution than sequential exposure, leading to weaker resistance at the same 
fitness cost.  
However, when phages targeted distinct receptors, we did observe order-effects 
of sequential treatment in the costs of resistance. Sequential exposure to an LPS-
binding phage following a Type IV pilus-binding phage decreased the relative 
fitness of the host, whereas there was no significant change in the cost between 
the two stages of sequential exposure in the opposite direction (i.e. Type IV pilus-
binding phage after LPS-binding phage). Similar Type IV pilus mutations were 
selected in both sequential treatment orders, commonly affecting gene products 
involved in motility [e.g. pilB, pilT and pilU encode motor proteins and pilY1 
encodes an anti-retraction factor (Chiang et al., 2008; Johnson et al., 2011)]. The 
LPS biosynthesis gene wzy (Islam et al., 2010) was targeted in both sequential 
treatments, but imposed only modest increases in cost, whereas mutations in 
galU, a uridylyltransferase also involved in LPS biosynthesis (Dean and 
Goldberg, 2002), were selected twice under selection with the LPS-binding phage 
14/1 following initial selection against the Type IV pilus-binding phage PA5P2 and 
caused severe decreases in bacterial fitness. Whereas mutations in wzy often 
affect only the B-band of LPS (Latino et al., 2016, 2017), galU mutations may 
cause broader structural changes, affecting both the LPS core and A-band 
(Choudhury et al., 2005; Dean and Goldberg, 2002), which may explain their 
more detrimental effect on bacterial fitness.  Additionally, it is possible that some 
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primary mutations limit the acquisition of secondary mutations, for example, in 
second-step clones exposed to Type IV pilus-binding phage PA5P2 we were 
unable to detect the LPS-associated mutations in rmlA and ssg present in the 
first-step sequenced clone  (Fernández et al., 2013; Rahim et al., 2000). Strong 
negative epistatic interactions between receptor-specific resistant mutations 
could limit or prevent the survival of bacteria carrying both mutations. Taken 
together these data suggest that sequential selection with Type IV pilus-binding 
phage followed by LPS-binding phage may both decrease the likelihood of 
multiple phage resistance genotypes arising, and impose substantial fitness costs 
upon those that do, which may be sufficient to allow eradication of the infection 
by antibiotic treatment, or even by the patient’s own immune system.  
Phages targeting the same receptor (LPS) provided strong cross-resistance to 
one another, such that the first-step of sequential resistance provided equally 
strong resistance to both LPS–binding phages through acquisition of a single 
mutation affecting LPS biosynthesis, irrespective of the focal LPS-binding phage 
used to select resistance. We therefore expected that simultaneous and second-
step sequential selection against two-LPS binding phages would be equivalent to 
the first step of sequential selection. Consistent with this, under sequential 
selection resistance to both LPS-binding phages was provided by single 
mutations in LPS biosynthesis associated genes, and although second-step 
mutations were observed upon second-step exposure to 14/1 (in PA0429), this 
mutation neither affected resistance or fitness. By contrast, under simultaneous 
exposure, multiple resistance mutations were observed in two out of three 
replicates, one of which was a large deletion affecting approximately 4% of the 
host genome. This suggests that even when phages target the same receptor, 
subtle differences in their target sites may make it harder to resist both phages 
simultaneously through a single mutation, even-though single mutations 
providing resistance to both of the phages are available when encountered 
individually. This is conceptually similar to the synergy effect between phage 
strains, where combined killing is more effective than killing achieved by each 
phage single (Schmerer et al., 2014). Although our experiment did not permit 
phage-mediated regulation of bacterial density (as we selected spontaneous 
resistant mutants), this may influence the availability of resistance mutations 
during simultaneous phage treatments by limiting genetic variation, as slight 
differences in host range may permit a larger proportion of bacterial genotypes to 
be targeted by phage cocktails than by individual phages. Alternatively, 
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simultaneous exposure to multiple phages may induce host stress responses that 
alter the mutational landscape available to the host (e.g. through stress-induced 
mutagenesis; Foster, 2007), to promote adaptation. Phage DNA can trigger 
stress responses directed by phage shock proteins, which alter gene expression 
via s54 the alternative sigma-factor RpoN (Weiner et al., 1991), affecting 
numerous systems including motility, iron uptake, protein secretion and cell 
envelope integrity (Darwin, 2013; Joly et al., 2010; Jovanovic et al., 2006). 
Further, the P. aeruginosa bac cluster, which contains proteins homologous to 
phage shock proteins, regulates cell mobility (via production of surfactants) and 
induces lifestyle switches to biofilm states via activation of s54 the alternative 
sigma-factor RpoN (Macé et al., 2008). We have previously observed mutations 
in rpoN which provide cross-resistance to both LPS-binding and Type IV-pilus 
binding phages (Chapter 3). Therefore, whilst simultaneous exposure to multiple 
phages may reduce resistance evolution compared to sequential exposure due 
to the limited number of potential mutations which can provide resistance to both 
phages, they may also promote broader host adaptation responses.  
Bacterial phenotypic responses to stressors may also explain why we were 
unable to identify resistance mutations in some hosts exposed simultaneously to 
multiple phage strains. Stochastic environmental changes which affect bacterial 
lifestyle traits can hinder phage infection in numerous ways and create 
heterogeneity in host phenotypes within a population (Lourenço et al., 2018): 
changes in temperature can affect the rigidity of the host cell membrane 
preventing phage infection (Labedan, 1984), and nutrient variability can reduce 
expression of phage receptors (Bull et al., 2014; Chapman-McQuiston and Wu, 
2008; Levin et al., 2013). Changes in receptor expression levels could potentially 
limit phage adsorption sufficiently to enable survival of the host under 
simultaneous selection with multiple phage strains without leaving a genetic trace. 
Such resistances may be incidental to phage infection, or induced by phage 
products in the environment and/or products of cellular lysis, and may be 
considered as a phenotypic phage resistance (Bull et al., 2014; Lourenço et al., 
2018). Alternatively, survival in the presence of multiple phages may require such 
costly resistance mutations that as soon as phage selection pressures are 
relieved reversion mutants restoring the original genotype rapidly outcompete the 
resistant genotype as the colony grows (Brockhurst et al., 2005; Chaudhry et al., 
2018). Although reversion is often much less likely than acquisition of 
compensatory mutations (Levin et al., 2000), we saw little evidence of 
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compensatory mutations in our experiment, however, we did observe secondary 
mutations in genes of unknown function which arose concurrently with receptor-
specific mutations suggesting that compensation may be occurring.  
Compared to sequential selection of resistance, simultaneous exposure 
promoted acquisition of weaker resistance. Whereas sequential resistances in 
different receptor targets provide additive resistance, simultaneous exposure to 
multiple phages promoted a trade-off between phage resistances, often resulting 
in single receptor-specific mutations which promote relatively weak resistance to 
only one phage strain, or more complex mutational effects (e.g. duplication and 
deletion events) targeting many genes including those not known to be 
associated with LPS or Type IV pilus. Although large deletions are commonly 
found to provide phage resistance in vitro (Le et al., 2014; Pires et al., 2017), the 
loss of a large number of genes are likely to have broad reaching pleiotropic 
effects in more complex environments where bacteria must adapt to various 
environmental stressors (Folkesson et al., 2012; Smith et al., 2006) and may be 
influenced by the resident microflora (Duan et al., 2003). Additionally, single 
mutations which do not provide resistance to all phages present in the cocktail 
may not be sufficient to allow survival under sustained phage pressure (i.e. if 
phage propagate in vivo). Overall, this suggests that there are fewer mutational 
routes promoting bacterial survival in the presence of multiple phages 
simultaneously.  
We found that fitness costs of multi-phage resistances could be maximised by 
promoting acquisition of multiple mutations in receptor genes in a particular order, 
specifically, by selecting resistance for Type IV pilus-associated resistance 
followed by LPS-associated resistance. As fitness costs are potentially 
exacerbated in vivo, due to more intense competition for resources and the 
requirement of expression of a broader range of traits (Cornforth et al., 2018; 
Rossi et al., 2018), maximising fitness costs associated with phage resistance 
could reduce the long-term success of resistant mutants. On the other hand, 
simultaneous exposure to multiple phage strains often imposed similar costs to 
sequential treatments, yet also promoted the evolution of weaker resistance to 
the phage combination. As phage treatment is a dynamic process, where as long 
as susceptible hosts remain, phage can propagate and potentially counter-adapt 
to bacterial resistance mechanisms, limiting the strength of evolved resistance 
may be just as beneficial as maximising host fitness costs. Further experiments 
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are warranted to determine the relative importance of these effects in vivo, as 
more complex environmental pressures may exacerbate fitness costs and buffer 
differences in resistance strength. Additionally, these results reflect the short-term 
evolution of resistance to a limited number of phage strains (only 3), targeting just 
2 different bacterial receptors, with only 3 independent replicates. To determine 
whether these principles are consistently reproducible over a more diverse set of 
phage strains, future work is needed to incorporate the effects of both genetic 
and functional diversity of phages (i.e. variation in the functional phage binding 
receptor). Lastly, we selected resistant mutants over very short time scales (less 
than 48h), however, over longer time periods, the evolutionary landscape may be 
more complex (e.g. allowing for amelioration of fitness effects of resistance 
mutations).  
These results highlight that the rational design of phage cocktails can limit the 
evolution of strong phage-resistance and determine the fitness cost of evolved 
resistance. Two strategies for rational design are proposed: simultaneous 
exposure to multiple phages targeting different bacterial receptors may limit the 
strength of evolved resistance, whilst maintaining relatively high resistance-
associated fitness costs, providing an effective long-term therapeutic option 
which does not preclude additional applications. In contrast, sequential 
application of single phage strains may promote the evolution of strong phage-
specific resistance mechanisms, but careful optimisation of phage combinations 
and order effects (i.e. Type IV pilus-binding phage followed by LPS-binding 
phage), may be the optimal way to impose the highest fitness effects and 
therefore promote the strongest suppression of bacterial growth. The choice of 
treatment strategy may be guided by the difference in relative benefits of these 
two strategies within the local context of disease (i.e. treatment of chronic versus 
acute infections), however, for both, it is clear that maximising the functional 
diversity of phage strains (i.e. targeting multiple bacterial receptors) is key to 
minimising the potential for resistance evolution.  
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Chapter Five 
Functional diversity determines the efficacy of 
phage cocktails 
5.1 Introduction 
Bacterial killing by lytic phages regulates bacterial turnover in microbial 
communities, influencing bacterial community dynamics in both environmental 
and clinical settings (Harrison, 2007; Levin and Bull, 2004). Phages also 
represent a promising alternative to antibiotics for treating bacterial infection 
where rates of antibiotic resistance are rapidly rising (Chan et al., 2013; Pires et 
al., 2015; World Health Organisation, 2014). Phage cocktails for therapeutic use 
are commonly designed to maximise host range (e.g. Kelly et al., 2011), as 
communities of phages may better suppress bacterial growth and improve the 
efficacy of treatment if they target a larger proportion of pathogen genotypes. 
Surprisingly, however, the effect of phage diversity on the efficacy of phage 
combinations to suppress bacterial growth has not been explicitly tested. Phage 
diversity is predicted to exceed that of their hosts by up to 10 times (Clokie et al., 
2011), and may vary between communities just metres apart (Frederickson et al., 
2003). A survey of phages able to infect Pseudomonas aeruginosa, a commonly 
multi-drug resistant opportunistic pathogen (Breidenstein et al., 2011), across 4 
continents identified 7 distinct phage groups with lytic activity against 87% of 
clinical bacterial strains tested (Ceyssens et al., 2009), and novel phage taxa are 
continually being discovered (Amgarten et al., 2017; Sepúlveda-Robles et al., 
2012). When designing a phage cocktail, is more diverse always better in terms 
of its efficacy?  
Increasing species richness has been shown to improve the function of microbial 
communities by two distinct mechanisms (Bell et al., 2005; Evans et al., 2017). 
Firstly, if species perform different ecological roles, then higher diversity 
communities can deliver higher performance due to functional complementarity, 
through filling more of the available niche space (Bell et al., 2005; Salles et al., 
2009). Secondly, more diverse communities are more likely to contain highly 
performing taxa simply by chance, leading to a positive relationship between 
diversity and function through the so-called selection effect (Bell et al., 2005; 
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Evans et al., 2017). Understanding the mechanisms of complementarity in 
community function and the roles performed by highly performing species are 
likely to aid the design of effective phage cocktails. 
On the other hand, functional redundancy among species in a community leads 
to diminishing returns of further increasing species richness, resulting in a 
saturating relationship between diversity and function (Petchey and Gaston, 
2006; Tilman et al., 1997; Yin et al., 2000). This suggests that if the functional 
diversity of phage combinations can be maximised at lower levels of species 
richness then simpler phage cocktails could achieve equivalent efficacy as more 
diverse cocktails, thus reducing the manufacturing and regulatory challenges 
(Brüssow, 2012; Merabishvili et al., 2018; Verbeken et al., 2012). For phages, a 
key functional trait is likely to be the bacterial cell-surface receptor used by the 
phage for adsorption during lytic infection. Thus phage combinations targeting 
higher numbers of receptors would be predicted to be more efficacious because 
they would limit the potential for bacteria to evolve resistance via cell surface 
modification since this would likely require multiple mutations (e.g. Betts et al., 
2018; Gurney et al., 2017; Tanji et al., 2004), potentially imposing additive fitness 
costs (Koskella et al., 2011), and reduce the competition among phages for 
shared adsorption sites.  
By applying the principles of biodiversity-ecosystem functioning to phage 
cocktails, we hope to determine the relative importance of species richness, 
functional diversity and phage identity effects on the efficacy of multi-phage 
treatments. We constructed 827 different phage combinations, ranging in species 
diversity from 1-phage to 12-phages, incorporating functionally diverse phages 
targeting either Type IV pilus or lipopolysaccharide (LPS) for adsorption. We 
show that phage diversity has a saturating relationship with efficacy (i.e., 
suppression of bacterial growth), such that low diversity phage combinations 
could provide high performance provided that they had high functional diversity 
(i.e., targeted multiple distinct adsorption receptors). Additionally, we developed 
a pathway analysis method to assess the influence of cross-resistance structure 
on phage combination performance and show that the addition of phage strains 
that do not promote cross-resistance to other members of the combination cause 
large improvements in the efficacy of the phage cocktail.  
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5.2 Materials and methods 
5.2.1 Phage combination design and assembly  
A set of 12 phages which were characterised in Chapter 3 were used to build 
phage combinations of varying diversity. Of these 12 phages, 4 were known to 
adsorb via the Type IV pilus, and 8 via LPS. In total, we assembled 827 different 
phage combinations, ranging from single phage (12), all possible 2- and 3-
member communities (66 and 220 respectively), a random partition of 4- and 6-
member communities (264 of each), and the full 12-member community. A 
random partition design was used to select 4 and 6-phage communities which 
equally represent all phage strains across both diversity levels, as described by 
Bell et al. (2009).  
Phage stocks were propagated using the bacterial host Pseudomonas 
aeruginosa PAO1. Overnight bacterial cultures, grown in 6ml KB and incubated 
at 37°C with shaking at 180rpm, were diluted 100-fold into new media (6ml KB), 
then phage were added directly from glycerol stocks (stored in 20% glycerol at -
80°C). Following overnight incubation phage cultures were filtered (0.22µm) to 
remove bacteria and stored at 4°C until use. To limit human error, triplicate master 
plates of phage communities were assembled in deep 96 well plates using a liquid 
handling robot (epMotionÒ 5070, Eppendorf, Germany). Equal volumes of each 
phage were added to give a final volume of 120µl per community. 
5.2.2 Measuring the efficacy of phage combinations 
Bacterial replicates were inoculated from three single colonies into 6ml KB and 
grown overnight at 37°C with shaking at 180rpm, before diluting 100-fold into 
assay plates containing 120µl of KB. Phage communities were transferred from 
the master plates (15µl per well) to give a multiplicity of infection of approximately 
100 phage per bacterial cell (actual MOI ~80.4±20.2 with initial bacterial density 
of ~9.6x107±1.1x107). Optical density (absorbance at 600nm; Abs600) was 
measured immediately, then after 24h incubation at 37°C, static. Cocktail efficacy 
was measured as reduction in bacterial growth (Eq 1, 1-RBG; Poullain et al., 
2008).  
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For phage i, bacteria j: 
																										𝑅𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛$% = 	1 −	 [)*+,--(/012)4)*+,--(/052)]78[)*+,--(/012)4)*+,--(/052)]9:;<=:>8																														(1) 
5.2.3 Modelling the diversity-efficacy relationship 
The relationship between phage diversity (i.e. strain richness) and reduction in 
bacterial growth was analysed using a linear model method designed to separate 
significant factors affecting biodiversity-ecosystem functioning (Bell et al., 2009). 
Phage diversity and functional diversity (i.e. number of different receptor targets) 
were included as interacting main effects, alongside other main effects of receptor 
targets (i.e. LPS and Type IV pilus), phage identity, non-linear phage diversity, 
and community ID. Due to the saturating relationship between phage diversity 
and reduction of bacterial growth, we also fitted a non-linear asymptotic 
exponential model to the data. Model parameters were determined using the 
nonlinear least squares function in R (R Core Team, 2016), and compared to 
equivalent linear models using Akaike Information Criterion (AIC).  
5.2.4 Characterisation and pathway analysis of cross-resistance 
To test the effect of cross-resistance (CR) structure on the efficacy of phage 
combinations, we determined stepwise changes in phage efficacy and cross-
resistance structure between phage communities which are subsets of one 
another. By adding community members in a stepwise manner it is possible to 
form pathways of increasing diversity (i.e. starting with a 1-phage community and 
introducing additional phage strains in a stepwise manner to produce 2, 3, 4, 6 
and 12 member communities; Figure 5.1). We identified 52,200 unique pathways 
based upon the 827 different phage communities in our experiment. For each 
community, we determined the cross-resistance structure of the phage 
combination based on previous characterisation of all pairwise cross-resistance 
interactions (Chapter 3). Some communities were composed of only one type of 
cross-resistance interaction (i.e. all symmetrical, or all asymmetrical), others had 
mixed symmetry (i.e. include both symmetrical and asymmetrical interactions), 
and communities containing any phage pairs which did not promote cross-
resistance were categorised separately (as Include Non-CR). By characterising 
the unique stepwise changes between adjacent diversity levels within each 
pathway (4,288 in total), we were able to determine how transitions in cross-
resistance structure influence the efficacy of phage combinations. Main effects of 
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existing cross-resistance structure and the introduction of phages to yield novel 
cross-resistance interactions on phage combination efficacy at different diversity 
levels were determined using an ANOVA with post-hoc Tukey tests to determine 
significant interactions.  
Figure 5.1 Illustration of the pathway analysis methodology 
This illustrates one potential pathway out of 52,200 unique possibilities within the 
dataset. A pathway is built of stepwise increases in phage diversity, starting with 
a 1-phage community, and building up to the full 12-phage community. At each 
level, the cross-resistance structure of the community can be characterised (note 
that the interactions shown here are purely illustrative), and the Reduction value 
demonstrates the efficacy of the combination. By comparing the stepwise 
changes in these characteristics (grey dashed arrows) we can determine the key 
factors of cross-resistance which influence the effectiveness of phage 
combinations.  
5.3 Results 
5.3.1 Diminishing returns of increasing phage diversity on phage cocktail efficacy 
To explore the effect of phage diversity on the suppression of bacterial growth, 
we constructed 827 different phage communities from a pool of 12 phages. This 
included all possible single, pairwise and tripartite phage combinations (12, 66 
and 220 communities respectively), a randomly partitioned subset of 4- and 6-
phage communities (264 of each), and the full 12-phage community. Phage 
diversity (i.e. number of strains) explained only 30% of variation in efficacy of 
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bacterial growth reduction (linear model: F1,5740=2497, p<0.0001, R2=0.303). Non-
linear models explained a greater proportion of the variation: the relationship 
between diversity and reduction of bacterial growth was best explained by an 
asymptotic exponential model (Figure 5.2; AIC linear model = 205; AIC asymptotic model = 
-1190) where the asymptote was reached when bacterial growth was completely 
suppressed (i.e. reduction = 1). This suggests that low diversity phage 
combinations were capable of suppressing bacterial growth equally well 
compared to much more diverse phage combinations indicative of functional 
redundancy in phage efficacy to reduce bacterial growth among the constituent 
phage strains.  
Figure 5.2 Saturating relationship between the efficacy and diversity of 
phage combinations  
Mean reduction (± s.e.) of bacterial growth in the presence of phage relative to 
phage-free growth, where 1 indicates complete suppression of bacterial growth 
by the phage community, with raw data in grey to emphasise distribution. An 
asymptotic exponential with the equation shown was fit to the data using a non-
linear least squares model.  
5.3.2 Higher functional diversity of phages improves cocktail efficacy  
Functional diversity can often explain variation in performance among 
communities better than species diversity, particularly where there is functional 
redundancy among the community members. In phages, one key functional trait 
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is the cell surface receptor used for adsorption. We have previously identified the 
cell-surface receptor targeted by each of the phages used here (see Chapter 3). 
Of these 12 phages, 4 phages adsorb to the Type IV pilus whilst the remaining 8 
phages adsorb to the lipopolysaccharide (LPS). We found that phage functional 
diversity and strain diversity together explained ~70% of the variation in reduction 
in bacterial growth (linear model with main effects of phage diversity and 
functional diversity and their interaction: F3,5738=4476, p<0.0001, R2=0.701). 
Although phage combinations required both LPS- and Type IV pilus-binding 
phages to be highly performing, Type IV pilus binding phages contributed more 
to phage combination efficacy than LPS-binding phages (linear model coefficient 
of Type IV pilus-binding phages: t=11.16, p<0.0001; linear model coefficient of 
LPS-binding phages: t=-24.57, p<0.001). Consistent with this, for combinations 
of phages targeting only one surface receptor type (i.e. low functional diversity), 
Type IV pilus-binding phages outperform LPS-binding phages, although both 
types show linear increases in efficacy with increasing phage diversity (Figure 
5.3A-B). By contrast, combinations containing both LPS- and type IV pilus-binding 
phages (i.e. high functional diversity) showed a saturating relationship between 
efficacy and phage diversity and were better able to completely supress bacterial 
growth at lower levels of phage diversity (Figure 5.3C). Phage identity accounted 
for only ~3% of remaining variation (linear model: F12,5730=15.45, p<0.0001), 
suggesting that although the presence of certain phage strains can influence 
phage combination efficacy (see Chapter 3), phage functionality (i.e. target 
receptor) is a much better predictor of its contribution to phage community 
function.  
When the efficacy of phage combinations were compared to that of their best 
constituent (i.e. the community member with the highest reduction value when 
tested alone), these results are further supported. All combinations with high 
functional diversity performed significantly better than their best constituent alone 
[multiple one-sided t-tests on relative reduction (Reductioncombination / Reductionbest 
constituent); all p-values<0.005], whereas phage pairs binding to the same receptor 
(i.e. low diversity combinations with limited functional diversity), performed no 
better than their best constituent alone (multiple one-sided t-tests on relative 
reduction; all p-values>0.05). This suggests that phage combinations with low 
functional diversity depend more strongly on the selection effect, where the 
efficacy of the community is dependent on the presence of more effective 
individual constituents, than combinations with a higher functional diversity. 
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Figure 5.3 Receptor classification determines the linearity of the diversity-
reduction relationship 
Reduction in bacterial growth by phage combinations where all phage target (A) 
LPS, or (B) Type IV pilus, and by combinations with diverse phage targets (C). 
Mean reduction (± s.e.) at each diversity level is shown in black, with raw data in 
grey to show distribution of data points. Optimal models for the effect of diversity 
on reduction of bacterial growth, determined by Akaike information criterion (AIC), 
are shown in blue, either as asymptotic exponential or linear regression.  
5.3.3 Addition of phages which minimise cross-resistance improves cocktail 
efficacy 
One possible explanation for the higher efficacy of high functional diversity phage 
combinations targeting multiple cell surface receptors is that they minimise the 
probability of cross-resistance evolution. Cross-resistance occurs when evolution 
of resistance against one phage provides bacteria with concomitant resistance to 
another distinct phage, and this is most likely to occur for phages that adsorb to 
the same cell-surface receptor. Having previously characterised the network of 
cross-resistance interactions for the phages used here (Chapter 3), we next 
assessed the contribution of cross-resistance to the efficacy of phage 
combinations.  Using a novel pathway analysis,  we identified subsets of  phage  
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communities linked by the stepwise addition of phages (Figure 5.1). We identified 
52,200 unique pathways among the 827 different phage communities in our 
experiment, comprising 4,288 unique transitions in community composition. For 
each stepwise addition, we then determined the change in cross-resistance 
structure (Figure 5.1) and phage combination efficacy (i.e. reduction in bacterial 
growth; Figure 5.4).  
Figure 5.4 Stepwise changes in cross-resistance structure reveal key 
transitions in the efficacy of phage combinations 
Pathways through adjacent diversity levels were broken down into 4,288 unique 
stepwise transitions. For each step, we characterised the cross-resistance 
structure of the original community (x-axis), with single-phage communities 
highlighted in dark blue, and classified the change in cross-resistance structure 
by the addition of novel interactions (panels). Improvements in cocktail efficacy 
were measured as the mean change in reduction of bacterial growth (± s.e.). 
 
The greatest improvements in the efficacy of phage combinations were gained 
when a phage was added that promoted no cross resistance to the other phages 
already present in the combination (Figure 5.4; Tukey test on ANOVA interaction: 
Non-CR v.s. Asymmetrical diff=0.280 p<0.0001; Non-CR v.s. Symmetrical 
diff=0.284 p<0.0001). This effect was strongest for transitions from a 1-phage to  
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a 2-phage combination and for higher diversity combinations where the pre-
existing structure of cross-resistance was symmetrical (Figure 5.4; Tukey test on 
ANOVA interaction: comparisons of single-phage treatments and symmetrically 
cross-resistant communities to communities with mixed symmetry or asymmetry 
only, all p<0.0001). Additionally, greater increases in phage efficacy were gained 
when a phage that was added promoted asymmetrical cross-resistance 
compared to symmetrical cross-resistance (Figure 5.4; Tukey test on ANOVA 
interaction: p=0.035) in transitions from 1-phage to 2-phage combinations. This 
pathway analysis suggests that adding phages that promote minimal cross-
resistance to the other phages already present in the combination provided the 
greatest improvement in performance of phage cocktails. 
5.4 Discussion 
To enable rational design of phage therapy cocktails, it is important to understand 
the factors which determine the efficacy of phage combinations in supressing 
bacterial growth. Applying concepts from the analysis of biodiversity-ecosystem 
function relationships, we determined the relative contributions of phage diversity, 
identity and functional diversity to phage cocktail efficacy. We observed a 
saturating relationship between phage richness and efficacy. Combinations with 
higher functional diversity in terms of the number of cell surface receptors 
targeted for phage adsorption were more effective at suppressing bacterial 
growth, and were able to do so completely at very low levels of diversity (2-3 
phages). Large improvements in the performance of combinations were driven by 
the stepwise addition of phage that did not promote cross resistance to other 
phages already present in the combination. Together, these data suggest that 
effective phage combinations can be designed by choosing specific strains that 
target multiple distinct cell surface receptors and promote low rates of cross-
resistance, both of which are properties that can be achieved at relatively low 
phage diversity levels. 
The mean efficacies of phage combinations using multiple receptor targets were 
best described by an asymptotic exponential model, demonstrating a saturating 
effect of diversity whereby additional phages do not improve cocktail efficacy 
presumably due to their functional redundancy. This suggests strong 
complementarity among phages targeting distinct bacterial cell-surface receptors 
(i.e. a complementation effect; Salles et al., 2009), possibly by limiting the 
evolution of host resistance. In contrast, phage combinations with low functional 
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diversity (i.e. only targeting one cell-surface receptor) were influenced more 
strongly by phage identity and diversity than functionally diverse phage 
communities. This indicates a potential selection effect as more diverse 
communities are more likely to contain highly effective individuals (Bell et al., 
2005; Evans et al., 2017). Additionally, we found that the efficacy of phage 
combinations with both low diversity and functional diversity were limited by the 
activity of their best constituent, which suggests a strong selection effect for these 
combinations. In contrast, combinations with a higher functional diversity, even 
with only 2 constituents, were able to outperform their best constituent, indicating 
complementation in the activity of phages which bind to different bacterial 
receptors. Whilst our phage combinations were assessed using one host 
genotype over a relatively short period of time, allowing higher host genotype 
diversity and extended time for resistance evolution to occur may reveal 
differences in the relative contribution of phage identity and richness compared 
to functional phage diversity. Functional diversity is likely to be important in 
chronic infections, where extensive diversification in bacterial genotype are 
typically observed during adaptation to the infection environment (Mowat et al., 
2011; Smith et al., 2006) and competing microflora (Harrison, 2007). Such within-
host adaptation frequently leads to highly heterogeneous bacterial populations 
that vary in expression of common phage receptor targets, including modification 
and even loss of LPS and Type IV pilus (Hancock et al., 1983; Huse et al., 2010; 
Mahenthiralingam et al., 1994). Higher functional diversity could allow infection of 
a broader range of bacterial genotypes even following within host diversification 
(Friman et al., 2013; Mattila et al., 2015). Here we were limited to a functional 
diversity of 2 receptor binding types, but further increases in functional diversity 
for example by adding phages targeting additional distinct receptors such as outer 
membrane porins (Chan et al., 2016) and other membrane anchored proteins 
such as TonB, which is involved in iron-siderophore uptake (Betts et al., 2018; 
Poole et al., 1996), is likely to lead to further increases in efficacy. Additionally, if 
rare bacterial genotypes are particularly important in causing serious disease, 
then strong identity effects are expected to apply to as phage targeting these 
bacterial cells will contribute more than average to the efficacy of the phage 
cocktail, suggesting it is important that phage therapies are designed to target a 
broad range of patient-specific bacterial genotypes (Pirnay et al., 2010). By 
combining these concepts into rational design principles, phage cocktails could 
be optimised to both target a broad range of host genotypes and maximise 
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functional diversity to create highly effective phage cocktails, which minimise 
resistance evolution, with minimal phage richness.  
A broader range of bacterial resistance mechanisms may be encountered in vivo, 
including adaptive resistance mechanisms such as CRISPR (Horvath and 
Barrangou, 2010). Unlike surface modification resistance mutations, CRISPR-
mediated resistance is likely to promote different cross-resistance interactions 
between phages due to their genetic similarity rather than their functionality (i.e. 
receptor target for adsorption). Additionally, inducible resistance mechanisms 
may be preferentially selected in vivo, if they impose fewer fitness compared to 
surface modification (Westra et al., 2015). This suggests that whilst functional 
diversity of phage strains is necessary to limit the evolution of cross-resistance 
via surface modification, maximising genetic diversity could be important to limit 
cross-resistance via alternative resistance mechanisms.  
Using a novel analysis method (‘pathway analysis’, see Figure 5.1) we 
determined how stepwise transitions in community structure changed phage 
cocktail efficacy. This analysis revealed that the largest improvements in cocktail 
efficacy were achieved by addition of phage strains which do not promote cross-
resistance to other phages already present in the cocktail. However, it was not 
necessary to completely restrict cross-resistance interactions to improve 
community function, as novel asymmetrical interactions were also beneficial to 
the overall efficacy. As asymmetrical cross-resistance is more common between 
Type IV pilus-binding phage than between LPS-binding phage (Chapter 3), which 
are more likely to promote symmetrical cross-resistance to one another, this may 
explain why minimal communities of pilus-binding phage had high efficacy, 
whereas even 6-phage communities were unable to completely suppress 
bacterial growth for combinations of phages that all targeted the LPS. Receptor 
loss may impose much higher fitness costs in vivo, due to pleiotropic effects 
(Bohannan et al., 2002; Scanlan et al., 2015a) and the requirement of a wider 
range of traits for fitness in more complex environments (Skurnik et al., 2013; 
Smith et al., 2006; Winstanley et al., 2016). We may, therefore, expect to observe 
a higher frequency of asymmetrical cross-resistance in complex environments 
where complete loss of a receptor is associated with severe fitness costs in the 
bacterium.  
Overall, we show that effective phage combinations maximise functional diversity 
in terms of receptors targeted for adsorption because this limits the evolution of 
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cross-resistance. We observed complementarity of phage combinations with high 
functional diversity, allowing them to outperform their best constituents even at 
low phage diversity, suggesting that highly effective combinations do not require 
high species diversity. Whilst other factors such as phylogenetic relatedness 
among phages and strong phage identity effects may play a role in determining 
efficacy in vivo, functional diversity provides a fundamental basis for phage 
cocktail design. Low diversity phage combinations which maximise functional 
diversity have the potential to simplify the design, manufacturing and regulatory 
requirements for therapeutic cocktails whilst optimising their efficacy and 
therefore warrant further investigation.   
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Chapter Six 
Discussion 
Lytic infection by phages regulates bacterial density and therefore phages shape 
the structure of microbial communities across a wide range of ecosystems, 
including within some clinical bacterial infections (James et al., 2015; Levin and 
Bull, 2004; Weinbauer and Rassoulzadegan, 2004). Phages may provide 
alternative or complementary therapies to replace or augment antibiotic 
treatments that are becoming less effective due to high rates of resistance (Chan 
et al., 2013; Torres-Barceló and Hochberg, 2016; World Health Organization, 
2014). Like antibiotics, bacteria readily evolve resistance to phages, thus to 
ensure that phage therapies are sustainable in the face of resistance evolution 
we must understand the ecological and evolutionary processes governing the 
emergence of phage resistance in bacteria. In this thesis, I explored how bacteria-
phage infection networks (BPINs) are influenced by environmental factors, and 
how the genetic mechanisms which promote cross-resistance underpin the 
structure of bacteria-phage communities and are likely to influence phage 
therapies. Imbalances in selection pressures at low resource levels, magnified by 
increased encounters in mixed environments, destabilised bacteria-phage co-
evolution and drove phage to extinction, in Pseudomonas fluorescens SBW25- 
phage F2 populations (Chapter 2). Network analysis of these populations through 
time revealed that phage populations were rescued by reinvasion of phage-
susceptible bacterial genotypes that swept through the population to high 
frequency (Chapter 2). This demonstrates that BPIN structures are dynamic 
through time, shaped by coevolutionary dynamics, and significantly influenced by 
the abiotic environment. Next, I characterised the genetic interactions which 
underpin BPIN structure, by assessing the structure of cross-resistance evolution 
by Pseudomonas aeruginosa PAO1 against a panel of 27 lytic phage strains. 
Cross-resistance was common between phage strains which adsorb to the same 
bacterial receptors, creating a modular cross-resistance network defined by 
phage target receptors (Chapter 3). The genetic basis of resistance was further 
explored by comparing the evolution of resistance under sequential versus 
simultaneous exposure to multiple phages. Whilst sequential exposure allowed 
the accumulation of multiple receptor-specific mutations which promoted strong 
resistances against both phages, simultaneous exposure to phages results in 
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weaker resistances, but imposed similar fitness costs (Chapter 4). Finally, I 
assessed the influence of phage diversity on the efficacy of phage combinations 
to suppress bacterial growth and found that highly effective combinations are 
characterised by high functional diversity (i.e. target multiple different adsorption 
receptors) (Chapter 5). These data provide insight into the mechanisms which 
drive resistance evolution against combinations of multiple phages and may be 
exploited to aid the rational design of phage cocktails to improve the efficacy and 
durability of phage therapy.  
6.1 Insights into community structure from network analysis 
6.1.1  Community structure is determined by resistance interactions 
We implemented two forms of network analysis to characterise the community 
structure of bacteria-phage interactions at the population level (Chapter 2), and 
at a genetic level, to show how cross-resistance evolution influences community 
structure (Chapter 3). Differences in connectance (i.e. the proportion of realised 
links) and the mean strength of interactions within bipartite bacteria phage-
infection networks (BPINs) of P. fluorescens SBW25 and phage F2, helped to 
reveal the mechanism of phage extinction in low resource communities; 
increased connectance with reduced interaction strengths indicate that highly 
phage susceptible bacterial genotypes sweep through the population to rescue 
phage from extinction (Chapter 2). To understand the more fundamental 
processes underlying phage resistance, and the mechanisms which promote 
cross-resistance in particular, we characterised the evolution of cross-resistance 
by Pseudomonas aeruginosa PAO1 against 27 different lytic phages, to produce 
a cross-resistance network (Chapter 3). This network elucidates the gene-gene 
interactions which underpin BPIN structure, specifically, how modification of 
bacterial cell-surface receptors has the potential to influence numerous 
interacting phage species. Therefore, a logical next step would be to investigate 
the genetic interactions between phage strains, and how this influences infectivity 
and host range, and gain a better understanding of how bacterial cross-resistance 
and phage cross-infectivity networks influence BPIN structure and bacteria-
phage co-evolution at the community level.  
6.1.2   Network parameters may be influenced by environmental context 
The modular structure of the cross-resistance network characterised in Chapter 
3 was determined by surface-modification based resistance evolution; cross-
resistance was more likely between phages which adsorb to the same receptor 
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than between phages using different receptors, as resistance was acquired by 
mutations which resulted in modification or loss of the adsorption receptor. 
Therefore, bacteria which have alternative resistance mechanisms may promote 
changes in the modularity of cross-resistance. Further, as the expression of 
different resistance mechanisms may vary across ecological landscapes 
depending on the relative investment in constitutive versus inducible defences 
(Westra et al., 2015), modularity is likely to be dynamic, depending on the 
variability and expression of different phage-resistance mechanisms present in 
the population.  
6.1.3   Future directions for network analysis in bacteria-phage interactions 
Network analysis is a highly adaptable tool which has the potential to uncover key 
ecological and evolutionary dynamics within bacteria-phage interactions. Cross-
resistance interactions are likely to be highly dependent on species diversity of 
both bacteria and phage. Multiple phages can interact synergistically (Schmerer 
et al., 2014), or may compete by interfering for lytic infection by exclusion 
(Dulbecco, 1952; Labrie et al., 2010) or by promoting phage lifestyle switches 
[e.g. choice between lytic and lysogenic infection, (Erez et al., 2017)]. Therefore, 
future experiments should consider variation in species diversity and adaptability 
as key factors which determine cross-resistance structure. Further, assessing the 
abiotic factors which influence connectance within BPINs and CR networks could 
improve our understanding of the structural dynamics of natural bacteria-phage 
populations, and how they remain robust to environmental and evolutionary 
changes. In relation to phage therapy, network analysis tools have the potential 
to identify key members of the pathogen community (i.e. hubs), which could be 
targeted to destabilise the bacterial community (e.g. Agler et al., 2016) and 
improve the chances of successful treatment. As many infections consist of 
communities of different species, creating a ‘pathobiome’ (Vayssier-Taussat et 
al., 2014), removing one species may destabilise the community sufficiently to 
allow the infection to be cleared by the patients’ immune system, or by antibiotic 
treatment. Additionally, by identifying how bacterial diversity influences the 
modularity of cross-resistance networks, phage therapies could be optimised to 
limit the evolution of resistance in more complex environments. 
6.2 Genetic basis of resistance determines network modularity 
6.2.1 Directional networks reveal cross-resistance asymmetry 
Previous studies have shown that cross-resistance, where resistance to a focal 
phage strain additionally protects the host from other phages, can result from the 
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modification of cell-surface receptors impeding phage adsorption (Betts et al., 
2016a; Lenski, 1984, 1988), and even increase susceptibility to antibiotics (Chan 
et al., 2016). Using directional cross-resistance networks, we have shown that 
cross-resistance isn’t always reciprocal, and asymmetrical interactions can 
frequently occur (Chapter 3). The evolution of asymmetry may simply be a 
product of the frequency at which different genes are mutated, and the strength 
of focal resistance they provide. If mutations in global regulators, such as RpoN 
(Lloyd et al., 2017; Totten et al., 1990), can provide the same degree of resistance 
as receptor-specific mutations, then a higher proportion of resistant genotypes 
may offer cross-resistance against phages targeting other receptors (Chapter 3). 
Resistance mutations targeting the same biosynthesis pathway, but at different 
positions, may determine the degree of cross-resistance provided to phage 
adsorbing to the same receptor. For Type IV pilus-binding phages, mutations near 
the end of the pathway, only affecting individual pilus components such as the 
motor proteins encoded by pilB and pilT (Chiang et al., 2008) provided weaker 
cross-resistance compared to mutations disrupting expression of pilus-specific 
genes, via RpoN and the two-component system which activates it (encoded by 
pilS and pilR; Hobbs et al., 1993) (Chapter 3). Although the specific mechanism 
is yet to be determined, we observed a similar effect for LPS-binding phages; 
whereas wzy mutations affecting biosynthesis of the LPS B-band (Islam et al., 
2010) provide strong cross-resistance to multiple LPS phages (Chapters 3 and 
4), mutations affecting rmlA, a thymidylyltransferase involved in LPS production 
(Rahim et al., 2000), provided weaker cross-resistance to other LPS-binding 
phages (Chapter 4). Further work is necessary to fully characterise the 
phenomenon of asymmetrical cross-resistance and determine its influence on 
microbial community structure and the evolution of phage resistance.  
6.2.2 Local context may determine network structure 
If the likelihood of asymmetrical cross-resistance is determined by the mutational 
landscape available to the host, then the structure of cross-resistance is likely to 
be strongly influenced by the local environmental context. For example, increased 
population sizes at high resource levels increase the mutational supply available 
to both bacteria and phage populations, providing larger genetic reservoirs for 
adaptation (Lopez Pascua et al., 2014; Lopez-Pascua and Buckling, 2008). The 
rate of bacterial adaptation may increase in more complex environments, such as 
in the presence of multiple phages (Betts et al., 2018), which could potentially 
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drive rapid changes in the structure of bacteria-phage communities and influence 
the potential of cross-resistance evolution.  
Conflicting selection pressures in complex environments are likely to constrain 
the evolution of cross-resistance where high fitness costs are incurred, for 
example if resistance mutations which provide cross-resistance negatively 
influence other traits such as nutrient uptake (Bohannan et al., 2002). Chronic 
bacterial infections provide an ideal study system for bacterial adaptation within 
a complex ecological setting, and can help us to assess the constraints upon 
resistance evolution in vivo: a diverse range of bacterial traits arise and coexist 
during adaption to the abiotic environment (i.e. nutrient availability and spatial 
structures) (Winstanley et al., 2016), the local microbiota (Duan et al., 2003), co-
infecting pathogens (Cox et al., 2010; Harrison, 2007), and attack by the host 
immune system and antibiotic treatments (Smith et al., 2006). Therefore, the 
fitness costs of phage resistance are likely to be inflated if they impose trade-offs 
in other expressed traits (Bohannan et al., 2002; Scanlan et al., 2015b). For 
example, this is likely to moderate the degree of surface modification; we 
commonly observed resistance genotypes with significantly impaired twitching 
motility, due to loss or significant modification of Type IV pilus (Chapter 3), 
however, if smaller structural changes can limit phage adsorption at lower cost, 
these are likely to be preferentially selected in vivo. Broader pleiotropic effects in 
complex environments, due to the requirement for bacterial expression of a 
greater number of traits, may also limit the evolution of between-module cross-
resistance. The increased fitness costs imposed by mutations in global regulators 
compared to receptor-specific mutations (Chapter 3), suggest that the spread of 
broadly cross-resistant genotypes may be constrained in vivo. Specifically, we 
observed mutations in the gene encoding the alternative sigma factor RpoN, 
which regulates the expression of nearly 700 genes, and influences a broad range 
of traits including motility, biofilm formation and production of molecules which co-
ordinate quorum sensing such as pyocyanin and pyoverdine (Lloyd et al., 2017). 
Therefore, mutations in rpoN are likely to have strongly negative pleiotropic 
effects in vivo, and may also moderate bacterial virulence (Lloyd et al., 2017). 
However, it is unclear how prolonged exposure to phages may influence this 
process, as more costly resistances may dominate if strong selection for phage 
resistance is sustained, and could potentially be ameliorated by the acquisition of 
compensatory mutations (Levin et al., 2000). Future experimental work is needed 
to understand how the fitness costs associated with phage resistance specifically 
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may be ameliorated, but there is a broad range of evidence demonstrating the 
occurrence of compensation mutations which ameliorate the fitness effects of 
antibiotic costs (Andersson and Hughes, 2010). Overall, this suggests that the 
evolution of cross-resistance may be more limited in more complex environments, 
promoting more modular network structures through prevalence of asymmetrical 
interactions. However, further work is necessary to determine how conflicting 
selection pressures may influence the fitness costs associated with phage 
resistance and alter the structure of cross-resistance within natural microbial 
communities.  
6.3 Rational design of phage therapeutics 
6.3.1  Maximising functional diversity limits the evolution of cross-resistance 
The bacterial surface receptor to which a phage adsorbs determines its host 
range, and as such is a key determinant of phage function. We found that phage 
combinations which have high functional diversity (i.e. target multiple different 
adsorption receptors) promote the least cross resistance to one other (Chapter 
3), and hence limit the evolution of resistance as multiple resistance mutations 
are required to provide strong specific resistance to each phage (Chapter 4). Both 
pairwise combinations (Chapter 3) and higher order phage combinations 
(Chapter 5) more effectively suppressed bacterial growth when functional 
diversity was maximised. Further, lower diversity phage combinations were 
required to achieve maximum suppression of bacterial growth when functional 
diversity was high. This suggests that phage cocktails can be rationally designed 
with fewer members targeting multiple distinct bacterial receptors, which would 
simplify the design and production of phage therapies making them easier to 
regulate (Sybesma et al., 2018).  
6.3.2 Functional diversity as an important predictor of treatment success 
In more complex systems, such as chronic infection of the cystic fibrosis lung, 
where adaptation to the local environment may influence expression and 
modification of cell-surface receptors resulting in diverse bacterial populations 
(Burns et al., 2001; Hancock et al., 1983; Harrison, 2007; Mahenthiralingam et 
al., 1994), phage functional diversity may be important to maximise the host range 
of phage cocktails. The pleiotropic effects of phage resistance mutations 
(Bohannan et al., 2002; Scanlan et al., 2015b) may result in inflated fitness costs 
within more complex environments, due to the broad range of traits required for 
survival and adaptation (Cornforth et al., 2018; Skurnik et al., 2013; Winstanley 
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et al., 2016). Hence, similarly to the concept of combinations therapies which 
combine antibiotics and phage to impose divergent selection pressures upon the 
bacterium thus limiting their capacity to adapt (Chan et al., 2016; Torres-Barceló 
and Hochberg, 2016), phage cocktails which target multiple adsorption receptors 
may limit the evolution of resistance even more strongly in vivo than we observed 
in vitro (Chapters 3 and 5). In these experiments, we observed complete 
suppression of bacterial growth by a phage combination with a functional diversity 
of 2 (i.e. targeting LPS and Type IV pilus only) (Chapter 5). Therefore, 
incorporating additional phage to increase functional diversity further [i.e. those 
targeting other membrane receptor such as TonB and OprM (Betts et al., 2018; 
Chan et al., 2016)], may further optimise phage combinations and help buffer any 
unforeseen adverse effects encountered in vivo. Overall, this suggests that phage 
combinations with high functional diversity may be even more effective in vivo, by 
targeting a broader range of hosts, and limiting the evolution of resistance, 
improving the evolutionary durability of the treatment.  
Additionally, reduced virulence appears to be a common collateral effect 
associated with phage resistance (Castillo et al., 2014; Laanto et al., 2012; León 
and Bastías, 2015). Phage adsorption receptors commonly contribute towards 
bacterial virulence, therefore by promoting modification or loss of these targets, 
phage therapy may moderate bacterial virulence, providing an additional benefit 
compared to antibiotic treatments. Both LPS and Type IV pilus influence the 
virulence of P. aeruginosa: LPS is a major virulence factor which elicits host 
inflammatory responses (Pier, 2007), and Type IV pilus promotes attachment to 
epithelial cells to aid colonisation of the host (Hahn, 1997). We have observed 
accumulation of resistance mutations against both of these targets within the 
same bacterium (Chapter 4) in addition to mutations affecting the global regulator, 
RpoN, which influences a broad range of virulence associated traits including 
motility and biofilm formation (Chapter 3, Lloyd et al., 2017), suggesting that 
phage combinations can result in modification of multiple virulence traits. 
Therefore, by combining phages which target multiple receptors which contribute 
towards bacterial virulence, phage therapy may substantially attenuate virulence 
of the bacterial host.  
6.3.3 Sequential or simultaneous application? 
Imamovic and Sommer (2013) developed sequential antibiotic treatment 
pathways which can optimise antibiotic use by minimising collateral resistance 
and maximising collateral sensitivity. However, it is unclear if this would also work 
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for phage therapies. A previous study investigating the effect of sequential phage 
administration to treat P. aeruginosa infections found that sequential phage 
treatments could perform as effectively as simultaneous treatments in vitro, 
however, they found that simultaneous application of phages was more effective 
than sequential treatments in a waxmoth model  (Hall et al., 2012).  We found 
that sequential exposure to phage pairs provided stronger phage-specific 
resistances through acquisition of multiple receptor-modifying mutations, 
whereas simultaneous exposure to phages resulted in weaker resistance to both 
phages (Chapter 4). Surprisingly, however, simultaneously selected resistances 
imposed similar fitness costs on average compared to those acquired 
sequentially, although directional effects of sequential treatments could 
potentially be exploited to maximise fitness costs imposed upon multiply resistant 
genotypes (Chapter 4). Unfortunately, we were unable to measure collateral 
sensitivity within our system, as the ancestral PAO1 strain is already highly 
susceptible to all phages used in this thesis, therefore further investigation 
including a more diverse range of host resistances is necessary to determine 
whether phage resistances can promote sensitivity to other strains in a similar 
manner as increasing antibiotic sensitivity (Chan et al., 2016). Whilst this 
suggests that simultaneous exposure to phages may constrain the evolution of 
resistance more so than sequential exposure, a fuller understanding of the 
relative fitness costs of sequentially and simultaneously selected resistance in 
vivo, and the potential interactions between specific mutations which promote 
negative epistasis, are needed to assess the implications for phage therapy.  
6.3.4 Maximise genetic diversity or functional diversity? 
The range of phage resistance mechanisms available to the bacteria will likely 
determine the structure of cross-resistance, and may therefore alter the relative 
contribution of genetic and functional diversities towards phage cocktail efficacy. 
For example, CRIPSR is a form of adaptive immunity, whereby the bacterial host 
can recognise and degrade phage DNA if it has previously been identified as 
‘foreign’ and stored as a CRISPR spacer (Barrangou et al., 2007; Horvath and 
Barrangou, 2010). Whilst receptor-based cross-resistance has the potential to 
protect the host from genetically distant phage, only requiring similarity in receptor 
binding sites within tail-fibres, cross-resistance in a CRISPR context may be 
stronger between genetically similar phages. As such, a different modular 
network may be created, grouping phages by phylogeny. Therefore, for phage 
therapy in the context of a bacterial infection, the relative importance of genetic 
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diversity and functional diversity on treatment efficacy will be dependent on the 
diversity of available phage resistance mechanisms, and therefore both forms of 
diversity should be maximised to produce effective cocktails. It is also important 
that pathogen diversity within the patient is fully characterised to enable the 
rational design of personalised treatments (e.g. Pirnay et al., 2010). A better 
understanding of cross-resistance structure, and the relative cost of different 
resistance mechanisms, in complex environments is needed to determine 
principles of rational cocktail design which promote both functional and genetic 
diversity.   
6.3.5 Limiting the evolution of phage resistance 
Bacterial infections are complex, and may vary as much between patients as 
through time in a single patient. Therefore, to maximise the chance of successful 
treatment using phage therapeutics, we must design phage treatments to suit 
specific needs. One of the main considerations must be the potential for 
resistance evolution, which is influenced to a great extent by the genetic diversity 
of the pathogen, which in turn may be determined by the context of disease. In 
contrast to our experimentally derived resistant mutants, which are spontaneous 
mutants selected from a lab-adapted bacterial strain allowed to proliferate and 
develop population diversity over just 24-48h, chronic infections are established 
over long time periods (perhaps years) and as such can develop very high levels 
of genetic diversity as the pathogen adapts to the local ecological conditions (both 
biotic and abiotic; see section 6.2.2). Within this genetically diverse population, 
phage-resistant mutants likely already dwell, and may also have accumulated 
mutations which ameliorate their fitness (Andersson and Hughes, 2010). The 
results presented in this thesis provide a number of potential strategies which 
may limit the evolution of resistance in such circumstances. Maximising phage 
functional diversity to limit the potential for cross-resistance increases the 
chances that bacterial genotypes which have resistance to numerous phage 
strains within a combination treatment are present. However, this may be further 
optimised by strategic implementation of phage treatments. For example, 
simultaneous applications with numerous phage strains require either very high 
doses to be administered, or in situ propagation of the phage within the infection 
site to ensure that bacterial genotypes which are susceptible to a single phage 
(or subset of phages) within a diverse cocktail actually encounter phage strains 
to which they are susceptible. Although these same factors would also influence 
the efficacy of single phage treatments, our data has indicated that sequential 
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exposure to single phage strains may select for stronger phage-specific 
resistance mutations which impose greater fitness costs, and therefore sequential 
treatments with phages which are functionally diverse, permitting time for phage 
in situ propagation between treatments, may be better able to treat infections 
where the pathogen community is highly diverse. However, future experimental 
work and clinical trials are necessary to determine the extent of phage 
propagation within an infection site and to optimise dosing strategies for phage 
application.  
6.3.6 Practical implementation of phage therapy – future directions 
Phage therapy is not a new idea, but more work is necessary to develop a broadly 
implementable methodology which meets the regulatory requirements of the 
western world. As a priority we must start to assess the practical application of 
single phage strains within clinical settings, focussing on the treatment of acute 
single species infections would allow optimisation of dosage and assessment of 
safety. Whilst phage therapies implemented in Eastern Europe are often under-
documented and lack the rigorous clinical trials required in the UK, we can learn 
from their success: broad range cocktails, such as those commercially produced 
by the Eliava Institute in Georgia (see Section 1.6.1), are regularly updated by 
testing newly isolated phages against pathogenic bacterial strains in current 
circulation. This type of rapid and recurrent adaptation of therapeutic cocktails 
would not be possible under our current Good Manufacturing Practices which are 
applied to pharmaceutical products, and can retain novel products within the 
development pipeline for many years. Several options are available to overcome 
these issues. We can either adopt an alternative regulatory framework for phage 
treatments (see section 1.5.4 for a successful example of this in Belgium), or 
develop phage treatments which are more durable to the inevitable evolution of 
phage resistance. One way in which we can do this is to minimise the number of 
phage required to optimise the efficacy of phage treatments by maximising 
functional diversity of phage strains. The results presented in Chapters 5 
demonstrate that phages which target different bacterial receptors have a 
complementary effect, primarily by limiting the evolution of cross-resistance, 
meaning that cocktails with a low species diversity can have high efficacy. 
However, much further work is needed to fully understand the complexities of 
these interactions, for example, whilst it seems clear that combinations which do 
not promote cross-resistance should be favoured, we do not fully understand the 
mechanistic basis of asymmetrical cross-resistance.  
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6.4 Conclusions 
Bacteria-phage interactions shape microbial communities in both ecological and 
clinical scenarios. As such, it is important that we determine the factors which 
influence community structures, and their resilience to perturbations, to better 
understand how microbial communities function and how bacterial infections can 
be sustainably treated with phages. This work highlights the power of network 
analyses to characterise community structures and uncover the mechanisms 
which drive the evolution of resistance to multiple phages. Further, an 
understanding of these fundamental processes can aid the rational design of 
phage treatments, to both maximise the efficacy with which bacterial growth is 
suppressed and limiting the evolution of phage resistance to improve their 
evolutionary robustness.  
Whilst we have determined a number of useful concepts to aid the rational design 
of phage therapies, further work is required to assess how these mechanisms 
may be influenced within complex in vivo environments. The simplest of these 
concepts to implement in cocktail design is maximisation of functional diversity; 
by combining phage strains which target different adsorption receptors, phage 
cocktails can be optimised with fewer members. Additionally, our work suggests 
that simultaneously application of phages may better constrain resistance 
evolution compared to sequential treatments. Both of these outcomes simplify the 
design of phage cocktails, which would hopefully minimise the regulatory hurdles 
facing phage therapy legislation and shorten the timeframe for phage therapy 
implementation in the EU. A more complete picture of cross-resistance evolution 
in vivo is necessary to determine the relative importance of each mechanism in 
the design of phage cocktails, but this works suggests that there are fundamental 
processes which can be harnessed to limit the evolution of resistance and 
optimise phage treatments.   
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Appendix A (Chapter Three) 
 
 
 
Figure S3.1. Relative bacterial growth (RBG) distributions and binary 
resistance threshold. The frequency histogram shows the relative bacterial 
growth values for 263 resistant mutants against all 27 phages.  The blue curve 
shows the normal distribution of the resistance peak (RBG=1). The threshold of 
binary resistance was calculated as the 95% confidence interval of the normal 
distribution (blue dashed line; RBG=0.798).  
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Figure S3.2. Growth curves showing the fitness impact of resistance 
mutations. Growth curves of all 263 spontaneous resistant mutants grouped by 
focal phage resistance (up to 10 mutants per focal phage), and the wild type 
ancestor (PAO1).  
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Figure S3.3. Frequency histograms of growth parameters for PAO1 and 
resistant mutants. Frequency histograms of growth parameters extracted from 
the bacterial growth curves (S10 Fig): maximum absorbance reached in 24 hours 
(OD600), lag period calculated as x-axis intercept (time, hours) of a tangent to 
the growth curve at the point of maximum growth rate, maximum growth rate, and 
integral of growth curve. Red histogram shows the wild type PAO1 ancestor, and 
blue shows 263 spontaneous resistant mutants.  
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Figure S3.4. Correlation of growth parameters. Multiple linear regression of 
growth parameters for 263 spontaneous resistant mutants (S11 Fig): the diagonal 
shows the distribution of each growth parameter, the bottom quadrant plots 
correlations for each pair of growth parameters, and the top quadrant gives 
corresponding R2 values.  
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Figure S3.5. Cross-resistance subnetwork. A subset of the cross-resistance 
network showing all pairwise cross-resistance interactions between the ten phage 
strains used in the mutational frequency experiment and the suppression of 
bacterial growth assays.  
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Figure S3.6. Bacteria phage infection network. Infection network showing 
resistance profiles of spontaneous mutants selected against individual phage. 
Spontaneous PA01 mutants are grouped so that each row represents up to 10 
replicates selected against the same phage. Each column denotes individual 
phage strains which mutants were individually challenged against. Colour 
shading corresponds to the proportion of replicates which were susceptible to the 
corresponding phage (see key). 
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Figure S3.7. Characterisation of phage genetic diversity. A) Banding patterns 
produced by RAPD PCR (random amplified polymorphic DNA) analysis of 27 
phages (columns) by the molecular weight of PCR products from 9 different 
primers (rows; S3 Table). B) Difference matrix summarising the dissimilarity of 
banding patterns between phages (i.e. 1 - proportion of bands in common). C) 
Neighbour-joining tree produced from the phage dissimilarity matrix.  
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Figure S3.8. Cross-resistance network structure at different resistance 
thresholds. Number and type of links between phage pairs within and between 
each cross-resistance module for different values of the binary threshold of 
resistance.   
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Figure S3.9. Phage infection of PAO1 versus a pilB transposon mutant. 
Plaque forming units per ml when plated on the piliated wildtype (Black; 
‘Ancestor’) and the unpiliated pilB transposon mutant (Grey).  
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Figure S3.10. Cross-resistance profiles of sequenced resistant mutants. 
Bacteria phage infection network showing sequenced resistant mutants where 
gene location of SNPs are identified (rows), against 27 phage strains (columns). 
Strength of resistance (RBG) scales from complete resistance (white) to complete 
susceptibility (dark blue).  
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Figure S3.11. Absolute frequencies of resistance mutations against phage 
pairs. Frequency of resistance mutations against single phage (+) and phage 
pairs coloured by cross-resistance type associated with each phage pair (blue - 
no cross resistance; green - asymmetrical cross-resistance; red - symmetrical 
cross-resistance).  
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Figure S3.12. Suppression of bacterial growth by phage monocultures and 
pairwise phage combinations. Bacterial density was measured as OD (600nm, 
y-axis) over 24 hours (x-axis) in the presence of single phages (white 
background), or two phages (grey backgrounds). Dark grey background denotes 
phage pairs that exert symmetric cross-resistance, mid grey for phage pairs that 
show asymmetric cross-resistance, and light grey for no observed cross-
resistance.   
Symmetrical cross resistance
 120 
 
Table S3.1.  Overview of phage strains. Details of the isolation and 
characterisation of the phage collection.  
Strain Source Date	first	
isolated
Isolation	Host Morphotype Genome	size	
(kb)
Accession	
number
KZ Sewage	water,	
Kazakhstan
1975 Myoviridae 280.33 NC_004629.1
PNM Mtkvari	River,	
Tbilisi,	Georgia
1999 Podoviridae 42.72 -
PT7 Lake	Ku,	Tibilisi,	
Georgia
1999 Myoviridae 58.2 -
"14/1" Sewage	water,	
Regensburg,	
Germany
2000 Myoviridae 66.23 NC_011703.1
PA1P1 Pseudomonas	aeruginosa	
61841
- - -
PA1P2 Pseudomonas	aeruginosa	
61841
- - -
PA1P3 Pseudomonas	aeruginosa	
61841
- 66.46 -
PA1P4 Pseudomonas	aeruginosa	
61841
- - -
PA1P5 Pseudomonas	aeruginosa	
61841
- - -
PA2P1 Pseudomonas	aeruginosa	
61823
- - -
PA4P2 Pseudomonas	aeruginosa	
61432
- - -
PA5P1 Pseudomonas	aeruginosa	
11AN03663
- - -
PA5P2 Pseudomonas	aeruginosa	
11AN03663
- - -
PA7P1 Pseudomonas	aeruginosa	
62314
- - -
PA7P2 Pseudomonas	aeruginosa	
62314
- - -
PA8P1 Pseudomonas	aeruginosa	
62263
- - -
PA8P2 Pseudomonas	aeruginosa	
62263
- - -
PA10P1 Pseudomonas	aeruginosa	
62206
- - -
PA10P2 Pseudomonas	aeruginosa	
62206
- - -
PA10P3 Pseudomonas	aeruginosa	
62206
- - -
PA11P1 Pseudomonas	aeruginosa	
62180
- 66.06 -
PA11P2 Pseudomonas	aeruginosa	
62180
- - -
PA12P1 Pseudomonas	aeruginosa	
62181
- - -
PA12P2 Pseudomonas	aeruginosa	
62181	
- - -
PA13P1 Pseudomonas	aeruginosa	
62172
- - -
PA13P2 Pseudomonas	aeruginosa	
62172
- - -
PA14P2 Pseudomonas	aeruginosa	
62109
- - -
Sewage	water,	
Jyväskylä,	Finland
2015
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Table S3.2.  RAPD PCR primers 
Primers used in the RAPD-PCR analysis of phage genetic relatedness. 
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Appendix B (Chapter Four) 
 
Table S4.1. Identity and function of genes where mutations were identified  
Category Gene name Operon/cluster Gene product activity Chromosome 
position (bp)
Effect type Putative 
impact
Treatment Ancestor
2215599-
2215679
deleton (80bp) HIGH PA5P2->14/1 PAO1_FT2
2215816 stop gained HIGH PA5P2->14/1 PAO1_FT1
14/1 PAO1_FT3
14/1->PA10P2 PAO1_FT3
PA5004 
(wapH)
PA5005-PA5004-
PA5003-PA5002-
PA5001
probable glycosyl 
transferase
5622353-
5622444
deletion (91bp) HIGH PA10P2->14/1 PAO1_FT3
PA10P2 PAO1_FT3
PA10P2->14/1 PAO1_FT3
PA10P2+14/1 PAO1_FT2
PA5P2+14/1 PAO1_FT2
PA10P2 PAO1_FT2
PA10P2->14/1 PAO1_FT2
PA10P2->PA5P2 PAO1_FT2
14/1 PAO1_FT1
14/1->PA5P2 PAO1_FT1
14/1->PA10P2 PAO1_FT1
14/1 PAO1_FT2
14/1->PA5P2 PAO1_FT2
14/1->PA10P2 PAO1_FT2
PA5P2->PA10P2 PAO1_FT1
PA10P2 PAO1_FT1
PA10P2+14/1 PAO1_FT3
PA5P2->14/1 PAO1_FT3
PA5P2->PA10P2 PAO1_FT2
PA5P2->PA10P2 PAO1_FT3
PA5P2+PA10P2 PAO1_FT3
PA5P2+PA10P2 PAO1_FT2
PA10P2->14/1 PAO1_FT1
PA10P2->PA5P2 PAO1_FT1
PA5P2 PAO1_FT3
PA5P2->14/1 PAO1_FT3
PA5P2->PA10P2 PAO1_FT3
PA10P2->PA5P2 PAO1_FT1
pilE fimU-pilV-pilW-pilX-
pilY1-pilY2-pilE
minor pilin 5104842 conservative 
inframe 
insertion (12bp)
MODERATE 14/1->PA5P2 PAO1_FT1
PA5P2 PAO1_FT2
PA5P2->14/1 PAO1_FT2
PA5P2->PA10P2 PAO1_FT2
PA5P2 PAO1_FT1
PA5P2->14/1 PAO1_FT1
PA5P2->PA10P2 PAO1_FT1
pilT+pilU twitching motility 
proteins
437058-438250 deletion 
(1,192bp)
HIGH 14/1->PA5P2 PAO1_FT2
5101958 stop gained HIGH PA10P2->PA5P2 PAO1_FT2
5103165 frameshift HIGH PA10P2+14/1 PAO1_FT1
PA0142-nuh 163275 intergenic MODIFIER PA10P2+14/1 PAO1_FT3
480379 missense 
variant
MODERATE PA10P2->14/1 PAO1_FT2
480952 stop gained HIGH PA10P2->14/1 PAO1_FT1
PA0845-
PA0846
intergenic 923945 intergenic MODIFIER PA5P2->PA10P2 PAO1_FT2
PA1065 unknown 1151442 missense 
variant
MODERATE PA10P2+14/1 PAO1_FT3
PA1567 predicted oxidation-
reduction activity
1709197 conservative 
inframe 
insertion (6bp)
MODERATE PA5P2->14/1 PAO1_FT3
PA3722-
PA3723
4167572 intergenic MODIFIER PA10P2+14/1 PAO1_FT1
PA5P2 PAO1_FT3
PA5P2->14/1 PAO1_FT3
PA5P2->PA10P2 PAO1_FT3
PA5P2+PA10P2 PAO1_FT3
PA5P2+PA10P2 PAO1_FT1
PA5P2+PA10P2 PAO1_FT3
PA5P2+PA10P2 PAO1_FT1
2194891-
2445323
large deletion 
(>250 kb)
PA10P2+14/1 PAO1_FT1
5812961 missense 
variant
Duplication and 
insertion
Duplication and 
insertion
frameshift HIGH
missense 
variant
MODERATE
missense 
variant
MODERATE
missense 
variant
MODERATE
missense 
variant
MODERATE
frameshift HIGH
galULPS 
biosynthesis
Type IV pilus 
biosynthesis
fimU-pilV-pilW-pilX-
pilY1-pilY2-pilE
putative anti-retraction 
factor 
MODERATE
stop gained HIGH
frameshift HIGH
frameshift HIGH
frameshift HIGH
Other gene 
variations
PA5001 
(Ssg)
wbpL
wzy
pilB
PA0429
PA4278
rmlA
Other
4746797-
4747035
3651299-
3651424
5618765
3529218
3538031
3538428
3538499
3538988
5070925
PA5005-PA5004-
PA5003-PA5002-
PA5001
wbp cluster
pilN
pilR
pilY1
UTP-glucose-1-phosphate 
uridylyltransferase
cell-surface sugar 
biosynthetic 
glycosyltransferase
inferred sporutlation-
related domain
birA-PA4279-PA4278
wbp cluster
glycosyltransferase
LPS B-band O-antigen 
polymerase
motor protein - pilus 
extension
type IV pilus assembly 
protein
pilM-pilN-pilO-pilP-
pilQ
pilS-pilR two-component 
response regulator
rmlB-rmlD-rmlA-rmlC glucose-1-phosphate 
thymidylyltransferase
predicted Nucleotide-
diphospho-sugar 
transferase
5679190
5095672
4786538
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Abbreviations 
Abi  
Abs  
AIC  
ANOVA  
ARD  
bp  
BPIN  
BREX  
CF  
CFU  
CR  
CRF  
CRI  
CRISPR  
DNA  
ERQ  
EU  
FRQ  
FSD  
GATK  
GLS  
kb  
KB  
LB  
LPS  
LS  
mb  
MF  
PCR  
PDR  
PFU  
PRI  
RAPD  
RBG  
RM  
RMF  
SE  
SNP  
Abortive infection 
Absorbance 
Akaike information criterion 
Analysis of variation 
Arms race dynamics 
Base pair 
Bacteria-phage infection network 
Bacteriophage exclusion 
Cystic fibrosis 
Colony forming units 
Cross-resistance 
Cross-resistance frequency 
Cross-resistance index  
Clustered regularly interspaced short palindromic repeats  
Deoxyribose nucleic acid 
Escalating Red Queen  
European Union 
Fluctuating Red Queen 
Fluctuating selection dynamics 
Genome analysis toolkit 
Generalised least squares 
Kilobase 
King’s Media B 
Luria broth 
Lipopolysaccharide 
Link strength 
Megabase 
Mutation frequency 
Polymerase chain reaction 
Pandrug resistance 
Plaque forming units  
Proportion of realised interactions 
Random amplification of polymorphic DNA 
Relative bacterial growth 
Restriction modification 
Relative mutation frequency 
Standard error 
Single nucleotide polymorphism 
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